UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

x

Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29 2017., 2023.

OR

OR

¨

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________.

Commission File Number 0-18655

EXPONENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

77-0218904

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

149 Commonwealth Drive, Menlo Park, California

94025

(Address of principal executive offices)

(Zip Code)

(650) (650) 326-9400

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, $0.001 par value $0.001 per share

The NASDAQ Stock

EXPO

Nasdaq Global Select Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes      No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes     No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes     No

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes x        No¨

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ¨        Nox

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yesx        No¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yesx        No¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerx

Accelerated filer¨

Non-accelerated filer¨

Smaller reporting company¨

Emerging growth company

(Do not check if a smaller

reporting company)

Emerging growth company¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨

Indicate by check mark whether the registrant ishas filed a shell company (as defined in Rule 12b-2report on and attestation to its management’s assessment of the Exchange Act).effectiveness of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

Yes¨        Nox

The aggregate market value of the common stock held by non-affiliates of the registrant based on the closing sales price of the common stock as reported on the NASDAQ Global Select Market on June 30, 2017,2023, the last business day of the registrant’s most recently completed second quarter, was $1,297,837,521.approximately $3.4 billion. Shares of the registrant’s common stock held by each executive officer and director and by each entity or person that, to the registrant’s knowledge, owned 10% or more of registrant’s outstanding common stock as of June 30, 20172023 have been excluded in that such persons may be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

The number of shares of the registrant’s common stock outstanding as of February 16, 20182024 was 25,769,113.50,563,193.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Definitive Proxy Statement for the registrant’s 20182023 Annual Meeting of Stockholders to be held on May 31, 2018June 7, 2024 are incorporated by reference into Part III of this Annual Report on Form 10-K.

Auditor Name: KPMG, LLP

Auditor Location: San Francisco, California

Audit Firm ID: 185


EXPONENT, INC.

FORM 10-K ANNUAL REPORT

FISCAL YEAR ENDED DECEMBERDecember 29, 20172023

TABLE OF CONTENTS

Page

PART I

Item 1.

Business

3Business

4

Item 1A.

Risk Factors

13

15

Item 1B.

Unresolved Staff Comments

17

23

Item 2.1C.

Properties

17Cybersecurity

24

Item 3.2.

Legal Proceedings

17Properties

25

Item 3.

Legal Proceedings

25

Item 4.

Mine Safety Disclosures

17

25

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of
Equity Securities

18

26

Item 6.

Selected Financial Data

20(Reserved)

27

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

20

28

Item 7A.

Quantitative and Qualitative Disclosures Aboutabout Market Risk

30

35

Item 8.

Financial Statements and Supplementary Data

31

36

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

31

36

Item 9A.

Controls and Procedures

31

36

Item 9B.

Other Information

31

36

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspection

36

PART III

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

31

37

Item 11.

Executive Compensation

32

37

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters

32

37

Item 13.

Certain Relationships and Related Transactions, and Director Independence

32

37

Item 14.

Principal Accounting Fees and Services

32

37

PART IV

Item 15.

Exhibits and Financial Statement Schedules

33

38

SignaturesExhibit Index

62

65

Exhibit IndexSignatures

63

67


FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended), including but not limited to statements regarding future growth and market opportunities, revenue, margins, headcount, utilization and operating expenses,amended (the “Exchange Act”) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, statements other than statements of current or historical fact are forward-looking statements. Thethe words “intend,” “anticipate,” “believe,” “estimate,” “continue”, “could”, “may”, “plan”, “expect” and similar expressions, as they relate to the Company or its management, identify certain of such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in this Annual Report under the heading “Risk Factors” and elsewhere.elsewhere in this Annual Report on Form 10-K.

2

The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligationdoes not intend to updaterelease publicly any updates or reviserevisions to any such forward-looking statements.

3


PART I

Item 1. Business

GENERAL

GENERAL

Exponent, Inc., together with its subsidiaries, (“Exponent”, the “Company”, “we”, “us” and “our”) is a science and engineering consulting firm that provides solutions to complex problems. Our multidisciplinaryinterdisciplinary team of scientists, physicians, engineers, and business and regulatory consultants brings togetherdraws from more than 90 different technical disciplines to solve the most pressing and complicated issueschallenges facing industrystakeholders today. The firm leverages over 50 years of experience in analyzing accidents and government today. Our services include analysisfailures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of product development, product recall, regulatory compliance,their users, and address the discoverychallenges of potential problems related to products, people, property and impending litigation.sustainability.

The history of Exponent, Inc. goes back to 1967, with the founding of the partnership Failure Analysis Associates, which was incorporated the following year in California and reincorporated in Delaware as Failure Analysis Associates, Inc. in 1988. The Failure Group, Inc. was organized in 1989 as a holding company for Failure Analysis Associates, Inc. and changed its name to Exponent, Inc. in 1998.

CLIENTS

CLIENTSGeneral

General

Exponent serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. Many of our engagements are initiated directly by large corporations or by lawyers or insurance companies whose clients anticipate, or are engaged in, litigation related to their products, equipment, processes or services. The scope of our services in failure prevention and technology evaluation has grown as the technological complexity of products has increased over the years. During fiscal 20172023, we provided services representing approximately 27%22%, 18%, 17% and 11% of revenues to clients in the consumer products industry. During fiscal 2017 we provided services representing approximately 15% of revenues to clients in theindustry, energy and utilities industries. During fiscal 2017 we provided services representing approximately 15% of revenues to clients in theindustries, transportation industry. No client accounted for more than 10% of our consolidated revenues for 2016industry and 2015. One client accounted for 14% of our consolidated revenues for 2017.chemical industry, respectively.

Pricing and Terms of Engagements

We provide our services on either a fixed-price basis or on a time and material basis, charging in the latter case hourly rates for each staff member involved in a project, based on his or hertheir skills and experience. Our standard rates for professionals range from $180$200 to $750$985 per hour. Our engagement agreements typically provide for monthly billing, require payment of our invoices within 30 days of receipt and permit clients to terminate engagements at any time. Clients normally agree to indemnify us and our personnel against liabilities arising out of the use or application of the results of our work or recommendations.

SERVICES

SERVICES

Exponent provides high quality engineering and scientific consulting services to clients around the world. Our service offerings are provided on a project-by-project basis. Many projects require support from multiple practices. We currently operate 18the following 17 practices in two reportable operating segments, (i) Engineering and Other Scientific and (ii) Environmental and Health:

ENGINEERING AND OTHER SCIENTIFIC

·Biomechanics
·Biomedical Engineering
·Buildings & Structures
·Civil Engineering
·Construction Consulting
·Electrical Engineering & Computer Science
·Human Factors
·Industrial Structures
·Materials & Corrosion Engineering
·Mechanical Engineering
·Polymer Science & Materials Chemistry
·Statistical & Data Sciences
·Thermal Sciences
·Vehicle Analysis

3
Biomechanics
Biomedical Engineering & Sciences
Buildings & Structures
Civil Engineering
Construction Consulting
Data Sciences
Electrical Engineering & Computer Science
Human Factors
Materials & Corrosion Engineering
Mechanical Engineering
Polymer Science & Materials Chemistry

4


Thermal Sciences
Vehicle Engineering

ENVIRONMENTAL AND HEALTH

Chemical Regulation & Food Safety
Ecological & Biological Sciences
Environmental & Earth Sciences
Health Sciences

·Chemical Regulation & Food Safety
·Ecological & Biological Sciences
·Environmental & Earth Sciences
·Health Sciences

ENGINEERING AND OTHER SCIENTIFIC

Biomechanics

Our Biomechanics Practice uses engineering and biomedical scienceprinciples of biomechanics to solve complex problems at the intersection of biology and engineering. Our expertise is used to understand and evaluate the interaction between the human body as a biological system and the physical environment to explore the cause, nature, and severity of injuries. Additionally, we utilize biomechanical principles to evaluate injury potential associated the use (and misuse) of consumer and industrial products.

During the past year, our biomechanics staff performed analyses of human injuries which occurred while individuals were utilizing a variety of products including recreational vehicles, sporting goods, trucks, trains, aircraft, industrial equipment, and automobiles. They also looked at the implications of using protective devices (such as restraint systems, airbags, and helmets) on reducing the potential for injury, and assessed injuries in the workplace, in the home, and during recreational activities. Our consultants also evaluated product designs for performance, hazards, and injury risks to assist clients with design modifications, address consumer feedback, and respond to regulators.

Biomedical Engineering and Sciences

Our Biomedical Engineering and Sciences Practice applies engineering principles and scientific methodologies to medical technologies, including the evaluation of designs and performance of medical devices, pharmaceuticals, and biologics. Our engineers and scientists assist clients with characterization of biomaterials, medical devices, and their interactions with pharmaceuticals, cells, and tissues. To assist in regulatory clearance and approval, we perform preclinical testing, help formulate related regulatory strategy, and conduct design verification and validation. We also assist with design and manufacturing failure analyses, root cause assessment, recall management, and medical device explant analysis. In addition, our staff performs analysis of clinical outcomes for medical devices and related procedures using administrative claims databases. Our expertise is also utilized in product liability, intellectual property litigation, technology acquisition and due diligence matters.

Buildings & Structures

The basic function of a building, bridge, or other type of structure is to provide structurally sound,a safe, durable, economically constructed and environmentally controlled spacesystem to house, andtransport, or otherwise protect occupants and contents. If thisthese basic function isfunctions are not achieved, it is because one or more aspect(s) of the buildingstructures design or construction has failed to perform its intended function.meet a performance objective. Our architects, structural engineers, and material scientists have been investigating such failures for decades, and we use this experience to solve problems with buildinga variety of structural systems and components, including finding the best repair options and mitigating the risk of future failures.

During the past year, we have evaluated numerous problems with residential, commercial, transportation, and industrial structures for owners, designers, and builders.builders at project sites around the world. Our evaluations often include property inspections, laboratory or on siteon-site testing, engineering analysis, and the development of repair recommendations. In addition, we have worked with owners to assess and mitigate the risk of failure associated with hazards such as hurricanes, flooding, earthquakes, tsunamisexplosions, ground movement, and aging infrastructure. We have assessed these risks to high-rise buildings, bridges, tunnels, industrial facilities, pipelines and nuclear power plant structures.structures and provided testimony both in the U.S. and international courts of law.

5


Civil Engineering

Our Civil Engineering Practice provides broad expertise that includes geotechnical engineering, geological engineering, engineering geology, and geology to address a host of geo-failures, includingcomplex international and domestic construction claims, and disputes involving expert consultation and testimony. Examples of geo-failures evaluated by the practice include landslides, foundation and retaining wall failures, pipeline failures, dam and levee failures,failures.

The practice’s evaluation of complex construction claims involves geotechnical design issues, site characterization, and construction claims. We also provide peer review services for complicated structures. Our water resources staff specializes in the application of proven hydrologic, hydraulic, hydrodynamic, and sediment transport research and science to provide scientifically sound and cost-effective solutions to our clients.

damage from adjacent construction. Over the past year, our consultants have been engaged in a number of investigations related to wildland fires, landslides,landslide evaluations, construction claim and defect evaluations, foundation and retaining wall failures, and foundation failures, large construction claims, floodingeffects of infrastructure projects on the surrounding environments. The practice has been a leader in using advanced remote sensing technologies to evaluate complex problems and sediment transport.applying this state of the art technology to solutions and insight into clients' engineering challenges. This practice provided services for property owners, contractors, design professionals, state agencies, international government agencies, attorneys and insurance carriers.

4

Construction Consulting

Our Construction Consulting Practice provides expertise in the areas of project advisory, risk analysis, strategic planning, dispute resolution, delay analysis and assessment of financial damages services. During the past year, we expandeddamages. We have continued to expand the practice by leveraging key client relationships in several constructionindustry sectors including utilities, mining,data centers, infrastructure, and oil and gas. The practice has expanded to Asia

Over the past year, our team of advisors and employs senior personnel based in Exponent’s Hong Kong office and hasexperts have been retained on numerous complex projects around the world. Our advisors and experts have successfully collaborated with our clients on numerous assignments, from assisting in establishing best-in-class construction and risk management processes and structures, managing a variety of programs and projects, to providing forensic analysis and expert advice in analyzing and resolving project performance, cost and schedule impact claims in both domestic and international arbitrations.arbitration, and private and public litigation matters. Our multi-disciplinary staff, which includes engineers, architects, constructionproject and program managers, schedulers, accountants,quantity surveyors, and technicalcost specialists, providesprovide these services to both the public and private sectors for clients who represent a diverse mix of companiescorporations, law firms, and agencies.

Our projects includesupport many sectors of the construction and engineering industry which include electric and gas utilities, refineries, petrochemical facilities, data centers, building construction, transportation systems, infrastructure, power plants, transmissionhospitals, airports, and distribution facilities, petrochemical facilities, water treatment plants, bridgessporting arenas.

Data Sciences

The Data Sciences practice comprises our core capabilities in statistics, data analytics, and roads, raildedicated data collection. Drawing on experience in a breadth of engineering, science, health, and environmental applications, we assist clients with their most complex data challenges at all stages of the product or process life cycle. Our team of interdisciplinary scientists and engineers designs sampling plans, surveys, and experiments to create, manage, and analyze data sets of all sizes and varieties. User-focused visualizations support data-driven decision-making and help clients measure risks and benefits to determine appropriate courses of action. Utilizing rigorous statistical methods, our team can help assess and improve quality and reliability and mitigate risk. Our experience helps clients build products that perform for a wide variety of users while preventing data bias, collecting personal data with consideration for privacy, and managing the risks associated with global data collection.

During the past year, our team worked on diverse projects for government, industry, and legal clients. We performed assessments of manufacturing quality systems, tunnels, airports, sporting arenasevaluated the durability and gaming facilities. We provide services to firms involved inreliability of smart cards for identity management and credentialing, examined the engineeringin-service safety record of home appliances and construction industry including corporate clients, public agencies, lending agencies, engineeringmedical devices and construction contractors, subcontractors, attorneys and insurance carriers.developed sampling plans associated with product recall campaigns.

Electrical Engineering & Computer Science

Our Electrical Engineering and Computer Science Practice offers a broad range of expertise to address complex issues for industrial, government and privatelegal clients. Our power engineers advise and offer guidance to clients on problemschallenges relating to reliability of electrical systems, includingfailures in power generation, transmission and distribution. distribution as well as on distributed generation, and renewables. In the area of energy storage, we are a leader in the industry in expertise and capabilities for safety of large format batteries, whether for electric vehicles or distributed storage.

6


Our team of electricalelectronic engineers works on failure analysis, product robustness and reliability for consumer devices, industrial electronics and industrial electronics.the health industry. Our computer scientists and engineers advise high-tech industry clients and scientists work with high-tech industries and computer controlledcomputer-controlled applications to evaluate product safety and software reliability. The computer engineeringscience and scienceengineering expertise we offer encompasses a breadth of areas including machine learning and artificial intelligence, information and numerical sciences, algorithms and data structures, computer graphics, computer architecture, networking and communications, as well as security and cryptography. We operate laboratories for testing heavy equipment and electronics and we have a broad capability in analyzing computer software.

Over the past year, we performed a wide array of investigations ranging from assessing electrical damage to electrical power infrastructure from the effect of weather relatedweather-related events to working with clients to develop sophisticated machine learning algorithms applied to large quantities of unstructured data. We continue to work with consumer electronics manufacturers and the transportation industry on the reliability and robustness of computer controlledcomputer-controlled equipment for user safety.

Human Factors

Our Human Factors Practice evaluates human performance and safety in product and system use. Our consultants study how the limitations and capabilities of people, including memory, perception, attention, reaction time, judgment, physical size and dexterity, affect the way they use a product, interact with an organization or environment, process information or participate in an activity.

We review warnings and labeling issues related to consumer products, pharmaceuticals, motor vehicles, medical devices and industrial products supporting the development of safety information to accompany products and assessing claims that the safety information provided was inadequate.

We apply our expertise in human behavior, warnings, and decision making in class actions suits, and in evaluating claims seeking to establish a class. In addition, we assist manufacturers with compliance with regulatory guidelines related to products and work with them regarding analysis of adverse event reports and consumer complaints in publicly available databases overseen by the Consumer Product Safety Commission and the U.S. Food and Drug Administration.

We examine the role that attention plays in human perception, memory, and behavior, and how attention, inattention, and distraction may affect safety in a wide range of settings and activities (e.g., operating vehicles and machinery, walking, and using consumer products).We address the reliability of human memory and retrospective reporting in the gathering of fact-based evidence. We utilize scientific investigations and research (e.g., human perception, reaction time, and looking behavior) to assess driver behavior in both accident investigations and during the design of automotive systems.Exponent’s Our Human Factors scientists have been actively engaged in research and project work with Advanced Driver Assistive SystemAssistance Systems (ADAS) and automated vehicle technology, in order to understand and advise our clients on how these technologies may change the nature and dynamic of driving, and the role and performance of the driver.

5

We provide user experience research, including focus groups, usability testing, and complex user studies with custom-tailored designs, across a wide range of industries, including consumer electronics, medical devices, and vehicle technologies. Our state-of-the-art Phoenix User Research Center, with 5,000 square feet of research space, has six lab suites, including a dedicated focus group room, an ophthalmological lab, a motion capture lab, and wearable eye tracking technology, plus connectivity to our vehicle test track. The scope of human factors engagements rangeranges from consulting on our clients’ research to providing turnkey research solutions, for which we operationalize our clients’ business questions, recruit participants, provide research space, execute customized study designs using specially-built apparatuses, analyze the data,solutions.

We perform incident investigations and report results to stakeholders.

Industrial Structures

Our Industrial Structures Practice, basedroot cause analyses of near-misses and accidents involving human error in Düsseldorf, Germany with offices in Hamburg and Berlin, provides specialized engineering expertise required for industrial structures subject to extreme conditions. We have provided planning, condition assessment, rehabilitation design and engineered demolition and dismantling for more than 1,000 industrial facilities around the world. Much of our Industrial Structures Practice centers on three types of facilities: antenna masts and towers, power plants, and specialized industrial structures such as refractories to protect against high process temperatures or tanks containing potentially dangerous product. Each year we provide quality assurance, including both inspection and engineering analysis, on almost 1,000 tower structures for a variety of facilities including telecommunications, overhead lines, wind energy,occupational and industrial chimneys. settings. Our Human Factors scientists have advanced technical systems training and experience required to understand how humans contribute to the initiation of, and emergency response to, explosions, fires, chemical releases, and major equipment failures in the manufacturing, utility, oil and gas, and construction industries, among others. We also capitalize on this knowledge to conduct human error risk and culture assessments to help clients proactively control human performance gaps, improve occupational and process safety performance, and create administrative controls and procedures.

7


In addition our consultants provide inspection services to assist ourhelping clients with on-time, quality construction on their projects.address the frequency and severity of incidents related to human error, fatigue, and performance, these and other similar project activities can be leveraged to improve efficiency, reliability, and maintainability of normal operations.

We have developed in-house, specialized computer software for non-linear material behavior that can provide realistic performance assessment of a wide variety of specialized structures such as cracked reinforced concrete components, multi-layer refractories and masonry towers. In addition, our staff regularly participates in the creation of consensus engineering standards for assessment and design of industrial facilities.

Materials & Corrosion Engineering

Our in-depth knowledge of materials science, corrosion, and metallurgical engineering combined with the breadth of our collective experience across many industries and disciplines gives our Materials and Corrosion Engineering Practice a unique ability to efficiently provide our clients with solutions to their complex materials-based problems. We use our knowledge and experience to understand how and why materials, products, and processes may not perform their intended function,function. Further, we use this knowledge to help our clients minimize the risk for future failures of new products as well as to prevent future problems. Inaging infrastructure.

Over the past year, our Materials and Corrosion Engineering Practice helped clients solve critical materials-related issues in the consumer electronics, medical device,devices, battery systems, chemical processing, transportation, energy, utilities, and aerospace fields, among others. The Materials and Corrosion Engineering Practice continues to expand its presence in Asia with hires in our Shanghai and Hong Kong offices and expects accelerated growth thereOur support of dispute resolution in the coming years.intellectual property, premises and product liability fields continued to grow supported by our strong position in direct industrial consulting.

Mechanical Engineering

We provide clients with a thorough comprehension of current and alternativealternate designs of mechanical systems to identify vulnerabilities before failures occur, develop appropriate risk mitigation methods, and provide post-failure investigations.

Our consultants review the performance and reliability of industrial processes, manufactured products, and engineered systems, and we determine the root cause of failures. We assist in legal and insurance matters, failure investigations, product recall investigations, internal compliance programs, product development, workplace safety evaluations, and intellectual property matters.

Our staff members develop and utilize detailed and validated computational models and laboratory experimental methods to evaluate products, systems, and equipment. We perform field inspections, rely on industry standards, and utilize operational data to inform our analyses. We have performed these activities in a broad range of industries including transportation, heavyenergy, industrial equipment, building systems, medical devices, energy, and consumer products.

During the past year, our mechanical engineers worked on a wide variety of projects ranging from high-profile consumerincluding international construction disputes, product recall investigations to oilfield equipment failuresrecalls, and workplacemechanical safety issues.in product development.

6

Polymer Science & Materials Chemistry

Our Polymer Science and Materials Chemistry Practice consults with industrial, government, legal, insurance and individual clients regarding polymers and textiles used in diverse applications as well as chemicalthe chemistry, materials and processing aspects of batteries, drug delivery systems, and other products that depend on highly controlled manufacturing environments.

We assist clients in understanding the short- and long-term performance of plastic, rubber, adhesive, coating, composite, reactive chemical systems, and electrochemical energy storage systems when challenged by physical, chemical, thermal and other operational stressors. Our work also includes customized chemical, electrochemical and rheological testing and leverages significantexpanding internal electron microscopyinfrastructure for instrumented analysis and computerized tomographyadvanced imaging capabilities.

Our consultants participate in product development programs, perform failure analyses and provide support to clients involved in regulatory and legal proceedings and the protection of intellectual property. Clients value our technical expertise related to chemistry, formulation, manufacturing and materials performance, our understanding of the history and evolution of these materials, and our ability to assist them in identifying and incorporating emerging materials and manufacturing technologies into their businesses.

During the past year, significant program activities addressed aspects of automotive materials, battery systems, consumer electronics, wearable devices, sporting goods, implantable medical devices, combination drug delivery systems, historical formulations and components, manufacturing technology, industrial textiles, performance apparel,medical diagnostics, building materials, water handling systems, oil and gas applications, the plastics supply chain, fire retardancy and flammability, technology

8


scouting, materials science aspects of health risk, service life prediction, sustainability, and intellectual property related to consumer, recreational, medical, pharmaceutical, food packaging and other products, including trade secrets.products.

Statistical & Data Sciences

The Statistical and Data Sciences Practice comprises our core capabilities in methods for the collection, management, visualization, and inferential analysis of data. Drawing on experience in a breadth of engineering, science, health, and environmental applications—and frequently working in collaboration with other practices—we assist clients at all stages of the product or process life cycle: designing and analyzing product development studies; improving and controlling manufacturing process and product quality; and monitoring the safety, reliability, and performance of products in use by customers.  We design sample surveys and experiments, create value-added databases through synthesis of client-supplied and public data, and implement innovative techniques for machine learning and predictive analytics. Our approach to studies is intended to support data-driven decision making and to help clients measure their risks and benefits to determine appropriate courses of action.

During the past year, our statisticians and data scientists worked on diverse projects for government, industry, and legal clients. We performed assessments of manufacturing quality systems, evaluated the durability and reliability of smart cards for identity management and credentialing, supported research and development of an automated medical device through data visualization and reduction, examined the in-service reliability of home appliances and components, and provided forecasts for a utility integrity management program from statistical analysis of field inspection data.


Thermal Sciences

Our Thermal Sciences Practice provides multi-disciplinary expertiserapid response expert analysis to assist clientsinvestigate failures involving thermo-fluid systems, fires, and explosions in chemical, fire protection,industrial, residential, commercial, and mechanical engineering.transportation sectors. We have investigated and analyzed thousands of fires and explosionsthermal incidents ranging from high loss disasters at manufacturing facilities, energy facilities andaccidents in the oil and gas installationssector and major wildland fires, to small insurance claims. Information gained from these analyses has helpedallowed us assist clients with preventive measures related to the design of their facilities and products. Wealso assist clients in minimizing theproactively making their assets and products safer.

Our staff, consisting of mechanical, chemical, fire protection, aeronautical & astronautical and nuclear engineers, have assisted clients in assessing risk of firesto, and explosions, wefrom, their facilities, consumer product recalls, regulatory compliance and frequently provide regulatory consulting for permitting new industrial facilities,expert testimony in domestic litigation and we assist manufacturers in addressing the risk of fires associated with consumer products.international arbitration. Our engineers use fire modeling and otheradvanced computational fluid dynamics, fire, and explosion modeling tools to supplement our analytical, experimental, and field-based activities. Preventive services include process safety hazard analysis for the chemical, oil & gas, and oil and gassemiconductor industries, fire protection engineering, product development support, risk-based asset management, and dust explosion consulting.

In recent years, the Thermal Sciences Practice has developed tools to evaluate fire and explosion risks of lithium-ion batteries. We have consulted with a variety of clients to evaluate and mitigate fire and explosion hazards of batteries in applications including consumer products, vehicles, and grid-scale energy storage. We continue to be very active in wildland fire investigation and continue to assist our clients in making informed risk-based decisions related to their assets and wildfires. We have also developed analytical tools to assist utility clients assess the risk of ignition from their infrastructure.

During the past year, we have continued to grow in our work in oil and gas exploration and production, Liquefied Natural Gas (LNG)liquefied natural gas and downstream oil & gas. Our work in fire detection and gas sectorsprotection related issues has continued. Our servicesremained robust, and our work in these areas include assessing new oil well control technologies, assessing potential fireconsumer product recall and explosion risks and consequences, investigating loss of containment incidents and assessing the integrity of fixed assets.international arbitration has also grown.

7


Vehicle Analysis
Engineering

We have performed thousands of investigations for the automotive, trucking, recreational vehicle, marine, aerospace, and rail industries. Internal research programs and client projects have resulted in technological contributions that have assisted manufacturers in the understanding of product performance and provided insight to government agencies in establishing policy and regulations. Information gained from these analyses has also assisted clients in assessing preventive measures related to the design of their products, as well as evaluating failures.

Our Test and Engineering Center located in Phoenix, Arizona, is used for our most complex testing and analysis. We have gained a worldwide reputation for our ability to mobilize resources expeditiously and efficiently, integrate a broad array of technical disciplines, and provide valuable insight that is objective and withstands rigorous scrutiny. Many of our projects involve addressing the cause of accidents and our clients rely on us to determine what happened in an accident and why it happened. In many cases, clients also want us to assess what could have been done to reduce the severity of the accident or to mitigate occupant injuries to those involved.

Current advances in emerging transportation technologies and concepts allow the multi-disciplineour multi-disciplinary team of scientists, engineers, and analysts across numerous practices to focus on the development and implementation of connected vehicles, automated vehicles, connected/smart cities, and data analyses. Whether the objective is design analysis, component testing, failure analysis, or accident reconstruction, our knowledge of vehicle systems and engineering principles coupled with our experience from conducting full-scale tests aim to add insight and proficiency to every project.

9


ENVIRONMENTAL AND HEALTH SCIENCES

Chemical Regulation & Food Safety

Our Chemical Regulation and Food Safety Practice includes both technical and regulatory specialists who are experiencedexperts in dealing with foods, food ingredients, cosmetics, dietary supplements, pesticidepesticides and biocides (including conventional chemicals, biochemicals, microbials, antimicrobials/biocides, biopesticides, emerging technologies and products of biotechnology), industrial chemicals, pesticide/biocide devices, consumer products, medical devices and industrial chemicals.pharmaceuticals. We provide practical, scientific and regulatory support to meet global business objectives at every stage of the product life cycle, from research and development to retail and beyond.

During the past year, our Chemical Regulation and Food Safety staff have conducted a wide array of work. The European and U.S. sides of the practice were jointly involved with the ongoing support of multipleseveral new pesticide active ingredients and end-use products. The European side of our business was involved with many projects related to plant protection and biocidal product regulatory submissions, from new active substances and those under review to product-specific dossiers for individual European member states. This has included new technologies in plant protection that meet the regulatory pressures to achieve greater sustainability. We have provided support for reviews of a large number of biocidal products through European and South Korean regulatory reviews. In addition, we provided many specialist assessments relating to human and environmental exposure, risk and product efficacy as well as national and international Maximum Residue Limit/import tolerance submissions.submissions covering countries such as South Korea, Taiwan and Hong Kong. The U.S. side of our business was also involved in many projects related to agrochemical, antimicrobial, emerging technologies and biochemical product regulatory submissions in the U.S., Canada and Mexico. These included new active ingredients, end-use products, emerging technologies and import tolerances (EPA and FDA). Our state registration business remained solid in the U.S. In Europe and the U.S., we continued to provide clients with regulatory compliance support for food contact materials, food additives, novel foods, nutrition-related analyses, as well as undertaking safety assessments for food, cosmetic and cosmeticsconsumer products. Our European and U.S. teams have been working together to help clients navigate and comply with the new FDA MoCRA Cosmetics regulations that took effect in 2023.

We also provided proactive and reactive product safety and litigation support. For industrial chemicals, we continued to provide full regulatory support for our clients who prepared and submitted registrations and risk assessmentsassessments. Our European and our European Offices have been particularlyU.S. offices were active in dealingsupporting our clients with the EU REACHtheir E.U. and U.K. Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and U.S. Toxic Substances Control Act regulatory requirements as the 2018 deadline approaches. In the U.S. we continued to provide services related to new pesticide active ingredients and end-use product development and registrations in the U.S., Canada, and Mexico, registration review under EPA, import tolerances in the U.S. and Canada, due diligence related to product and/or business sales, and data compensation, as well as the approval of new pesticide inert ingredients and new non-pesticide active ingredient approvals.requirements.


Ecological & Biological Sciences

Our ecological and biological scientists provide strategic support on issues related to the environment and natural resources damages associated with chemicals and forest fires, international environmental disputes, ecosystem service assessments for businesses, adverse weather events/climate change, ecological risk assessment, ecotoxicology, novel remediation methods, restoration of wetlands and other natural resources, large development projects, resource utilization (such as mineral mining, oil and gas, wood pulp, transportation, etc.), agriculture land-use impacts, genomic assessments, product stewardship, and the use of chemicals and other products in commerce. TheFocusing on both legacy and emerging contaminants, the practice specializes in assessing the integrated affectseffects of chemical, biological, and physical stressors on aquatic and terrestrial ecosystems. Many of these assessments utilize a causal analysis approach to determine causation systematically and transparently determine causation in complex and interrelated situations. The practice is comprised of nationally and internationally recognized experts that cover disciplines related to the fate and effects of chemical constituents and other stressors, including the ecological implications and risks associated with these projects.

8

Environmental & Earth Sciences

Our environmental scientists and engineers provide cost-effective, scientifically defensible and realistic assessments and solutions to complex environmental issues. We offer technical, regulatory, and litigation support to industries that include oil and gas, mining and minerals, chemicals, forest products, railroads, aerospace, development, and trade associations, and to municipal and governmentgovernmental clients. Our consultants specialize in the areas of environmental fate and transport, environmental chemistry and forensics, hydrogeology, air toxics, modeling and monitoring, water quality and water supply, data analytics, remediation consulting, environmental engineering and waste management, and natural resources damages assessment.

10


Our expertise also includes hydrology and hydrogeology, modeling and monitoring, water quality, water rights and water resources, extreme weather event and climate impacts,change risk management, and evaluation of environmental and social risks.

Our work oftenfrequently involves complex and high visibility environmental problems and issues, often the focus of environmental or toxic tort claims, where evaluation of contamination and historical reconstruction of events, releases, and doses and water resource issues are central to problem resolution.

We provide case-specific strategic and advisory consulting on risk mitigation, planning, and environmental regulatory and policy issues, as well as high-level technical strategic consulting to support critical business decisions and for complex matters where understanding the long-term implications of early technical actions is critical to managing overall liability.

Health Sciences

Our health scientists, including epidemiologists, toxicologists, industrial hygienists, exposure scientists, biostatisticians, risk assessors,assessment scientists, and physicians, apply scientific and medical principles to examine and address complex health-relatedhuman-health-related risk, benefit, and value issues in a variety of settings. The members of our staffOur consultants are recognized nationally and internationally for their outstanding expertise and credentials, and their decades of experience in government, academia, and industry sectors.

Our work has included numerous community and environmental health assessments, disease cluster investigations, air quality investigations and analyses, survey research, real-world data platforms, cohort and case-control studies, exposure assessment and simulation studies, biologically-basedbiologically based modeling, and preparation of meta-analyses, and state-of-the-art literature reviews. We have specifically addressed critical issues for clients on industrial chemicals, pesticides, mineral fibers, drugs,pharmaceuticals, medical devices, consumer products, digital health technology, nanotechnology, and other agents and products as they relate to human health risk.

Our multidisciplinary team has extensive experience investigating a broad variety of health concerns such as claims of adverse health effects from exposures to a wide range of physical agents (e.g., ionizing radiation, and low- and radio-frequency electromagnetic fields); chemical agents (e.g., volatile organic compounds, metals, dusts, and other airborne particulates,air pollutants, mineral fibers, fumes, nanoparticles, and pharmaceuticals)nanoparticles); and biological agents (fungi, (fungi/molds, bacteria, and other micro-organisms). Our atmospheric scientists provide air quality and meteorological modeling, permitting, and licensing support services. Our health scientists

We can assess the potential health effects of occupational and environmental exposures,exposures; investigate accidental releases of chemicals and evaluate fate and transport of chemical substances, simulate and analyzesubstances; characterize consumer and workplace exposures through simulation and exposure reconstruction; develop measures of prevention and exposure control,control; and assist clients with occupational safety and health evaluationsevaluations.

In the past few years, we have expanded our expertise to include pharmacoepidemiology; the development and emergency preparednessapplication of real-world evidence (RWE) for regulated medical products (pharmaceuticals and response.biologics, vaccines, devices, and combination products); and digital therapeutics, across the product life cycle from pre-approval planning to market access to post-approval safety evaluation and regulatory consulting on emergent safety issues. Our Health Sciences team, working closely with Biomechanics, Biomedical Engineering & Sciences, Data Sciences, Human Factors, Polymer Science & Materials Chemistry, and other practices, has considerable expertise in healthcare data science; strategy, design, and application of health economics and outcomes research such as burden-of-illness assessment; selection, quality assessment, and analysis of electronic health records (EHR) and healthcare claims and the explication of methodological issues such as randomization, bias, data linkages, drug interactions, and identification of high-risk populations.

COMPETITION

The marketplace for our services is fragmented and we face different sources of competition in providing various services. In addition, the services that we provide to some of our clients can be performed in-house by those clients. Clients that have the capability to perform such services themselves will retain Exponent or other independent consultants because of independence concerns.

In each of our practices, we believe that the principal competitive factors are: technical capability and breadth of services, ability to deliver services on a timely basis, professional reputation and knowledge of litigation and

11


regulatory processes. Although we believe that we generally compete favorably in each of these areas, some of our competitors may be able to provide services acceptable to our clients at lower prices.

We believe that the barriers to entry are low and that for many of our technical disciplines, competition is increasing. In response to competitive forces in the marketplace, we continue to look for new markets for our various technical disciplines.

9

BUSINESS SEGMENTS AND GEOGRAPHIC OPERATIONS OVERVIEWHUMAN CAPITAL

We report two operating segments based on two primary areas of service: Engineering and Other Scientific, and Environmental and Health. Engineering and Other ScientificExponent is a broad service group providingglobal engineering and scientific consulting firm that partners with clients to deliver breakthrough insights and answers. In a world experiencing accelerating change over our 50+ years in business, we still deliver the same vital promise: technical consultingexcellence, unrivaled expertise, and a unique multidisciplinary approach to asking and answering the right questions. Our vision is to work together, with our teams and our clients, to solve the most formidable scientific and engineering challenges to create a safer, healthier, sustainable world.

We work toward this vision by creating an unrivaled environment of engineering and scientific expertise, collaboration, and opportunity for exceptional people to achieve breakthrough insights and objective solutions for our clients’ vital challenges. Attracting, exciting, developing, and rewarding these people is central to our mission and our success. Our culture actively supports the development of our professionals and their potential by creating a stimulating, growth-oriented, and inclusive environment.

We keep our values and responsibilities front-and-center in different practices primarilyeverything we do: our hiring, our training, our processes, and our daily effort. These values include objectivity and work grounded in engineering. Environmentalevidence and Health provides servicesfacts; excellence in our work and rigorous commitment to the highest standards of quality and integrity; respect and care for our teammates, peers, and partners; a commitment to a diversity of ideas, disciplines, and lived experiences; and a shared belief in the areaimportance of environmental, epidemiologyservice, responsibility, and health risk analysis. This segment providesmaking a wide rangepositive difference for our peers, our professions, and our communities.

We advance scientific and engineering knowledge through the work of consulting services relatingemployees, but also through a comprehensive commitment to environmental hazardseducation, teaching, mentoring, publishing, and risksserving. Recognized leaders in their fields, Exponent staff serve on more than 250 individual scientific and engineering committees and advisory boards. Others serve in leadership roles or are actively working to develop technical standards. Exponent’s professionals routinely contribute to peer-reviewed scientific literature and publish articles, chapters, and books each year. To date, Exponent staff have published more than 1,200 articles in scientific and engineering journals. And today, more than 50 Exponent consultants serve as professors, lecturers, instructors, and advisors at universities and academic institutions across the impact on both human healthcountry and around the environment. Forworld.

To enable a culture where diversity, equity, and inclusion are embedded we have articulated four pillars of actions: communication, development, outreach, and recruiting.

Communication - Our annual employee survey and Diversity, Equity & Inclusion Advisory Committee help increase transparency and ensure a two-way dialogue between employees and leadership.

Development - We foster equitable opportunities via our development pathways. Our mentoring, sponsorship, and buddy programs provide unbiased growth opportunities, support, and connection.

Outreach - Our Diversity, Equity & Inclusion outreach leverages science, technology, engineering, and math (STEM) to empower the communities around us. Initiatives include staff volunteering in classrooms, professional societies, and direct gifts to universities.

Recruiting - We engage graduate students at more information about the financial condition and results of operations of each segment, please seePart II - “Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations”and“Item 8: Financial Statements and Supplementary Data.” For information about the Company’s operationsthan 100 universities, including those in different geographical areas, please see “Note 15: Segment Reporting” of ourNotesconnection with affinity professional organizations. We employ a behavioral, competency-based interviewing process to Consolidated Financial Statements. For information about the Company’s disclosures regarding foreign currency exchange rate risk, please see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk.”actively avoid bias.

EMPLOYEES

As of December 29, 2017,2023, we employed 1,0751,320 full-time, part-time and hourlyintermittent employees, including 8481,047 engineering and scientific staff, 6173 technical support staff and 166200 administrative and support staff. Our staff includes 760955 employees with advanced degrees, of which 547746 employees have achieved doctorate degrees. As of December 29, 2023 approximately 89% of our employees were located in the levelUnited States and 11% were located in other global regions.

12


Technical full-time equivalent employees is a key metric that we use to analyze our revenues. During 2023 technical full-time equivalent employees increased 10% to 1,048 as compared to 955 during the prior year. We attribute our ability to grow technical full-time equivalent employees to a number of Ph.D., Sc.D. or M.D.factors, including exciting and challenging assignments, strong leadership and management, the opportunity to learn new skills and advance careers, along with competitive and equitable total rewards. To ensure a compelling total rewards philosophy and practice, we have practices in place to deliver fair and equitable compensation for employees based on their contribution and performance. We also offer a comprehensive set of benefits for employees and their families.

AVAILABLE INFORMATION

ADDITIONAL INFORMATION

The address of our Internet website is www.exponent.com.www.exponent.com. We make available, free of charge through our website, access to our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other periodic and current Securities and Exchange Commission (SEC)(“SEC”) reports, along with amendments to all of those reports, as soon as reasonably practicable after we file or furnish the reports with the SEC. Additionally, copies of materials filed or furnished by us with the SEC may be accessed at the SEC’s Public Reference Room at 100 F Street NE, Washington, D.C. or at the SEC’s website at http://www.sec.gov. For information about the SEC’s Public Reference Room, the public may contact 1-800-SEC-0330. Copies of material filed or furnished by us with the SEC may also be obtained by writing to us at our corporate headquarters, Exponent, Inc., Attention: Investor Relations, 149 Commonwealth Drive, Menlo Park, CA 94025, or by calling (650) 326-9400. The content of our Internet website is not incorporated into and is not part of this Annual Report on Form 10-K.

10

EXECUTIVE OFFICERS OF THE REGISTRANT

The executive officers of Exponent and their ages as of February 23, 20182024 are as follows:

Name

Age

Position

Paul R. Johnston, Ph.D.64Chief Executive Officer and Director

Catherine Ford Corrigan, Ph.D.

49

55

President and Chief Executive Officer

Eric Guyer, Ph.D.

47

Robert I. Haddad, Ph.D.60

Group Vice President

Brad A. James, Ph.D.

58

Harri K. Kytomaa, Ph.D.59

Group Vice President

Steven J. Murray, Ph.D.43Group Vice President
John D. Osteraas, Ph.D.63Group Vice President

John D. Pye, Ph.D.

47

53

Group Vice President

Joseph Rakow, Ph.D.

47

Group Vice President

Richard Reiss, Sc.D.

51

57

Group Vice President

Maureen T.F. Reitman, Sc.D.

55

Group Vice President

Richard L. Schlenker, Jr.

52

58

Executive Vice President, Chief Financial Officer and Corporate Secretary

Sally B. Shepard

57

63

Chief Human Resources Officer

Executive officers of Exponent are appointed by the Board of Directors of the Company (the “Board of Directors”) and serve at the discretion of the Board orof Directors until the appointment of their successors. There is no family relationship between any of the directors and officers of the Company.

Paul R. Johnston, Ph.D.,joined the Company in 1981, was promoted to Principal Engineer in 1987, and to Vice President in 1996. In 1997, he assumed responsibility for the firm’s network of offices. In 2003 he was appointed Chief Operating Officer and added responsibility for the Health and Environmental Groups. In 2006, he assumed line responsibility for all of the firm’s consulting groups. Dr. Johnston was named President in May 2007. He was named Chief Executive Officer and elected to the Board of Directors in May 2009. Dr. Johnston received his Ph.D. (1981) in Civil Engineering and M.S. (1977) in Structural Engineering from Stanford University. He received his B.A.I. (1976) in Civil Engineering with First Class Honors from Trinity College, University of Dublin, Ireland where he was elected a Foundation Scholar in 1975. Dr. Johnston is a Registered Professional Civil Engineer in the State of California and a Chartered Engineer in Ireland.

Catherine Ford Corrigan, Ph.D., joined the Company in 1996. She was promoted to Principal in the Biomechanics practice in 2002 and was appointed Group Vice President in May 2012. Dr. Corrigan was named President in July 2016. She was named Chief Executive Officer and elected to the Board of Directors in May 2018. Dr. Corrigan earned her Ph.D. (1996) in Medical Engineering and Medical Physics and M.S. (1992) in Mechanical Engineering from the Massachusetts Institute of Technology and her B.S. in Bioengineering from the University of Pennsylvania. Prior to joining Exponent, Dr. Corrigan was a researcher in the OrthopaedicOrthopedic Biomechanics Laboratory at Beth Israel Hospital and Harvard Medical School. On February 9, 2021, Dr. Corrigan was elected to the National Academy of Engineering.

Robert I. Haddad,Eric Guyer, Ph.D.,joined the Company in May 2016 as a Corporate Vice President and Principal Scientist.2005. He was promoted to Principal Engineer in 2011 and was appointed Corporate Vice President in 2019. Dr. Guyer was appointed Group Vice President on April 1, 2023. Dr. Guyer received his Ph.D. (2005) in October 2016.Materials Science and Engineering and M.S. (2003) in Materials Science and Engineering from Stanford University, and B.S. (2000) in Chemical Engineering from Iowa State University. Prior to joining the Company,Exponent, Dr. HaddadGuyer was Chief, Assessment & Restoration Division, Office of Response & Restorationemployed as a Senior Materials Engineer at the National Oceanic and Atmospheric Administration from 2007 to 2016 where he was responsible for the strategic evaluation and tactical resolution of environmental problems. From 2002 to 2007, Dr. Haddad was President and Principal Scientist at Applied Geochemical Strategies, Inc. where he was responsible for providing litigation support and expertise in environmental forensics, human health and ecological risk assessments, and natural resource damage assessments to regional, national, and international clients. Dr. Haddad received hisLockheed Martin’s Advanced Technology Center.

Brad A. James, Ph.D. (1989) in Chemical Oceanography from the University of North Carolina, Chapel Hill and B.S. (1979) in Geology from the University of California, Los Angeles. Dr. Haddad has published in peer-reviewed technical publications and scientific journals, and has authored over 300 technical reports and confidential documents for a variety of projects.

11

Harri K. Kytomaa, Ph.D.,joined the Company in 1994. He was promoted to Principal Engineer in 19992005 and was appointed Corporate Vice President in 2006.2014. Dr. KytomaaJames was appointed Group Vice President in October 2016.on January 4, 2020. Dr. KytomaaJames received his Ph.D. (1986)(1994) in Mechanical EngineeringMetallurgical and M.S. (1981) in MechanicalMaterials Engineering from the California InstituteColorado School of Technology,Mines and B.Sc. (1979)his B.S. (1988) in Metallurgical Engineering Science from Durhamthe University England.of Washington. He is a Registered Professional Engineer licensed professional engineer

13


in 9the states of California and a Certified Fire and Explosion Investigator in accordance with the National Association of Fire Investigators National Certification Board.Texas. Prior to joining Exponent, Dr. KytomaaJames was Assistant Professor and Associate Professor of Mechanical Engineeringemployed as a Research Engineer, Materials Performance Division, at the Massachusetts Institute of Technology, where he was head of the Fluid Mechanics Laboratory.Babcock and Wilcox R&D Center.

Steven J. Murray, Ph.D.,joined the Company in 2001. He was promoted to Principal Engineer in 2008. Dr. Murray was promoted to Corporate Vice President in May 2014 and Group Vice President in January 2015. Dr. Murray received his Ph.D. (2000) in Materials Science and Engineering (Electronic Materials Panel) from the Massachusetts Institute of Technology, B.S. (1996) in Materials Science and Mineral Engineering and B.S. (1996) in Mechanical Engineering from the University of California, Berkeley. He is a Registered Professional Electrical Engineer in the State of Oregon and Registered Professional Mechanical Engineer in the State of California.

John D. Osteraas, Ph.D., worked for the Company from 1982 to 1985 as a Senior Engineer. He rejoined the Company in 1990 as a Managing Engineer. He was promoted to Principal Engineer in 1992 and Group Vice President in 2006. Dr. Osteraas received his Ph.D. (1990) in Civil Engineering, M.S. (1977) in Civil Engineering: Structural Engineering from Stanford University and B.S. (1976) in Civil and Environmental Engineering from the University of Wisconsin. Dr. Osteraas is a Registered Professional Engineer in 17 states and is a Fellow of the American Society of Civil Engineers.

John D. Pye, Ph.D.,joined the Company in 1999. He was promoted to Principal Engineer in 2006 and was appointed Corporate Vice President in 2009. Dr. Pye was appointed Group Vice President in January 2014. Dr. Pye received his Ph.D. (1999) in Aerospace Engineering from Stanford University, M.S. (1993) in Aerospace Engineering from Stanford University, and B.A.Sc. (1992) in Engineering Science from the University of Toronto, Canada. He is a Registered Professional Mechanical Engineer in the State of California. Prior to joining Exponent, Dr. Pye held a research position in the Aerospace Fluid Mechanics Lab at Stanford University where he was responsible for the renovation and redesign of the Stanford Low-Speed wind tunnel as well as managing the Stanford experimental facilities for the Stanford/NASA Ames Joint Institute for Aeronautics and Astronautics.

Joseph Rakow, Ph.D., joined the Company in 2005. He was promoted to Principal Engineer in 2012 and was appointed Corporate Vice President in 2021. Dr. Rakow was appointed Group Vice President on April 1, 2023. Dr. Rakow received his Ph.D. (2005) in Aerospace Engineering and M.S. (2000) in Aerospace Engineering from the University of Michigan, and B.S. (1999) in Physics from the University of California, Davis. He is a licensed professional engineer in the state of California and a Fellow of the American Society of Mechanical Engineers. Prior to joining Exponent, Dr. Rakow held teaching and research positions at the University of Michigan and Sandia National Laboratories. As a volunteer, Dr. Rakow serves on multiple academic advisory boards at the university level, and is a Structures Specialist with FEMA Urban Search & Rescue.

Richard Reiss, Sc.D.,joined the Company in 2006 as a Principal Scientist. He was promoted to Group Vice President in January 2015. Dr. Reiss earned his Sc.D. (1994) in Environmental Health from the Harvard University School of Public Health, M.S. (1991) in Environmental Engineering from Northwestern University and B.S. (1989) in Chemical Engineering from the University of California, Santa Barbara. Prior to joining Exponent he was a Vice President with Sciences International. Dr. Reiss is a Fellow of the Society of Risk Analysis.

Maureen T.F. Reitman, Sc.D., joined the Company in 2002. She was promoted to Principal Engineer in 2006 and was appointed Corporate Vice President in 2014. Dr. Reitman was appointed Group Vice President on January 4, 2020. Dr. Reitman received her Sc.D. (1993) in Materials Science and Engineering from the Massachusetts Institute of Technology and her B.S. (1990) in Materials Science and Engineering from the Massachusetts Institute of Technology. She is a registered Professional Mechanical Engineer in the state of Maryland and a fellow of the Society of Plastics Engineers. Prior to joining Exponent, Dr. Reitman worked for the 3M Company in both research and management roles. Her activities at 3M included technology identification, materials selection and qualification, product development, customer support, program management, acquisition integration, intellectual property analysis, and patent litigation support. On February 6, 2024, Dr. Reitman was elected to the National Academy of Engineering.

Richard L. Schlenker, Jr., joined the Company in 1990. Mr. Schlenker is the Executive Vice President, Chief Financial Officer and Corporate Secretary of the Company. He was appointed Executive Vice President in April 2010, Chief Financial Officer in July 1999 and Secretary of the Company in November 1997. Mr. Schlenker was the Director of Human Resources from 1998 until his appointment as Chief Financial Officer. He was the Manager of Corporate Development from 1996 until 1998. From 1993 to 1996, Mr. Schlenker was a Business Manager, where he managed the business activities for multiple consulting practices within the Company. Prior to 1993, he held several different positions in finance and accounting within the Company. Mr. Schlenker holds a B.S. in Finance from the University of Southern California.

12

Sally B. Shepard, rejoined the Company in 2014 as Vice President - Human Resources and was promoted to Chief Human Resources Officer in 2017. From 2012 to 2014 she served as Vice President Human Resources at 41st Parameter, which was acquired by Experian. From 2002 to 2009 she served as Vice President Human Resources at CoWare, Inc., which was acquired by Synopsys. From 2000 to 2001 Ms. Shepard served as Vice President Human Resources at Lutris Technologies. She also provided Human Resources consulting services for a variety of companies between roles. From 1981 to 1999 Ms. Shepard held a variety of roles at Exponent including Managing Engineer, Business Manager, Director of Human Resources and Information Technology, and Vice President of Corporate Human Resources. Ms. Shepard holds a B.S. (1982) in Mechanical Engineering from Stanford University.

14


Item 1A. Risk Factors

Exponent operates in a rapidly changing environment that involves a number of uncertainties, some of which are beyond our control and may have a material adverse effect on our financial condition and results of operations. These uncertainties include, but are not limited to, those mentioned elsewhere in this report and those set forth below. Although the risks are organized by headings, and each risk is discussed separately, many are interrelated.

Risks Related to Our Clients and Demand for Our Services

The unpredictable and reactive nature of our business can create uneven performance in any given quarter or fiscal year.

Revenues are primarily derived from services provided in response to client requests or events that occur without notice, and engagements, generally billed as services are performed, are terminable or subject to postponement or delay at any time by clients. As a result, backlog at any particular time is small in relation to our quarterly or annual revenues and is not a reliable indicator of revenues for any future periods. Revenues and operating margins for any particular quarter are generally affected by staffing mix, resource requirements and timing and size of engagements.

Our financial results could suffer if our clients’ needs change more rapidly than we are able to secure the appropriate mix of trained, skilled and experienced personnel.

As our clients’ needs change, new technologies develop, and legal and regulatory processes change, we may be unable to timely hire or train personnel with the appropriate new set of skills and experience which could negatively impact our growth and profitability.

We may not manage our growth effectively, and our profitability may suffer.

FailureOur expected future growth presents numerous managerial, administrative, operational and other challenges. Our ability to manage the growth of our operations will require us to continue to improve our information systems and other internal systems and controls. In addition, our growth will increase our need to attract, develop, motivate and retain key employees may adversely affectboth our business.

Exponent’s business involves the delivery ofmanagement and professional services and is labor-intensive. Our success depends in large part upon our ability to attract, retain and motivate highly qualified technical and managerial personnel. Qualified personnel are in great demand and are likely to remain a limited resource for the foreseeable future. We cannot provide any assurance that we can continue to attract sufficient numbers of highly qualified technical and managerial personnel and to retain existing employees. The lossinability to effectively manage growth or the inability of key managerialour employees business generators or any significant number of employeesto achieve anticipated performance could have a material adverse impacteffect on our business, including our ability to secure and complete engagements.business.

CompetitionThe loss of a large client could reduce our pricing and adversely affect our business.

The markets for our services are highly competitive. In addition, there are relatively low barriers to entry into our markets and we have faced, and expect to continue to face, additional competition from new entrants into our markets. Competitive pressure could reduce the market acceptanceWe currently derive a significant portion of our servicesrevenues from clients in the chemical, construction, consumer products, energy, life sciences and result in price reductions thattransportation industries. The loss of any large client could have a material adverse effect on our business, financial condition or results of operations.

The loss of a large client could adversely affect our business.

We currently derive a significant portion of our revenues from clients in the chemical, consumer electronics, energy, insurance, transportation and utilities industries and the government sector. The loss of any large client, organization or insurer could have a material adverse effect on our business, financial condition or results of operations.

Our clients may be unable to pay for our services.

If a client's financial difficulties become severe, the client may be unwilling or unable to pay our invoices in the ordinary course of business, which could adversely affect collections of both our accounts receivable and unbilled services. Recent global economic volatility and increased cost of capital could impact the ability of our customers to pay for our services. On occasion, some of our clients have entered bankruptcy, which has prevented us from collecting amounts owed to us. The bankruptcy of a client with substantial accounts receivable could have a material adverse effect on our financial condition and results of operations.

We hold substantial investments that could present liquidity risks.

Our cash equivalent and short-term investment portfolio as of December 29, 2017, consisted primarily of obligations of U.S. government agencies and the U.S. Treasury. We follow an established investment policy to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

13

Investments in some financial instruments may pose risks arising from liquidity and credit concerns. As of December 29, 2017, we had no impairment charge associated with our investment portfolio relating to such adverse financial market conditions. Although we believe our current investment portfolio has a low risk of impairment, we cannot predict future market conditions or market liquidity and can provide no assurance that our investment portfolio will remain unimpaired.

Our business is dependent on our professional reputation.

The professional reputation of Exponent and its consultants is critical to our ability to successfully compete for new client engagements and attract or retain professionals. Proven or unproven allegations against us may damage our professional reputation. Any factors that damage our professional reputation could have a material adverse effect on our business.

15


Our business can be adversely impacted by deregulation or reduced regulatory enforcement.

Public concern over health, safety and preservation of the environment has resulted in the enactment of a broad range of environmental and/or other laws and regulations by local, state and federal lawmakers and agencies. These laws and the implementation of new regulations affect nearly every industry, as well as the agencies of federal, state and local governments charged with their enforcement. To the extent changes in such laws, regulations and enforcement or other factors significantly reduce the exposures of manufacturers, owners, service providers and others to liability, the demand for our services may be significantly reduced.

Tort reform can reduce demand for our services.

Several of our practices have a significant concentration in litigation support consulting services. To the extent tort reform reduces the exposure of manufacturers, owners, service providers and others to liability, the demand for our litigation support consulting services may be significantly reduced.

Our engagements may result in professional or other liability.

Our services typically involve difficult engineering and scientific assignments and carry risks of professional and other liability. Many of our engagements involve matters that could have a severe impact on a client's business, cause a client to lose significant amounts of money, or prevent a client from pursuing desirable business opportunities. Accordingly, if a client is dissatisfied with our performance, the client could threaten or bring litigation in order to recover damages or to contest its obligation to pay our fees. Litigation alleging that we performed negligently, disclosed client confidential information, lost or damaged evidence, infringed on patents, were forced to withdraw from a legal matter due to a conflict or otherwise breached our obligations to a client could expose us to significant liabilities to our clients or other third parties or tarnish our reputation.

Potential conflicts of interest may preclude us from accepting some engagements.

We provide litigation support consulting and other services primarily in connection with significant disputes, or other matters that are usually adversarial or that involve sensitive client information. The nature of our consulting services mayhas and will continue to preclude us from accepting engagements with other potential clients because of conflicts. Accordingly, the nature of our business limits the number of both potential clients and potential engagements.

We are subject to unpredictable risks of litigation.

Although we seek to avoid litigation whenever possible, from time to time we are party to various lawsuits and claims. Disputes may arise, for example, from employment issues, regulatory actions, business acquisitions and real estate and other commercial transactions. There can be no assurances that any lawsuits or claims will be immaterial in the future. Any material lawsuits or claims could adversely affect our business and reputation.

14

We may experience security breaches that could lead to the inability to protect confidential information.

Despite the implementation of security measures, our operating systems are vulnerable to electronic breaches of security. Such breaches could lead to disruptions of our operations and potential unauthorized disclosure of confidential information, which could result in legal claims or proceedings. While we have taken reasonable steps to prevent and mitigate the damage of a security breach by continuously improving our design and coordination of security controls across our business, those steps may not be effective and there can be no assurance that any such steps can be effective against all possible risks.

Impairment of goodwill may require us to record a significant charge to earnings.

On our balance sheet, we have $8,607,000 of goodwill subject to periodic evaluation for impairment. Failure to achieve sufficient levels of cash flow at reporting units, the loss of key employees, changes to the scope of operations of our business or a significant and sustained decline in our stock price could result in goodwill impairment charges. During times of financial market volatility, significant judgment is required to determine the underlying cause of the decline and whether stock price declines are short-term in nature or indicative of an event or change in circumstances.

Impairment of long-lived assets or restructuring activities may require us to record a significant charge to earnings.

Our long-lived assets, including our office, laboratory and warehouse space in Menlo Park, California and our test and engineering center in Phoenix, Arizona, are subject to periodic testing for impairment. Failure to achieve sufficient levels of cash flow at the asset group level could result in impairment of our long-lived assets. In addition, we have operating lease commitments for office, warehouse and laboratory space of $27,428,000 as of December 29, 2017. Changes in the business environment could lead to changes in the scope of operations of our business. These changes, including the closure of one or more offices, could result in restructuring and/or asset impairment charges.

Our international operations create special risks that could adversely affect our business.

In addition to our offices in the United States, we have physical offices in the United Kingdom, Germany, Switzerland, Hong Kong and China and conduct business in several other countries. We expect to continue to expand globally and our international revenues may account for an increasing portion of our revenues in the future. Our international operations carry special financial, business and legal risks, including cultural and language differences; employment laws and related factors that could result in lower utilization, higher staffing costs, and cyclical fluctuations of utilization and revenues; currency fluctuations that adversely affect our financial position and operating results; burdensome regulatory requirements and other barriers to conducting business; managing the risks associated with engagements with foreign officials and governmental agencies, including the risks arising from the United States Foreign Corrupt Practices Act and the United Kingdom Bribery Act of 2010; greater difficulties in managing and staffing foreign operations; successful entry and execution in new markets; restrictions on the repatriation of earnings; and potentially adverse tax consequences.

Inherent risks related to government contracts may adversely affect our business.

We work for various United States and foreign governmental entities and agencies. Government contracts entail, among other things, the obligation to comply with numerous regulations and requirements that may not otherwise apply to us. Government entities reserve the right to audit our contracts and conduct inquiries and investigations of our business practices with respect to government contracts. Findings from an audit may result in fees being refunded to the government or prospective adjustment to previously agreed upon rates that will affect future margins. If a government client discovers improper or illegal activities in the course of audits or investigations, we may become subject to various civil and criminal penalties and administrative sanctions, which may include termination of contracts, forfeiture of profits, suspension of payments, fines and suspensions or debarment from doing business with other agencies of the government. The inherent limitations of internal controls may not prevent or detect all improper or illegal activities, regardless of the adequacy of such controls. Government contracts, and the proceedings surrounding them, are often subject to more extensive scrutiny and publicity than other commercial contracts. Negative publicity related to our government contracts, regardless of whether it is accurate, may further damage our business by affecting our ability to compete for new contracts.

15

A decline in the U.S. Government budget, changes in budgetary priorities or timing of contract awards may adversely affect our business.

Our operating results could be adversely affected by spending caps or changes in the budgetary priorities of the U.S. Government, as well as delays in program starts or the award of contracts or task orders under contracts. Current U.S. Government spending levels may not be sustained and future spending and program authorizations may not increase or may decrease or shift to programs in areas in which we do not provide services or are less likely to be awarded contracts. Such changes in spending authorizations and budgetary priorities may occur as a result of the rapid growth of the federal budget deficit, increasing political pressure and legislation. The U.S. Government also conducts periodic reviews of strategies and priorities, which may shift budgetary priorities, reduce overall U.S. Government spending or delay contract or task order awards. In addition, changes to the U.S. Government acquisition system and contracting models could affect whether and how we pursue certain opportunities and the terms under which we are able to do so. A significant decline in overall U.S. Government spending, the substantial reduction or elimination of particular programs or significant delays in contract or task order awards could adversely affect our business.

GovernmentsClients may terminate, cancel, modify or curtail our contracts at any time prior to their completion.

Under many of our contracts, including our government contracts, the client generally has the right not to exercise options to extend or expand our contracts and may otherwise terminate, cancel, modify or curtail our contracts at its convenience. Our engagements can therefore terminate suddenly and without advance notice to us. Any decision by the client not to exercise contract options or to terminate, cancel, modify or curtail our programs or contracts would adversely affect our revenues, revenue growth and profitability.

Risks Related to Our Operations

Failure to attract and retain key employees may adversely affect our business.

Our business involves the delivery of professional services and is labor-intensive. Our success depends in large part upon our ability to attract, retain and motivate highly qualified technical and managerial personnel. Qualified personnel are in great demand and are likely to remain a limited resource for the foreseeable future. We cannot provide

16


any assurance that we can continue to attract sufficient numbers of highly qualified technical and managerial personnel and retain existing employees. We have experienced and expect to continue to experience employee turnover. The loss of key managerial employees, business generators or any significant number of employees could incurhave a material adverse impact on our business, including our ability to secure and complete engagements. We rely heavily on our executive officers, group vice presidents, and practice/office directors to manage our operations. Given the highly specialized nature of our services and the scale of our operations, our executive officers, group vice presidents and practice/office directors must have a thorough understanding of our services and operations, as well as the skills and experience necessary to manage a large organization in diverse geographic locations. We are unable to predict with certainty the impact that leadership transitions and the loss of certain employees in leadership roles may have on our business operations, prospects, financial results, client relationships, or employee retention or morale.

Our engagements may result in professional or other liability.

Our services typically involve difficult engineering and scientific assignments and carry risks of professional and other liability. Many of our engagements involve matters that could have a severe impact on a client's business, cause a client to lose significant amounts of money, or prevent a client from pursuing desirable business opportunities. Accordingly, if a client is dissatisfied with our performance, the client could threaten or bring litigation in order to recover damages or to contest its obligation to pay our fees. Litigation alleging that we performed negligently, disclosed client confidential information, lost or damaged evidence, infringed on patents, were forced to withdraw from a legal matter due to a conflict or otherwise breached our obligations to a client could expose us to significant liabilities and suffer negative publicity if peopleto our clients or propertiesother third parties or tarnish our reputation.

We are harmed by the products and systems we sell or the services we offer.

We design, develop, manufacture, sell, service and maintain various products and systems. In some instances, we also train operators of such products and systems. Many of these products and systems utilize software algorithms that are probabilistic in nature and subject to significant technical limitations.unpredictable risks of litigation.

Although we seek to avoid litigation whenever possible, from time to time we are party to various lawsuits and claims. Disputes may arise, for example, from employment issues, regulatory actions, business acquisitions and real estate and other commercial transactions. There can be no assurances that any lawsuits or claims will be immaterial in the future. Any material lawsuits or claims could adversely affect our business and reputation.

We are many factors, somesubject to security breaches that may disrupt our operations and/or lead to the inability to protect confidential information.

We have experienced, and expect to continue to be subjected to, security breaches and threats, none of which have been material to us to date. Despite the implementation of security and business continuity measures, our information technology infrastructure and networks are beyondvulnerable to electronic breaches of security. Furthermore, we are subject to risks to information security posed by external or insider threats, including unauthorized access, manipulation, misuse, or improper disclosure of proprietary, sensitive, or confidential information by employees, contractors, or other insiders. Any such breaches could lead to disruptions of our control,operations and potential unauthorized disclosure of confidential and/or personal information, which could result in legal claims or proceedings, have impacts to our operations, and/or cause harm to our reputation. Our systems and data are protected by a comprehensive Information Security program detailed in our Information Security Management System. Dedicated security, privacy, information governance, and compliance professionals maintain the program with oversight provided by the Board of Directors in conjunction with senior leadership. See Item 1C. for more information about our Cybersecurity Risk Management and Strategy. While we have taken reasonable steps to prevent and mitigate the damage of a security breach by continuously improving our design and coordination of security controls across our business, those steps may not be effective and there can be no assurance that any such steps can be effective against all possible risks.

Laws regarding data protection continue to rapidly evolve, and failure to protect client and employee data may have an adverse effect on our business.

We manage, utilize, and store sensitive or confidential client and employee data, including personal data and protected health information. As a result, we are subject to numerous laws and regulations designed to protect this information, such as the U.S. federal and state laws governing the protection of health or other personally identifiable information, including the Health Insurance Portability and Accountability Act, and international laws such as the European Union General Data Protection Regulation and the People’s Republic of China’s Data Security Law. In addition, many states, U.S. federal governmental authorities and non-U.S. jurisdictions have adopted, proposed, or are considering adopting

17


or proposing, additional data security and/or data privacy statutes or regulations. For instance, we may be subject to Federal Trade Commission (FTC) enforcement actions if the FTC has reason to believe we have engaged in unfair or deceptive privacy or data security practices in violation of the FTC Act. In addition, an increasing number of U.S. states have enacted U.S. state privacy laws that set forth comprehensive privacy and security obligations regarding the collection and processing of personal data, including such as the California Consumer Privacy Act, as amended by the California Privacy Rights Act, and other state laws that set forth comprehensive privacy and security obligations regarding the collection and processing of personal data. These laws and regulations are increasing in complexity and number. As a result of these legal and regulatory requirements we incur and expect to continue to incur significant ongoing costs as part of our productsefforts to comply with applicable law. Failure to comply with these laws and regulations may lead to significant monetary damages, regulatory enforcement actions, fines, penalties or systems. The failureother regulatory liabilities, such as orders or consent decrees forcing us to modify business practices, and reputational damage or third-party lawsuits for any noncompliance with such laws. If any person, including any of our productsemployees, negligently disregards or intentionally breaches our established controls with respect to client or employee data, or otherwise mismanages or misappropriates that data, we could also be subject to significant monetary damages, regulatory enforcement actions, fines, and/or criminal prosecution. In addition, unauthorized disclosure of sensitive or confidential client or employee data, whether through systems failure, employee negligence, fraud, or misappropriation, could damage our reputation and cause us to lose clients and their related revenue in the future.

Our international operations create special risks that could adversely affect our business.

In addition to our offices in the United States, we have a presence in the United Kingdom, Switzerland, Hong Kong, China, Singapore, Ireland, Germany, and Canada, and conduct business in several other countries. We expect to continue to expand globally and our international revenues may account for an increasing portion of our revenues in the future. Our international operations carry special financial, business and legal risks, including cultural and language differences; employment laws and related factors that could result in lower utilization, higher staffing costs, and cyclical fluctuations of utilization and revenues; currency fluctuations that adversely affect our financial position and operating results; burdensome regulatory requirements and other barriers to conducting business; tariffs/trade disputes and other trade barriers; geopolitical risks that could result in an adverse impact to our clients and Exponent, such as cyberattacks, trade sanctions, and increased regulatory scrutiny on operations; armed conflicts and wars, including the Russia-Ukraine war and the conflicts in the Middle East; managing the risks associated with engagements with foreign officials and governmental agencies, including the risks arising from the United States Foreign Corrupt Practices Act and the United Kingdom Bribery Act of 2010; managing the risks associated with global privacy and data security laws and regulations including the General Data Protection Regulation in Europe and China’s data protection and national security laws; greater difficulties in managing and staffing foreign operations; successful entry and execution in new markets; restrictions on the repatriation of earnings; potentially adverse tax consequences; and other impending legislation that could add additional risks to the business.

Employee or contractor misconduct, or our failure to comply with governmental, regulatory and legal requirements or with our company-wide Code of Business Conduct and Ethics and related policies could lead to injury, death,governmental or extensive propertylegal proceedings that could expose us to significant liabilities and damage our reputation.

Misconduct, fraud, non-compliance with applicable laws and mayregulations or other improper activities by one of our employees, agents or partners could have a significant negative impact on our business and reputation. Such misconduct could include the failure to comply with government procurement regulations, regulations regarding the protection of classified information, regulations prohibiting bribery and other foreign corrupt practices, regulations regarding the pricing of labor and other costs in government contracts, regulations on lobbying or similar activities, regulations pertaining to the internal controls over financial reporting, environmental laws and any other applicable laws or regulations. Our Code of Business Conduct and Ethics and related policies mandate compliance with applicable laws including anti-bribery, and insider trading. Nonetheless, we cannot assure that our policies, procedures and related training programs will ensure full compliance with all applicable legal requirements. Illegal or improper conduct by our executive officers, directors, employees, independent consultants or contractors, or others who are subject to our policies and procedures could damage our reputation in the U.S. and internationally, which could adversely affect our existing client relationships or adversely affect our ability to attract and retain new clients, or lead to product liability, professional liability,litigation or other claimsgovernmental or regulatory proceedings in the U.S. or foreign jurisdictions, or could subject us to fines and penalties, loss of security clearances and suspension or debarment from contracting, any or all of which could harm our reputation, reduce our revenue and profits and subject us to criminal and civil enforcement actions.

18


Failure to comply with domestic and international export laws could adversely affect our business.

To the extent we export technical services, data and information outside of the locations where we operate, we are subject to U.S. and international laws and regulations governing international trade and exports, including but not limited to the International Traffic in Arms Regulations, the Export Administration Regulations and trade sanctions against us. Further, if our productsembargoed countries. A failure to comply with these laws and regulations could result in civil or systems fail,criminal sanctions, including the imposition of fines, the denial of export privileges and suspension or are perceived to have failed, the negative publicitydebarment from such incidentparticipation in U.S. government contracts, which could have a material adverse effect on our business.

Our business depends on our ability to use and access information systems, and modernize or replace such systems from time to time, and failure to effectively maintain such systems or modernize or replace systems, or difficulties encountered in implementing new or replacement systems could materially adversely affect our business and operations and harm our reputation.

We depend on multiple internal and external information systems for operating our business. We utilize commercially available third-party technology solutions, which in many cases are customized to our business needs. Our information systems may be compromised by power outages, computer and telecommunications failures, computer viruses, security breaches, hackers, catastrophic events, human error and other events, many of which are beyond our control, and are subject to obsolescence and technological changes. If our information systems fail to work properly or otherwise become unavailable, or if we encounter difficulties in integrating new or replacement systems, we may incur substantial time, efforts and costs to repair or replace such systems, or otherwise carry out our operations without the ability to use such systems. Failure of any such information system could result in delays, significant additional costs, incorrect information, failure of internal control and harm to our reputation as well as expose us to regulatory actions and claims any of which could adversely affect our business and results of operations and our reputation.

Increases in operating expenses may adversely affect our profitability and margins.

Increases in compensation and related expenses, other operating expenses, general and administrative expenses, and tax expenses due to inflation, supply chain disruptions, labor market conditions, real estate market conditions, geographic conditions, regulatory requirements, or other economic or political factors may adversely affect our profitability and margins. Increases in compensation and related expenses that exceed our bill rate increases, increases in rent when our operating leases expire, increases in compliance costs associated with new regulations, and increases in tax rates would adversely affect our profitability.

General Risks

Competition could reduce our pricing and adversely affect our business.

The markets for our services are highly competitive. In addition, there are relatively low barriers to entry into our markets and we have faced, and expect to continue to face, additional competition from new entrants into our markets. Competitive pressure could reduce the market acceptance of our services and result in limitations in our ability to implement billing rate increases or maintain billing rates that could have a material adverse effect on our business, financial condition or results of operations.

We hold substantial investments that could present liquidity risks.

Our cash equivalent portfolio as of December 29, 2023 consisted primarily of obligations of the U.S. Treasury. We follow an established investment policy to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

Investments in some financial instruments may pose risks arising from liquidity and credit concerns. As of December 29, 2023, we had no impairment charge associated with our investment portfolio relating to such adverse financial

19


market conditions. Although we believe our current investment portfolio has a low risk of impairment, we cannot predict future market conditions or market liquidity and can provide no assurance that our investment portfolio will remain unimpaired.

Impairment of goodwill may require us to record a significant charge to earnings.

On our balance sheet as of December 29, 2023, we have $8,607,000 of goodwill subject to periodic evaluation for impairment. Failure to achieve sufficient levels of cash flow at reporting units, the loss of key employees, changes to the scope of operations of our business or a significant and sustained decline in our stock price could result in goodwill impairment charges. During times of financial market volatility, significant judgment is required to determine the underlying cause of the decline and whether stock price declines are short-term in nature or indicative of an event or change in circumstances.

Impairment of long-lived assets or restructuring activities may require us to record a significant charge to earnings.

Our long-lived assets, including our office, laboratory and warehouse space in Menlo Park, California, our Test and Engineering Center in Phoenix, Arizona, and our office and laboratory facilities in Natick, Massachusetts, are subject to periodic testing for impairment. Failure to achieve sufficient levels of cash flow at the asset group level could result in impairment of our long-lived assets. In addition, we have operating lease right-of-use assets for office and laboratory space which are also subject to impairment. Changes in the business environment could lead to changes in the scope of operations of our business. These changes, including the closure of one or more offices, could result in restructuring and/or asset impairment charges.

Changes in, or interpretations of, accounting principles could have a significant impact on our financial position and results of operations.

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”). These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant changes to our systems, processes and controls.

Uncertainty about current and future economic conditions and other adverse changes in general political conditions in any of the countries in which we do business could adversely affect our operating results.

Our business can be adversely affected by downturnsWe are subject to risks arising from adverse changes in economic and political conditions, both domestically and globally, including unfavorable changes in economic conditions, such as inflation, rising interest rates or a recession, and other events beyond our control, such as geopolitical developments, economic sanctions, natural disasters, pandemics, epidemics, political instability, armed conflicts and wars, including the Russia-Ukraine war and the conflict in the overall economy.

The markets that we serve are cyclicalMiddle East. Worsening economic conditions have had and subjectmay continue to general economic conditions. The directionhave an adverse impact on the businesses and relative strengthfinancial health of the global economy continues to be uncertain. If economic growth in the United States, where we primarily operate, slows,many of our clients. As a result, current or potential clients may consolidate or go out of business and thus demand for our services couldmay be reduced significantly. Political changes and trends such as populism, protectionism, economic nationalism and sentiment toward multinational companies, as well as tariffs, export controls, restrictions on outbound investment or other trade barriers, sanctions, currency controls, or changes to tax or other laws or policies, have been and may continue to be disruptive to our business. These can interfere with our global operating model, client relationships, and competitive position. Further escalation of any specific trade tensions between the U.S. and China, or in global trade conflict more broadly could be harmful to global economic growth or to our business in or with China or other countries.

Our quarterly results may vary.

Variations in our revenues and operating results occur from time to time, as a result of a number of factors, such as the significance of client engagements commenced and completed during a quarter, the timing of engagements, the number of working days in a quarter, employee hiring and utilization rates, and integration of companies acquired.rates. Because a high percentage of our expenses,

20


particularly personnel and facilities related expenses, are relatively fixed in advance of any particular quarter, a variation in the timing of the initiation or the completion of our client assignments can cause significant variations in operating results from quarter to quarter.

16

The market price of our common stock may be volatile.

Many factors could cause the market price of our common stock to rise and fall. These include the risk factors listed above and below; changes in estimates of our performance or recommendations by securities analysts; future sales of shares of common stock in the public market; market conditions in the industry and economy as a whole; acquisitions or strategic alliances involving us or our competitors; restatement of financial results; and changes in accounting principles or methods. In addition, the stock market often experiences significant price fluctuations. These fluctuations are often unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the market price of our common stock. When the market price of a company's stock drops significantly, shareholders often institute securities class action litigation against that company. Any litigation against us could cause us to incur substantial costs, divert the time and attention of our management and other resources, or otherwise harm our business.

There can be no assurance that we will continue to declare cash dividends or repurchase our shares at all or in any particular amounts.

Our Board of Directors has declared quarterly dividends since March 2013. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and, in the case of dividends, periodic determinations by our Board of Directors that cash dividends are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends by us. Future dividends and share repurchases may also be affected by, among other factors: our views on potential future capital requirements for investments, including acquisitions; legal risks; stock repurchase programs; changes in federal and state income tax laws or corporate laws; contractual restrictions; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments or share repurchase activity could have a negative effect on our stock price.

Catastrophic events may disrupt our business.

We rely on our network infrastructure and certain third-party hosted services to support our operations. A disruption or failure of these systems in the event of a major earthquake, fire, flood, tsunami or other weather event, power loss, telecommunications failure, software or hardware malfunctions, pandemics, cyber-attack, war, terrorist attack or other catastrophic event that our disaster recovery plans do not adequately address, could have a material adverse effect on our business, financial condition or results of operations.

Unavailability or cancellation of third-party insurance coverage would increase our overall risk exposure as well as disrupt the management of our business operations.

We maintain insurance coverage from third-party insurers as part of our overall risk management strategy and because some of our contracts require us to maintain specific insurance coverage limits. If any of our third-party insurers fail, suddenly cancel our coverage or otherwise are unable to provide us with adequate insurance coverage, then our overall risk exposure and our operational expenses would increase and the management of our business operations would be disrupted. In addition, there can be no assurance that any of our existing insurance coverage will be renewable upon the expiration of the coverage period or that future coverage will be affordable at the required limits.

Climate change may disrupt our business.

The areas where we conduct business are vulnerable to the effects of climate change. For example, in California, wildfire danger increases the probability of planned power outages which may impact our employees’ abilities to commute to work and to stay connected. Climate-related events, including the increasing frequency of extreme weather events and their impact on critical infrastructure, have the potential to disrupt our business.

21


Changes in interpretation and application of tax laws could harm our business, revenue, cash flows and financial results.

Tax reform remains a legislative priority for the U.S. government and certain legislations have already been enacted. While there is current uncertainty regarding what changes will eventually be enacted, such new laws may affect our operating results and financial conditions. On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 that includes, among other provisions, changes to the U.S. corporate income tax system, including a fifteen percent minimum tax based on “adjusted financial statement income,” and a one percent excise tax on net repurchases of stock after December 31, 2022. Changes, if any, to the U.S. or non-U.S. taxation of our operations may increase our worldwide effective tax rate, result in additional taxes, or other costs or have other material consequences, which could harm our business, revenue, cash flows and financial results.

22


Item 1B. Unresolved Staff Comments

None.

23


Item 1C. Cybersecurity

Risk Management and Strategy

We recognize the critical importance of cybersecurity and data privacy in safeguarding our operations, sensitive data, and maintaining the trust of our stakeholders. Cybersecurity incidents and threats as potential risks that may impact our operations and information systems. We have developed and implemented cybersecurity and data privacy programs in accordance with the requirements of ISO standards 27001:2013 and 27701:2019, which are intended to appropriately preserve the confidentiality, integrity, and availability of information maintained by our company. These programs identify, select, maintain, operate, and improve cybersecurity and privacy controls.

We have implemented processes for assessing, identifying, and managing material risks from cybersecurity threats. These processes are designed to preserve the confidentiality, integrity, and availability of our information systems and the information residing therein. Our cybersecurity incident response plan is based on the NIST 800-61r2 “Computer Security Incident Handling Guide.” This plan is used to process security events identified through our real-time, 24x7 monitoring, and conducts security incident tabletop exercises. The incident response plan includes detailed steps for incident leadership, escalation to established partners, response protocols based on the type of incident, responsibilities for follow-up and reporting, and steps to capture lessons learned and improvement opportunities. Our vulnerability management processes include real-time monitoring for vulnerabilities and standardized reporting for managing remediation efforts. Our cybersecurity risk management processes are integrated into our overall risk management system to ensure alignment with our business objectives and strategies. We engage assessors, consultants, auditors and other third parties to execute certification audits, penetration tests, and security framework risk assessments. These external entities provide specialized expertise and insights to enhance the effectiveness of our cybersecurity risk management processes.

We have established processes to oversee and identify cybersecurity risks associated with our use of third-party service providers. We conduct due diligence assessments and evaluate contractual obligations to mitigate potential risks arising from third-party relationships.

Cybersecurity threats, including previous incidents, have the potential to materially affect our company, including our business strategy, results of operations, and financial condition. While we have not experienced material adverse effects from cybersecurity threats to date, we recognize the evolving nature of these risks and remain vigilant in our efforts to mitigate potential impacts.

Governance

Our Board of Directors provides oversight of risks from cybersecurity threats. The Security and Privacy Management Committee (the “SPMC”) consists of our Chief Financial Officer, General Counsel, Vice President of Information Technology, Chief Human Resources Officer, Director of Information Security and Director of Environmental Health and Safety. The SPMC is tasked with ensuring risks are adequately addressed within our governance framework.

We maintain a dedicated team of cybersecurity professionals. The Director of Information Security, the Information Security team, the SPMC, the Vice President of Information Technology, and the Information Technology leadership team are principally responsible for assessing and managing cybersecurity risks for our company. These individuals possess relevant expertise in cybersecurity risk management and are equipped to address the evolving nature of cyber threats. Our Director of Information Security has over 20 years of cybersecurity experience, holds several professional certifications and is an adjunct faculty member teaching courses on information security management and governance. Our cybersecurity professionals have a proven track record of executing strategic security objectives across various sectors, including utility, government, healthcare, and consulting. They bring with them experience in designing, implementing, and managing information security programs focused on quality, performance, and compliance.

Our information security team and our third-party security service providers actively monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents, ensuring timely response and resolution. Processes are in place to inform relevant management positions and committees about emerging threats and incident response activities. The Director of Information Security provides regular updates on cybersecurity risks and incidents to the Board of Directors, the SPMC, and IT leadership.

24


Item 2.Properties

Our Silicon Valley office facilities consist of a 153,738 square foot building, with office and laboratory space located on a 6.3-acre tract of land we own in Menlo Park, California and an adjacent 27,000 square feet of warehouse storage space on a 1.1-acre tract of land that we also own.

Our Test and Engineering Center (TEC) occupies 147 acres in Phoenix, Arizona. We lease this land from the state of Arizona under a 30-year lease agreement that expires in January 2028 and have options to renew for two fifteen-year15-year periods. We constructed ana 21,613 square foot indoor test facility as well as ana 44,053 square foot engineering and test preparation building at the TEC.

Our office facilities in Natick, Massachusetts, consist of a 60,480 square foot building, with office and laboratory space located on a 2.9 acre tract of land that we own and an adjacent building that consists of 9,100 square feet of office space located on a 0.81 acre tract of land that we also own.

In addition, we lease office warehouse and laboratory space in 1821 other locations in 13 states and the District of Columbia, as well as in Germany, China, Hong Kong, Singapore, Switzerland and the United Kingdom. Leases for these offices warehouse and laboratory facilities have terms generally ranging between one and ten10 years. Aggregate lease expense in fiscal 2017 for all leased properties was $6,712,000.

Item 3. Legal Proceedings

Exponent is not engaged in any material legal proceedings.

Item 4. Mine Safety Disclosures

Not applicable.

17

25


PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Exponent’s common stock is traded on the NASDAQ Global Select Market, under the symbol “EXPO.” The following table sets forth for the fiscal periods indicated the high and low sales prices for our common stock.

Stock prices by quarter High  Low 
Fiscal Year Ended December 30, 2016:        
First Quarter $51.99  $44.82 
Second Quarter $58.65  $48.39 
Third Quarter $59.71  $45.00 
Fourth Quarter $64.80  $48.42 
         
Fiscal Year Ended December 29, 2017:        
First Quarter $60.85  $55.75 
Second Quarter $63.80  $56.95 
Third Quarter $75.43  $57.05 
Fourth Quarter $77.15  $69.60 

As of February 16, 2018,2024, there were 182166 holders of record of our common stock. Because many of the shares of our common stock are held by brokers and other institutions on behalf of stockholders, we believe that there are considerably more beneficial holders of our common stock than record holders.

We paid $21.6 million, $18.6 million and $15.5 million of dividends during fiscal 2017, 2016 and 2015, respectively. Total dividends paid per share were $0.84, $0.72 and $0.60 during fiscal 2017, 2016 and 2015, respectively. On February 1, 2018, our Board of Directors announced a quarterly cash dividend of $0.26 per share of the Company’s common stock, payable March 23, 2018, to stockholders of record as of March 2, 2018. We anticipate paying quarterly dividends each year in March, June, September and December, subject to declaration by our Board of Directors. See Part II, “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources.”

18

The following table provides information on the Company’s share repurchases (of Company common stock) for the quarter ended December 29, 20172023 (in thousands, except price per share):

 

 

Total
Number
of Shares
Purchased

 

 

Average
Price
Paid Per
Share

 

 

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs

 

 

Approximate Dollar
Value of Shares
That May Yet Be
Purchased Under
the Plan or Program

 

September 30 to October 27

 

 

44

 

 

$

73.51

 

 

 

44

 

 

$

42,411

 

October 28 to November 24

 

 

54

 

 

 

73.73

 

 

 

54

 

 

$

38,390

 

November 25 to December 29

 

 

-

 

 

 

-

 

 

 

-

 

 

$

38,390

 

Total

 

 

98

 

 

 

73.63

 

 

 

98

 

 

$

38,390

 

  Total Number
of Shares
Purchased
  Average
Price Paid
Per Share
  Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
  Approximate Dollar
Value of Shares That
May Yet Be Purchased
Under the Plan or
Program
 
             
September 30 to October 27  -  $-   -  $48,876 
October 28 to November 24  -   -   -  $48,876 
November 25 to December 29  46  $75.36   46  $45,376 
Total  46  $75.36   46     

Repurchases of the Company’s common stock were effectedaffected pursuant to a repurchase program authorized by the Company’s Board of Directors. On May 29, 2014,February 22, 2022 the Company’s Board of Directors authorized $35,000,000announced approval of $150,000,000 for the repurchase of the Company’s common stock. On October 20, 2015,February 1, 2024 the Company’sCompany's Board of Directors authorized $35,000,000an additional $61,600,000 for the repurchase of the Company’s common stock. On October 18, 2016, the Company’s Board of Directors authorized $35,000,000 for the repurchase of the Company’sCompany's common stock. These repurchase programs have no expiration dates. As of December 29, 2017, there remained $45,376,000 available for repurchases under these authorizations.

COMPANY STOCK PRICE PERFORMANCE GRAPH

TheThis graph compares the Company’s cumulative total stockholder return calculated on a dividend-reinvested basis from 20122019 through 20172023 with those of the Standard & Poor’s (“S&P”) 500 Index, the S&P MidCap 400 Index, and the S&P SmallCap 600 Index. The Company does not have a comparable peer group and thus has selected the S&P Small CapMidCap 400 Index. In prior years the company used the S&P SmallCap 600 Index. During 2023, the company was added to the S&P MidCap 400 Index. As such the company selected this index for 2023. The graph assumes that $100

26


was invested on the last day of 2012.2018. Note that the historic stock price performance is not necessarily indicative of future stock price performance.

img37928738_0.jpg 

 

19

Item 6. Selected Financial Data(Reserved)

27


The following selected consolidated financial data are derived from our consolidated financial statements. This data should be read in conjunction with the consolidated financial statements and notes thereto, and withPart II - “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

  Fiscal Year 
(In thousands, except per share data) 2017  2016  2015  2014  2013 
                
Consolidated Statements of Income Data:                    
                     
Revenues before reimbursements $329,664  $299,197  $295,705  $289,209  $280,043 
Revenues $347,799  $315,076  $312,832  $304,704  $296,168 
Operating income $72,051  $61,911  $68,933  $63,549  $55,946 
Net income $41,305  $47,480  $43,599  $40,701  $38,640 
                     
Net income per share:                    
Basic $1.57  $1.79  $1.64  $1.51  $1.42 
Diluted $1.53  $1.75  $1.60  $1.47  $1.38 
                     
Cash dividends declared per share $0.84  $0.72  $0.60  $0.50  $0.30 
                     
Consolidated Balance Sheet Data:                    
                     
Cash and cash equivalents $124,794  $114,967  $125,751  $129,490  $122,948 
Short-term investments $71,604  $58,755  $45,842  $24,913  $33,171 
Working capital $222,402  $193,808  $192,312  $176,153  $171,402 
Total assets $439,589  $403,744  $387,507  $365,299  $344,166 
Long-term liabilities $57,394  $50,162  $44,229  $41,666  $36,960 
Total stockholders’ equity $289,088  $273,346  $262,804  $244,288  $235,059 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section of this Annual Report on Form 10-K generally discusses 2023 and 2022 items and year-to-year comparisons between 2023 and 2022. Discussions of 2022 and year-to-year comparisons between 2022 and 2021 that are not included in this Annual Report form 10-K can be found in Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2022.

OVERVIEW

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 50 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges of sustainability.

CRITICAL ACCOUNTING ESTIMATES

In preparing our consolidated financial statements, we make assumptions, judgments and estimates that can have a significant impact on our revenue, operating income and net income, as well as on the value of certain assets and liabilities on our consolidated balance sheet. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis we evaluate our assumptions, judgments and estimates and make changes accordingly. We believe that the assumptions, judgments and estimates involved in accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. We discuss below the assumptions, judgments and estimates associated with these policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. For further information on our critical accounting policies, seeNote 1: Summary of Significant Accounting Policies”1 of ourNotes to Consolidated Financial Statements.

20

Revenue recognition.We derive our revenues primarily from professional fees earned on consulting engagements, fees earned for the use of our equipment and facilities, as well as reimbursements for outside direct expenses associated with the services that are billed to our clients.

Substantially all of our engagements are service contracts performed under time and material or fixed-price billing arrangements. For time and material and fixed-price service projects, revenue is generally recognized as the services are performed. For substantially all of our fixed-price service engagements, we recognize revenue based on the relationship of incurred labor hours at standard rates to our estimate of the total labor hours at standard rates we expect to incur over the term of the contract. Our estimate of total labor hours we expect to incur over the term of the contract is based on the nature of the project and our past experience on similar projects. We believe this methodology achieves a reliable measure of the revenue from the consulting services we provide to our customers under fixed-price contracts.

Management judgments and estimates must be made and used in connection with the revenues recognized in any accounting period. These judgments and estimates include an assessment of the estimate as to the total effort required to complete fixed-price projects. If we made different judgments or utilized different estimates, the amount and timing of our revenue for any period could be materially different.

All contracts are subject to review by management, which requires a positive assessment of the collectability of contract amounts. If, during the course of the contract, we determine that collection of revenue is not reasonably assured, we do not recognize the revenue until its collection becomes reasonably assured, which in those situations would generally be upon receipt of cash. We assess collectability based on a number of factors, including past transaction history with the client, as well as the credit-worthiness of the client. Losses on fixed-price contracts are recognized during the period in which the loss first becomes evident. Contract losses are determined to be the amount by which the estimated total costs of the contract exceeds the total fixed price of the contract.

Estimating the allowance for contract losses and doubtful accounts.We make estimates of our ability to collect accounts receivable and our unbilled but recognized work-in-process. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations to us or for disputes with customers that affect our ability to fully collect our accounts receivable and unbilled work-in-process, we record a specific allowance to reduce the net recognized receivable to the amount we reasonably believe will be collected. For all other customers we recognize allowances for contract losses and doubtful accounts taking into consideration factors such as historical write-offs, customer concentration, customer credit-worthiness,creditworthiness, current and forecasts of future economic conditions, and aging of amounts due.

21

28


The following table sets forth, for the periods indicated, the percentage of revenues of certain items in our consolidated statements of income and the percentage increase (decrease) in the dollar amount of such items year to year:

 

 

Percentage of Revenues for

 

 

Period to

 

 

 

Fiscal Years

 

 

Period Change

 

 

 

2023

 

 

2022

 

 

2023 v 2022

 

Revenues

 

 

100.0

%

 

 

100.0

%

 

 

4.6

%

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Compensation and related expenses

 

 

59.6

 

 

 

51.5

 

 

 

21.1

 

Other operating expenses

 

 

7.7

 

 

 

6.8

 

 

 

18.4

 

Reimbursable expenses

 

 

7.4

 

 

 

9.6

 

 

 

(20.0

)

General and administrative expenses

 

 

4.6

 

 

 

4.6

 

 

 

3.3

 

 

 

79.3

 

 

 

72.6

 

 

 

14.2

 

Operating income

 

 

20.7

 

 

 

27.4

 

 

 

(21.0

)

 

 

 

 

 

 

 

 

 

Other income, net

 

 

4.6

 

 

 

(1.7

)

 

 

385.5

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

25.3

 

 

 

25.8

 

 

 

2.8

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

6.6

 

 

 

5.8

 

 

 

18.9

 

 

 

 

 

 

 

 

 

 

Net income

 

 

18.7

%

 

 

19.9

%

 

 

(1.9

)%

  PERCENTAGE OF REVENUES  PERIOD TO 
  FOR FISCAL YEARS  PERIOD CHANGE 
  2017  2016  2015  2017 vs. 2016  2016 vs. 2015 
                
Revenues  100.0%  100.0%  100.0%  10.4%  0.7%
                     
Operating expenses:                    
Compensation and related expenses  60.5   61.4   59.0   8.7   4.8 
Other operating expenses  8.5   9.0   8.6   4.0   5.3 
Reimbursable expenses  5.2   5.0   5.5   14.2   (7.3)
General and administrative expenses  5.1   4.9   4.9   14.8   1.3 
   79.3   80.3   78.0   8.9   3.8 
Operating income  20.7   19.7   22.0   16.4   (10.2)
                     
Other income, net  3.0   2.3   0.7   45.0   227.8 
                     
Income before income taxes  23.7   22.0   22.7   19.4   (2.8)
                     
Provision for income taxes  11.8   6.9   8.8   90.4   (21.4)
                     
Net income  11.9%  15.1%  13.9%  (13.0)%  8.9%

EXECUTIVE SUMMARY

Revenues for 20172023 increased 10%5% and revenues before reimbursements also increased 10%7% as compared to the prior year. The increase in revenues before reimbursements was due to an increase in billable hours and an increase in billing rates. Our multidisciplinary team of scientists and engineers continues to provide critical data, analyses and insights for our clients as society raises expectations for safety, health and the environment. Growth during 2023 was driven by our reactive business, which experienced strong demand for failure investigations and dispute-related work. Demand for our services across the transportation and energy sectors was strong during 2023. Proactive revenues for the consumer electronics sector declined during 2023 due to ongoing industry headwinds and product lifecycle timing. The remainder of our proactive portfolio grew during 2023 primarily driven by safety-related work evaluating the impacts of chemicals on human health and the environment.

Society is raising the bar for safety, health, sustainability and reliability, and clients are increasingly seeking our interdisciplinary proactive solutions. As our suite of offerings and key markets expands, so does the demand for our multidisciplinary services. We continue to see demand forexpand our proactive services inclient relationships and enhance our reputation and capabilities across the areas of designfirm. As innovation and regulatory consulting, specifically related to consumer electronics. We also continue to see demand for our reactive services in construction disputes, medical device litigations, consumer product and automobile recalls, and product liability claims.

During 2017, we had strong growth in our chemical regulation & food safety, construction consulting, human factors, mechanical engineering, and polymer science & materials chemistry practices. We have been engaged to perform human factors assessments by appliance manufacturers, consumer electronics companies, medical device firms, and video game developers, including work in augmented reality. Duringtechnology become increasingly complex, the year, we worked on a large human factors assessment for a client in the consumer products industry, driving increases in both revenue and profitability. This project represented approximately 6%critical nature of our revenues before reimbursements for 2017 and leveraged staff across many ofinsights uniquely positions Exponent to address our practices and offices.clients’ needs throughout the product lifecycle.

During the year, we increased our international construction disputes work with current mining, gas terminal and power plant projects. We also experienced growth from lithium-ion battery consulting for clients in the consumer products, transportation, medical device, and utility industries. Our interdisciplinary team of chemists, electrical engineers, materials scientists and mechanical engineers has guided clients with respect to the performance, reliability, and safety of new products, as well as with respect to recalls and litigation matters involving existing products with lithium-ion batteries.

22

Net income decreased to $41,305,000was $100,339,000 during 20172023 as compared to $47,480,000$102,330,000 during 2016.2022. Diluted earnings per share decreased to $1.53$1.94 for 20172023 as compared to $1.75$1.96 for 2016. The decrease in net2022. Net income and diluted earnings per share for 2023 and 2022 benefited from the excess tax benefit associated with stock-based awards. The excess tax benefit associated with stock-based awards decreased to $3,620,000 during 2023 as compared to $5,829,000 during 2022. The decrease in the excess tax benefit was due to the impact of the new tax legislation. During the fourth quarter of 2017, we recorded a tax expense of $16,507,000 related to the new tax legislation signed into law during the fourth quarter of 2017. We have domestic deferred tax assets primarily associated with our deferred compensation plan and stock-based compensation program, which were previously valued at the federal corporate income tax rate of 35%. Our deferred tax assets were re-measured at the lower enacted corporate tax rate of 21% which contributed $15,137,000 to thesmaller increase in income tax associated with the new tax legislation. We also have foreign earnings that were subject to the mandatory repatriation tax. The total mandatory repatriation tax, net of the benefitvalue of our foreign tax credits, contributed $1,370,000 tocommon stock between the increase in income tax expense associated withgrant date and the tax legislation.

Income before income taxes increased 19% to $82,509,000release date for the restricted stock units released during 20172023 as compared to $69,122,000 during 2016. We were able to improve pre-tax income by effectively managing headcount to align our resources with demand and benefited from a large human factors assessment for a client in the consumer products industry, which resulted in improved utilization and increased leverage of our cost structure.2022.

We remain focused on selectively adding top talentbuilding our world-class engineering and developingscientific team to position Exponent at the skills necessary to expand uponforefront of innovation and meet the ever-changing needs of our market position, providing clients with in-depth scientific research and analysis to determine what happened and how to prevent failures or exposures in the future.market. We also remain focused on capitalizing on emerging growth areas, managing other operating expenses, generating cash from operations, maintaining a strong balance sheet and undertaking activities such as share repurchases and dividends to enhance shareholder value.

29


OVERVIEW OF THE YEAR ENDED DECEMBERDecember 29, 20172023

Our revenues consist of professional fees earned on consulting engagements, fees for use of our equipment and facilities, and reimbursements for outside direct expenses associated with the services performed that are billed to our clients.

We operate on a 52-53 week fiscal year with each year ending on the Friday closest to December 31st. The fiscal years ended December 29, 2017, December 30, 2016 and January 1, 2016Fiscal period 2023 included 52 weeks of activity.activity and ended on December 29, 2023. Fiscal 2018period 2022 included 52 weeks of activity and ended on December 30, 2022. Fiscal period 2021 included 52 weeks of activity and ended on December 31, 2021. Fiscal period 2024 is 53 weeks and will end on Friday, December 28, 2018.January 3, 2025.

During 2017,2023, billable hours increased 9%2% to 1,218,0001,495,000 as compared to 1,118,0001,465,000 during 2016.2022. Our utilization increaseddecreased to 75%69% for 20172023 as compared to 70%74% for 2016.2022. The decrease in utilization during 2023 was due to an increase in technical full-time equivalent employees. Technical full-time equivalent employees increased 3%10% to 784 during 20171,047 for 2023 as compared to 764 during 2016 due to our recruiting and retention efforts.955 for 2022. We continue to selectively hire key talent to expand our capabilities.

FISCAL YEARS ENDED DECEMBERDecember 29, 2017,2023 AND DECEMBERDecember 30, 2016 2022

Revenues

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Engineering and Other Scientific

 

$

446,888

 

 

$

427,796

 

 

 

4.5

%

Percentage of total revenues

 

 

83.3

%

 

 

83.3

%

 

 

 

Environmental and Health

 

 

89,878

 

 

 

85,497

 

 

 

5.1

%

Percentage of total revenues

 

 

16.7

%

 

 

16.7

%

 

 

 

Total revenues

 

$

536,766

 

 

$

513,293

 

 

 

4.6

%

Revenues

  Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Engineering and Other Scientific $277,603  $248,297   11.8%
Percentage of total revenues  79.8%  78.8%    
Environmental and Health  70,196   66,779   5.1%
Percentage of total revenues  20.2%  21.2%    
             
Total revenues $347,799  $315,076   10.4%

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours and an increase in billing rates. Growth in this segment during 2023 was primary driven by demand for our services across the transportation and energy sectors. During 2017,2023, billable hours for this segment increased by 9.9%3% to 941,0001,188,000 as compared to 856,0001,153,000 during 2016. The increase was due2022. Utilization for this segment decreased to demand70% for services in our construction consulting, human factors, mechanical engineering, and polymer science & materials chemistry practices. Reactive services continued to grow as our engineers and scientists were engaged to address construction disputes, medical device litigations, and consumer product and automobile recalls. Proactive services expanded, as we performed human factors assessments for consumer products and design consulting for consumer electronics. Utilization increased to 77% for 20172023 as compared to 73%75% for 2016.2022 due to an increase in technical full-time equivalent employees. Technical full-time equivalentsequivalent employees in this segment increased 4.8%11% to 591818 during 2023 as compared to 736 for 2017 from 564 for 2016 due to our recruiting and retention efforts.2022.

The increase in revenues from our Environmental and Health segment was due to an increase in billing rates offset by a decrease in billable hours. Growth in this segment during 2023 was primarily driven by safety-related work evaluating the impacts of chemicals on human health and the environment. During 2017,2023, billable hours for this segment increaseddecreased by 5.7%2% to 277,000307,000 as compared to 262,000312,000 during 2016.2022. Utilization increasedfor this segment decreased to 64% for 2023 as compared to 69% for 20172022. Technical full-time equivalents increased 5% to 229 during 2023 as compared to 63%219 for 2016. During the year, the chemical regulation and food safety practice grew its proactive services to meet demand, as society remains concerned about chemicals affecting the global ecosystem and human health. Our environmental health scientists provided reactive services performing human health and environmental assessments. This segment’s contribution2022. The decrease in utilization was due to the large ongoing human factors assessment also contributed to the5% increase in billable hours and utilization. Technicaltechnical full-time equivalents decreased 3.5% to 193 during 2017 as compared to 200 for 2016 due to our efforts to align resources with anticipated demand.equivalent employees.

23

Revenues are primarily derived from services provided in response to client requests or events that occur without notice and engagements are generally terminable or subject to postponement or delay at any time by our clients. As a result, backlog at any particular time is small in relation to our quarterly or annual revenues and is not a reliable indicator of revenues for any future periods.

Compensation and Related Expenses

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Compensation and related expenses

 

$

319,886

 

 

$

264,235

 

 

 

21.1

%

Percentage of total revenues

 

 

59.6

%

 

 

51.5

%

 

 

 

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Compensation and related expenses $210,289  $193,397   8.7%
Percentage of total revenues  60.5%  61.4%    

30


The increase in compensation and related expenses during 20172023 was due to an increase in bonus expense, an increase in payroll expense, an increase in fringe benefits, and a change in the value of assets associated with our deferred compensation plan. During 2017, bonus expense increased by $7,718,000 due to a correspondingplan and an increase in income before income taxes, before bonus expense, and before stock-based compensation. During 2017, payrollwages and fringe benefits increased $4,769,000 and $991,000, respectively, due to the increase in technical full-time equivalent employees and our annual salary increase.benefits. During 2017,2023, deferred compensation expense increased $2,686,000$28,502,000 with a corresponding increase to other income, net, as compared withto the prior year due to the change in value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of the plan assets of $6,547,000$14,315,000 during 20172023 as compared to an increasea decrease in the value of the plan assets of $3,861,000$14,187,000 during 2016. We expect2022. Wages increased $21,084,000 and fringe benefits increased $4,888,000 during 2023 due to the impact of our compensation expense, excluding the changeannual salary increase and increase in valuenumber of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions.employees.

Other Operating Expenses

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Other operating expenses

 

$

41,541

 

 

$

35,083

 

 

 

18.4

%

Percentage of total revenues

 

 

7.7

%

 

 

6.8

%

 

 

 

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Other operating Expenses $29,544  $28,397   4.0%
Percentage of total revenues  8.5%  9.0%    

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses was primarily due to an increase in occupancy expense of $416,000,$2,037,000, an increase in computerdepreciation expense of $270,000,$1,837,000 and an increase in technical materialsinformation technology related expenses of $183,000, and several individually insignificant increases, which were associated with the$1,715,000. The increase in occupancy expenses was due to growth in technical full-time equivalent employees and investmentsthe transition back to our offices from a remote work environment. The increases in depreciation and information technology related expenses were due to continued investment in our corporate infrastructure. We expect other operating expenseexpenses to grow as we selectively add new talent and continue to make investments in our corporate infrastructure.

Reimbursable Expenses

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Reimbursable expenses

 

$

39,577

 

 

$

49,473

 

 

 

(20.0

)%

Percentage of total revenues

 

 

7.4

%

 

 

9.6

%

 

 

 

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Reimbursable expenses $18,135  $15,879   14.2%
Percentage of total revenues  5.2%  5.0%    

The increase in reimbursable expenses was primarily due to an increase in travel related costs associated with our large human factors assessment project. The amount of reimbursable expenses will vary from year to year depending on the nature of our projects. The decrease in reimbursable expenses as compared to 2022 was due to a decrease in proactive projects for the consumer electronics sector.

General and Administrative Expenses

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

General and administrative expenses

 

$

24,440

 

 

$

23,660

 

 

 

3.3

%

Percentage of total revenues

 

 

4.6

%

 

 

4.6

%

 

 

 

31


 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
General and administrative expenses $17,780  $15,492   14.8%
Percentage of total revenues  5.1%  4.9%    

The increase in general and administrative expenses during 20172023 was primarily due to an increase in travel and meals of $1,173,000,$953,000, an increase in contributionsbad debt expense of $250,000,$402,000 and an increase in marketing and promotionbusiness development expenses of $200,000$313,000, partially offset by a decrease in outside consulting expenses and an increase in legal expenseother professional services of $194,000.$736,000. The increase in travel and meals was due to a firm-wide managers’ meeting which occurs every other year.the continued easing of COVID-19 pandemic-related business and travel restrictions. The increase in bad debt expense was due to an increase in write-offs. The increase in marketing and promotionbusiness development expenses was due to several initiatives associated with the firm’s 50th anniversary. We expect general and administrative expenses toan increase as we selectively add new talent, expandin our business development efforts,activities. The decrease in outside consulting expenses and pursue staffother professional services was due a reduction in activity associated with developing content for our external website.

Operating Income

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Engineering and Other Scientific

 

$

153,918

 

 

$

152,679

 

 

 

0.8

%

Environmental and Health

 

 

28,432

 

 

 

27,340

 

 

 

4.0

%

Total segment operating income

 

 

182,350

 

 

 

180,019

 

 

 

1.3

%

Corporate operating expense

 

 

(71,028

)

 

 

(39,177

)

 

 

81.3

%

Total operating income

 

$

111,322

 

 

$

140,842

 

 

 

(21.0

)%

The increase in operating income for our Engineering and Other Scientific segment during 2023 as compared to 2022 was due to an increase in revenues, partially offset by an increase in expenses. The increase in revenues was due to an increase in billable hours and an increase in billing rates. Growth was driven by demand for our services across the transportation and energy sectors. The increase in expenses was due to an 11% increase in technical full-time equivalent employees and investments in our corporate infrastructure.

The increase in operating income for our Environmental and Health segment was due to an increase in revenues. The increase in revenues was due to an increase in billing rates, partially offset by a reduction in billable hours. Growth was driven by evolving regulatory requirements which drove safety-related engagements evaluating the impacts of chemicals on human health and the environment.

Certain operating expenses are excluded from our measure of segment operating income. These expenses include the costs associated with our human resources, finance, information technology, and business development initiatives.groups; the deferred compensation expense/benefit due to the change in value of assets associated with our deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in our allowance for contract losses and doubtful accounts.

24

The increase in corporate operating expenses during 2023 as compared to 2022 was primarily due to an increase in deferred compensation expense and an increase in the costs associated with our human resources, finance, information technology and business development groups. During 2023, deferred compensation expense increased $28,502,000, with a corresponding increase to other income, net, as compared to the prior year, due to the change in value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of plan assets of $14,315,000 during 2023 as compared to a decrease in the value of plan assets of $14,187,000 during 2022.

Other Income

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Other income

 

$

24,574

 

 

$

(8,608

)

 

 

(385.5

)%

Percentage of total revenues

 

 

4.6

%

 

 

(1.7

)%

 

 

 

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Other income $10,458  $7,211   45.0%
Percentage of total revenues  3.0%  2.3%    

Other income consists primarily of interest income earned on available cash, cash equivalents and short-term investments, changes in the value of assets associated with our deferred compensation plan and rental income from leasing excess space in our Silicon Valley facility.and Natick facilities. The increase in other income was primarily due to the change in value of assets associated with our deferred compensation plan. plan and a change in the realized gain and loss on foreign exchange partially offset by an increase in interest income and an increase in rental income.

During 2017,2023, other income increased $2,686,000$28,502,000 with a corresponding increase to deferred compensation expense as compared to 2016. This change consisted of an increase in the value of the plan assets of $6,547,000 during 2017 as compared to an increase in the value of the plan assets of $3,861,000 during 2016. The increase in other income during 2017 was also due to an increase in interest income of $611,000 due to higher interest rates for our cash equivalents and short-term investments.

Income Taxes

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2017  2016  Change 
          
Income taxes $41,204  $21,642   90.4%
Percentage of total revenues  11.8%  6.9%    
Effective tax rate  49.9%  31.3%    

The increase in income tax expense was due to an increase in pre-tax income and the impact of the new tax legislation signed into law during the fourth quarter of 2017, partially offset by an increase in the excess tax benefit associated with share-based payment awards. During 2017, we recorded a tax expense of $16,507,000 related to the new tax legislation. We have significant domestic deferred tax assets primarily associated with our deferred compensation plan and stock-based compensation program, which were previously valued at the federal corporate income tax rate of 35%. Our deferred tax assets were re-measured at the lower enacted corporate tax rate of 21%, which contributed $15,137,000 to the increase in income tax associated with the new tax legislation. We also have foreign earnings that were subject to the mandatory repatriation tax. The total mandatory repatriation tax, net of the benefit of our foreign tax credits, contributed $1,370,000 to the increase in income tax expense associated with the tax legislation.

The excess tax benefit associated with share-based payment awards increased to $6,528,000 during 2017 as compared to $4,827,000 during 2016. Excluding the impact of the new tax legislation and the excess tax benefit, the effective tax rate would have been 37.8% for 2017 as compared to 38.3% for 2016.

We expect our effective income tax rate to decrease to approximately 22% to 23% for the fiscal year ended December 28, 2018 as a result of the tax legislation.

FISCAL YEARS ENDED DECEMBER 30, 2016, AND JANUARY 1, 2016

Revenues

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Engineering and Other Scientific $248,297  $237,959   4.3%
Percentage of total revenues  78.8%  76.1%    
Environmental and Health  66,779   74,873   (10.8)%
Percentage of total revenues  21.2%  23.9%    
Total revenues $315,076  $312,832   0.7%

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours and an increase in billing rates. During 2016, billable hours for this segment increased by 2.5% to 856,000 as compared to 835,000 during 2015. The increase was due to demand for services in our materials & corrosion engineering, polymer science & materials chemistry, biomedical engineering, and human factors practices. The materials & corrosion engineering practice experienced growth from the utilities industry in failure analyses of systems and proactive services in asset integrity management. The polymer science & materials chemistry practice experienced growth in battery consulting services. The biomedical engineering practice realized growth in design consulting and product liability claims support. The human factors practice realized growth in user study services for the consumer products industry. This growth was partially offset by shifts in market conditions, such as reduced spending in the oil and gas industry and a slowdown in intellectual property litigation. Utilization decreased to 73% for 2016 as compared to 75% for 2015. Technical full-time equivalents increased 5.0% to 564 for 2016 from 537 for 2015 due to our recruiting and retention efforts.

25

The decrease in revenues from our Environmental and Health segment was due to a decrease in billable hours. During 2016, billable hours for this segment decreased by 9.7% to 262,000 as compared to 290,000 during 2015. Utilization decreased to 63% for 2016 as compared to 65% for 2015. The decrease in billable hours and utilization was due to completion of a major project during the third quarter of 2015 and lower revenues from the oil and gas and industrial chemicals industries. Technical full-time equivalents decreased 6.5% to 200 during 2016 as compared to 214 for 2015 due to our efforts to align resources with anticipated demand.

Compensation and Related Expenses

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Compensation and related expenses $193,397  $184,502   4.8%
Percentage of total revenues  61.4%  59.0%    

The increase in compensation and related expenses during 2016 was due to an increase in payroll and a change in the value of assets associated with our deferred compensation plan. During 2016 payroll increased $4,730,000 due to the increase in technical full-time equivalent employees and our annual salary increase. During 2016, deferred compensation expense increased $4,186,000 with a corresponding increase to other income as compared with the prior year2022 due to the change in value of assets associated with our deferred compensation plan. This increase

32


consisted of an increase in the value of the plan assets of $3,861,000$14,315,000 during 20162023 as compared to a decrease in the value of the plan assets of $325,000$14,187,000 during 2015.2022. During 2023, other income decreased $781,000 as compared to 2022 due to realized gain and loss on foreign exchange. This decrease consisted of a realized loss on foreign exchange of $259,000 during 2023 as compared to a realized gain on foreign exchange of $522,000 during 2022. During 2023, interest income increased by $5,054,0000 due to higher interest rates. During 2023, rental income increased $433,000 as compared to 2022 due to the addition of an additional tenant in our Natick facility and an increase in rent.

Income Taxes

(In thousands except percentages)

 

Fiscal Years

 

 

Percent

 

 

 

2023

 

 

2022

 

 

Change

 

Income taxes

 

$

35,557

 

 

$

29,904

 

 

 

18.9

%

Percentage of total revenues

 

 

6.6

%

 

 

5.8

%

 

 

 

Effective tax rate

 

 

26.2

%

 

 

22.6

%

 

 

 

Other Operating Expenses

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Other operating Expenses $28,397  $26,975   5.3%
Percentage of total revenues  9.0%  8.6%    

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expensesour effective tax rate was primarily due to an increase in depreciation expense of $652,000, an increase in occupancy expense of $344,000, an increase in computer expense of $250,000, and several individually insignificant increases, which were associated with the increase in technical full-time equivalent employees and investments in our corporate infrastructure.

Reimbursable Expenses

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Reimbursable expenses $15,879  $17,127   (7.3)%
Percentage of total revenues  5.0%  5.5%    

The decrease in reimbursable expenses was primarily due to a decrease in project-related costs in our materials & corrosion engineering, polymer science & materials chemistry, and mechanical engineering practices within our Engineering and Other Scientific segment. The amount of reimbursable expenses will vary from year to year depending on the nature of our projects.

General and Administrative Expenses

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
General and administrative expenses $15,492  $15,295   1.3%
Percentage of total revenues  4.9%  4.9%    

The increase in general and administrative expenses during 2016 was primarily due to an increase in travel and meals and bad debt partially offset by a decrease in outside consulting.

Other Income

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Other income $7,211  $2,200   227.8%
Percentage of total revenues  2.3%  0.7%    

26

Other income consists primarily of interest income earned on available cash, cash equivalents and short-term investments, changes in the value of assetsexcess tax benefit associated with our deferred compensation plan and rental income from leasingstock-based awards. The excess space in our Silicon Valley facility. The increase in other income was primarily due to the change in value of assetstax benefit associated with our deferred compensation plan. During 2016, other income increased $4,186,000 with a corresponding increasestock-based awards decreased to deferred compensation expense$3,620,000 during 2023 as compared to 2015. This change consisted of an$5,829,000 during 2022. The decrease in the excess tax benefit was due to a smaller increase in the value of our common stock between the plan assets of $3,861,000 during 2016grant date and the release date for the restricted stock units released in 2023 as compared to a decreaserestricted stock units released in 2022. Excluding the valueimpact of the plan assets of $325,000 during 2015. The increase in other income during 2016 was also due to an increase in interest income of $476,000 and an increase in rental income of $420,000.

Income Taxes

 Fiscal Years  Percent 
(In thousands exceptpercentages) 2016  2015  Change 
          
Income taxes $21,642  $27,534   (21.4)%
Percentage of total revenues  6.9%  8.8%    
Effective tax rate  31.3%  38.7%    

The decrease in income taxes and the decrease in our effective tax rate were primarily due to the early adoption of ASU No. 2016-09, on a prospective basis, during the first quarter of 2016. Under ASU No. 2016-09, excess tax benefits are recorded as an income tax benefit in the consolidated statement of income. Prior to the adoption of ASU No. 2016-09, excess tax benefits were recognized in additional paid-in capital. The tax benefit realized during 2016 was $4,827,000. Excluding the excess tax benefit, the effective tax rate would have been 38.3%28.8% and 27.0% for 2016.2023 and 2022, respectively. The increase in our effective tax rate, excluding the impact of the excess tax benefit, was primarily due to the re-measurement of our deferred tax assets in connection with relocating one of our offices to a location designated as tax exempt for all state and local taxes and a decrease in our foreign rate benefit.

LIQUIDITY AND CAPITAL RESOURCES

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

Net cash provided by (used in):

 

 

 

 

 

 

Operating activities

 

$

127,352

 

 

$

93,807

 

Investing activities

 

$

(16,356

)

 

$

(12,043

)

Financing activities

 

$

(86,009

)

 

$

(215,977

)

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Net cash provided by (used in):            
Operating activities $67,838  $66,946  $60,489 
Investing activities $(17,722) $(27,443) $(27,035)
Financing activities $(41,261) $(49,166) $(36,916)

We financed our business in 20172023 through available cash and cash flows from operating activities. We invest our excess cash in cash equivalents and short-term investments.equivalents. As of December 29, 2017,2023, our cash and cash equivalents and short-term investments were $196,398,000$187,150,000 as compared to $173,722,000$161,458,000 at December 30, 2016.2022. We believe our existing balances of cash and cash equivalents and short-term investments will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends and other liquidity requirements over at least the next 12 months.

Generally, our net cash provided by operating activities is used to fund our day-to-day operating activities. First quarter operating cash requirements are generally higher due to payment of our annual bonuses accrued during the prior year. Our largest source of operating cash flows is cash collections from our clients. Our primary uses of cash from operating activities are for employee-related expenditures, leased facilities, taxes, and general operating expenses including marketing and travel.expenses.

Net cash provided by operating activities was $67.8 million for 2017 as compared to $66.9 million and $60.5 million in 2016 and 2015, respectively. The increase in net cash provided by operating activities during 2016 as compared to 2015 was primarily due to the early adoption of ASU No. 2016-09. Under ASU No. 2016-09, the excess tax benefit of $4,827,000 for 2016 was classified as an operating activity in the statement of cash flows. The excess tax benefit of $6,396,000 for 2015 was classified as a financing activity.

During 2017, 2016 and 2015, net cash used in investing activities during 2023 as compared to 2022 was due to an increase in capital expenditures primarily relateddue to the purchase and sale or maturity of short-term investments. During 2016 we completed the purchase of a 1.1 acre parcel of landleasehold improvements associated with 27,000 square feet of warehouse storage space in Menlo Park, California adjacent to our ownednew operating lease for office and lab facilities. We had leased this warehouse storage space for the past 25 years. The total purchase price was $8,250,000.in Philadelphia.

The decrease in net cash used in financing activities during 2017,2023 as compared to 2016,2022 was primarily due to a decrease in repurchases of our common stock and a reduction in payroll taxes for restricted stock units, partially offset by an increase in our quarterly dividend payments.payment.

We lease office, laboratory, and storage space in 13 states and the District of Columbia, as well as in China, Germany, Hong Kong, Ireland, Singapore, Switzerland, and the United Kingdom under non-cancellable operating lease arrangements that expire at various dates through 2033. As of December 29, 2023, the value of our obligations under operating leases was $28,261,000. See Note 12 of our Notes to Consolidated Financial Statements for additional

33


information regarding our lease obligations. The increase in net cash used in financing activities during 2016, as compared to fiscal 2015,value of our non-cancellable unconditional purchase obligations was primarily due to the early adoption of ASU No. 2016-09. Under ASU No. 2016-09, the excess tax benefit of $4,827,000 for 2016 was classified as an operating activity in the statement of cash flows. The excess tax benefit of $6,396,000 for 2015 was classified as a financing activity. The increase in net cash used in financing activities during fiscal 2016 was also due to an increase in our quarterly dividend payments.not material at December 29, 2023.

27

We expect to continue our investing activities, including capital expenditures. Furthermore, cash reserves may be used to repurchase common stock under our stock repurchase programs, pay dividends, procure facilities and equipment or strategically acquire professional service firms that are complementary to our business.

The following schedule summarizes our principal contractual commitments as of December 29, 2017 (in thousands):

  Operating       
Fiscal Lease  Purchase    
year commitments  Obligations  Total 
2018 $8,442  $1,696  $10,138 
2019  7,115   -   7,115 
2020  4,513   -   4,513 
2021  3,477   -   3,477 
2022  2,399   -   2,399 
Thereafter  4,005   -   4,005 
  $29,951  $1,696  $31,647 

The above table does not reflect unrecognized tax benefits of $1,790,000, the timing of which is uncertain. Refer to“Note 6: Income Taxes” of theNotes to Consolidated Financial Statements for additional discussion on unrecognized tax benefits.

During April 2017, we entered into two agreements to purchase a total of 2.9 acres of land in Natick, Massachusetts on which we intend to build office and laboratory facilities. The total purchase price is $5,200,000. The purchase agreements are contingent on several items including feasibility studies, environmental assessments, and government approvals. If we determine that the property is unsuitable for the planned project, we can terminate the agreements to purchase the land at our sole discretion.

We maintain nonqualified deferred compensation plans for the benefit of a select group of highly compensated employees. Vested amounts due under the plans of $52,776,000$103,398,000 were recorded as a long-term liability on our consolidated balance sheet at December 29, 2017.2023. Vested amounts due under the plans of $6,274,000$13,166,000 were recorded as a current liability on our consolidated balance sheet at December 29, 2017.2023. Company assets that are earmarkeddesignated to payfund the benefits under the plans are held in a rabbi trust and are subject to the claims of our creditors. As of December 29, 2017,2023, invested amounts under the plans of $48,676,000$101,169,000 were recorded as a long-termnon-current asset on our consolidated balance sheet. As of December 29, 2017,2023, invested amounts under the plans of $4,674,000$14,018,000 were recorded as aother current assetassets on our consolidated balance sheet.

As permitted under Delaware law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director is, or was serving, at our request in such capacity. The indemnification period covers all pertinent events and occurrences during the officer’s or director’s lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have director and officer insurance coverage that reduces our exposure and enables us to recover a portion of any future amounts paid. We believe the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.

Off-Balance Sheet Arrangements

As part of our ongoing business, we do not engage in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities.

28

Non-GAAP Financial Measures

Regulation G, conditions for use of Non-Generally Accepted Accounting Principles (“Non-GAAP”) financial measures, and other SEC regulations define and prescribe the conditions for use of certain Non-GAAP financial information. Generally, a Non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We closely monitor two financial measures, EBITDA and EBITDAS, which meet the definition of Non-GAAP financial measures. We define EBITDA as net income before income taxes, interest income, depreciation and amortization. We define EBITDAS as EBITDA before stock-based compensation. We regard EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. These measures are used to evaluate our financial results, develop budgets and determine employee compensation. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable GAAP measure is set forth below.

The following table shows EBITDA as a percentage of revenues before reimbursements for fiscal years 2017, 20162023 and 2015:2022:

(In thousands, except percentages)

 

Fiscal Years

 

 

 

2023

 

 

2022

 

Revenues before reimbursements

 

$

497,189

 

 

$

463,820

 

EBITDA

 

$

137,662

 

 

$

137,217

 

EBITDA as a % of revenues before reimbursements

 

 

27.7

%

 

 

29.6

%

  Fiscal Years 
(in thousands, except percentages) 2017  2016  2015 
          
Revenues before reimbursements $329,664  $299,197  $295,705 
             
EBITDA $87,500  $74,570  $76,405 
             
EBITDA as a % of revenues before reimbursements  26.5%  24.9%  25.8%

The increase in EBITDA as a percentage of revenues before reimbursements for 2017 as compared to 2016 was primarily due to an increase in utilization. Utilization for 2017 was 75% as compared to 70% for the same period last year. The increase in utilization was due to strong demand for both our proactive and reactive services and the impact of the large human factors assessments we performed for a client in the consumer products industry.

The decrease in EBITDA as a percentage of revenues before reimbursements for 2016during 2023 as compared to 20152022 was primarily due to athe decrease in utilization. Utilization for 2016 was 70%utilization and an increase in other operating expenses. Our utilization decreased to 69% during 2023 as compared to 72%74% during 2015.2022. The decrease in utilization was due to the completion of a major project10% increase in technical full-time equivalent employees and historically strong utilization during the third quarter of 2015 and lower revenues from the oil and gas and industrial chemicals industries.

2022. Other operating expenses increased

29

34


during 2023 due to an increase in technical full-time equivalent employees and investments in our corporate infrastructure.

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for fiscal 2017, 20162023 and 2015:2022:

 Fiscal Years 
(in thousands) 2017  2016  2015 

(In thousands)

 

Fiscal Years

 

       

 

2023

 

 

2022

 

Net Income $41,305  $47,480  $43,599 
            

Net income

 

$

100,339

 

 

$

102,330

 

Add back (subtract):            

 

 

 

 

 

 

            
Income taxes  41,204   21,642   27,534 

 

 

35,557

 

 

 

29,904

 

Interest income, net  (1,294)  (683)  (207)

Interest income

 

 

(7,150

)

 

 

(2,096

)

Depreciation and amortization  6,285   6,131   5,479 

 

 

8,916

 

 

 

7,079

 

            
EBITDA  87,500   74,570   76,405 

 

 

137,662

 

 

 

137,217

 

            
Stock-based compensation  16,155   13,333   12,959 

 

 

20,357

 

 

 

20,364

 

            
EBITDAS $103,655  $87,903  $89,364 

 

$

158,019

 

 

$

157,581

 

Item 7A. Quantitative and Qualitative Disclosure Aboutabout Market Risk

Exponent is exposed to interest rate risk associated with our balances of cash and cash equivalents and short-term investments.equivalents. We manage our interest rate risk by maintaining an investment portfolio primarily consisting of debt instruments with high credit quality and relatively short average effective maturities in accordance with the Company’s investment policy. The maximum effective maturity of any issue in our portfolio of cash equivalents and short-term investments is 3three years and the maximum average effective maturity of the portfolio cannot exceed 12 months.

If interest rates were to instantaneously increase or decrease by 100 basis points, the change in the fair value of our portfolio of cash equivalents and short-term investments would not have a material impact on our financial statements. We do not use derivative financial instruments in our investment portfolio. Notwithstanding our efforts to manage interest rate risk, there can be no assurances that we will be adequately protected against the risks associated with interest rate fluctuations.

We have foreign currency risk related to our revenues and expenses denominated in currencies other than the U.S. dollar, primarily the British Pound, the Euro,Chinese Yuan, and the Chinese Yuan.Hong Kong Dollar. Accordingly, changes in exchange rates may negatively affect the revenues and net income of our foreign subsidiaries as expressed in U.S. dollars.

At December 29, 2017,2023, we had net assets of approximately $11.4$17.2 million with a functional currency of the British Pound, net assets of approximately $4.6$2.7 million with a functional currency of the Euro, andHong Kong Dollar, net assets of approximately $5.0$2.4 million with a functional currency of the Chinese Yuan, and net assets of approximately $2.3 million with a functional currency of the Singapore Dollar associated with our operations in the United Kingdom, Germany,Hong Kong, China, and China,Singapore respectively.

We also have foreign currency risk related to foreign currency transactions and monetary assets and liabilities denominated in currencies that are not the functional currency. We have experienced and will continue to experience fluctuations in our net income as a result of gains gains/(losses) on these foreign currency transactions and the re-measurement of monetary assets and liabilities. At December 29, 2017,2023, we had net assets denominated in the non-functional currency of approximately $3.5$8.7 million.

We do not use foreign exchange contracts to hedge any foreign currency exposures. To date, the impacts of foreign currency exchange rate changes on our consolidated revenues and consolidated net income have not been material. However, our continued international expansion increases our exposure to exchange rate fluctuations and as a result such fluctuations could have a significant impact on our future results of operations.

30

35


Item 8. Financial Statements and Supplementary Data

See Item 15 of this Annual Report on Form 10-K for required financial statements and supplementary data.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

None.

Item 9A. Controls and Procedures

KPMG LLP, an independent registered public accounting firm, has audited the internal control over financial reporting of Exponent, Inc., as stated in their report which is included in Part IV, Item 15 of this Annual Report on Form 10-K.

(a)
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures.

(a)Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13(a)-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.Annual Report on Form 10-K.

(b)
Management’s Report on Internal Control Over Financial Reporting.

(b)Management’s Report on Internal Control Over Financial Reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Our internal control over financial reporting is designed to provide reasonable assurance, but not absolute assurance, regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally accepted accounting principles. There are inherent limitations to the effectiveness of any system of internal control over financial reporting. These limitations include the possibility of human error, the circumvention or overriding of the system and reasonable resource constraints. Because of its inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework inInternal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework inInternal Control - Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective at the reasonable assurance level as of December 29, 2017.2023.

(c)
Changes in Internal Control Over Financial Reporting.

(c)Changes in Internal Control Over Financial Reporting.

There have not been any changes in the Company’s internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act, during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Item 9B. Other Information

Rule 10b5-1 Plans

None.None of the Company's directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arraangement during the Company's fiscal quarter ended December 29, 2023.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

36


PART III

Certain information required by Part III is omitted from this Annual Report on Form 10-K. We intend to file a definitive Proxy Statement pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, and certain information included therein is incorporated herein by reference.

Item 10. Directors, Executive Officers and Corporate Governance

The information required by this item is incorporated by reference to the Company’s definitive Proxy Statement for its 20182024 Annual Meeting of Stockholders (the "Proxy Statement"). See Part 1, Item 1 of this Annual Report on Form 10-K for information regarding the executive officers of the Company.

31

Item 11. Executive Compensation

The information required by this item is incorporated by reference to the Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item is incorporated by reference to the Proxy Statement. See also the table on the Company’s share repurchases in Part II, Item 5 above.

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required by this item is incorporated by reference to the Proxy Statement.

Item 14. Principal Accounting Fees and Services

The information required by this item is incorporated by reference to the Proxy Statement.

32

37


PART IV

Item 15. Exhibits, Financial Statement Schedules

(a)The following documents are filed as part of this Annual Report on Form 10-K.
(a)
The following documents are filed as part of this Annual Report on Form 10-K.

1.Financial Statements
1.
Financial Statements

The following consolidated financial statements of Exponent, Inc. and subsidiaries and theReport of Independent Registered Public Accounting Firm are included herewith:

Page

Report of Independent Registered Public Accounting Firm

34

39

Consolidated Statements of Income for the years ended December 29, 2017,2023, December 30, 20162022 and January 1, 2016December 31, 2021

36

41

Consolidated Statements of Comprehensive Income for the years ended December 29, 2017,2023, December 30, 20162022 and January 1, 2016December 31, 2021

37

42

Consolidated Balance Sheets as of December 29, 20172023 and December 30, 20162022

38

43

Consolidated Statements of Stockholders’ Equity for the years ended December 29, 2017,2023, December 30, 20162022 and January 1, 2016December 31, 2021

39

44

Consolidated Statements of Cash Flows for the years ended December 29, 2017,2023, December 30, 20162022 and January 1, 2016December 31, 2021

41

45

Notes to Consolidated Financial Statements

42

46

2.Financial Statement Schedules
2.
Financial Statement Schedules

The following financial statement schedule of Exponent, Inc. for the years ended December 29, 2017,2023, December 30, 20162022 and January 1, 2016December 31, 2021 is filed as part of this Annual Report on Form 10-K and should be read in conjunction with the consolidated financial statements of Exponent, Inc. and subsidiaries:

Page

Schedule II - Valuation and Qualifying Accounts

61

64

Schedules other than those listed above have been omitted since they are either not required, not applicable, or the information is otherwise included elsewhere in the report.

3.
Exhibits

3.

Exhibits

Page

(a)Exhibit Index

65

Page
(a)Exhibit Index63

33

38


Report of Independent Registered Public Accounting Firm

TheTo the Stockholders and Board of Directors and Stockholders


Exponent, Inc.:

Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated balance sheets of Exponent, Inc. and subsidiaries (the Company) as of December 29, 20172023 and December 30, 2016,2022, the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 29, 2017,2023, and the related notes and financial statement schedule II (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 29, 2017,2023, based on criteria established inInternal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 29, 20172023 and December 30, 2016,2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 29, 2017,2023, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 29, 2017,2023 based on criteria established inInternal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Change in Accounting Principle

The Company changed its method of accounting for excess tax benefits and tax deficiencies related to stock-based compensation as well as forfeitures of share-based awards as of January 2, 2016 due to the adoption of Accounting Standards Update 2016-09,Improvements to Employee Share-Based Payment Accounting.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying ManagementManagement's Report on Internal Control overOver Financial Reporting, appearing under Item 9A(b).Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

34

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable

39


assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Collectibility of accounts receivable

As discussed in Notes 1 and 6 to the consolidated financial statements, the Company’s allowance for contract losses and doubtful accounts was $5.3 million as of December 29, 2023. The Company’s accounts receivable, net was $167.4 million as of December 29, 2023 which represents 26% of total assets and 31% of revenue for the year ended December 29, 2023. As discussed in Note 1, the Company maintains allowances to estimate their ability to collect financial obligations from customers. The Company records a specific allowance in circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations.

We identified the assessment of the collectibility of accounts receivable as a critical audit matter. Specifically, the specific allowance is an estimate which involves assessing the likelihood of collection of a customer’s accounts receivable by considering various factors such as communications from the customer, historical collections, and number of days accounts receivables have been outstanding. Subjective auditor judgment was involved in evaluating the relevance and reliability of the evidence obtained in evaluating these factors.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the critical audit matter. This included controls related to the Company’s assessment of the specific allowance. We investigated significant fluctuations in the specific allowance as compared to gross accounts receivable and the prior year specific allowance. For a selection of customer invoices and projects, we inquired of Company personnel to evaluate the rationale for establishing a specific allowance for certain customers and assessed the Company’s estimate of the specific customer allowance by evaluating the underlying contractual documents, historical collection trends, communications with customers, number of days accounts receivable have been outstanding, and other additional factors. We also evaluated subsequent collections occurring after the balance sheet date for the selected customer invoices and projects and considered the impact of potential subsequent events on the estimate of the specific customer allowance.

/s/ KPMG LLP

We have served as the Company’s auditor since 1987.

San Francisco, California

February 23, 2018

2024

35

40


Exponent, Inc. and Subsidiaries

Consolidated Statements of Income

 Fiscal Years 

 

Fiscal Years

 

(In thousands, except per share data) 2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

       
Revenues:            

 

 

 

 

 

 

 

 

 

Revenues before reimbursements $329,664  $299,197  $295,705 

 

$

497,189

 

 

$

463,820

 

 

$

434,850

 

Reimbursements  18,135   15,879   17,127 

 

 

39,577

 

 

 

49,473

 

 

 

31,419

 

Revenues  347,799   315,076   312,832 

 

 

536,766

 

 

 

513,293

 

 

 

466,269

 

            

 

 

 

 

 

 

 

 

 

Operating expenses:            

 

 

 

 

 

 

 

 

 

Compensation and related expenses  210,289   193,397   184,502 

 

 

319,886

 

 

 

264,235

 

 

 

278,047

 

Other operating expenses  29,544   28,397   26,975 

 

 

41,541

 

 

 

35,083

 

 

 

32,594

 

Reimbursable expenses  18,135   15,879   17,127 

 

 

39,577

 

 

 

49,473

 

 

 

31,419

 

General and administrative expenses  17,780   15,492   15,295 

 

 

24,440

 

 

 

23,660

 

 

 

15,282

 

  275,748   253,165   243,899 

Total operating expenses

 

 

425,444

 

 

 

372,451

 

 

 

357,342

 

Operating income  72,051   61,911   68,933 

 

 

111,322

 

 

 

140,842

 

 

 

108,927

 

            

 

 

 

 

 

 

 

 

 

Other income:            

 

 

 

 

 

 

 

 

 

Interest income  1,294   683   207 

 

 

7,150

 

 

 

2,096

 

 

 

66

 

Miscellaneous income, net  9,164   6,528   1,993 

 

 

17,424

 

 

 

(10,704

)

 

 

16,844

 

Income before income taxes  82,509   69,122   71,133 

 

 

135,896

 

 

 

132,234

 

 

 

125,837

 

            

 

 

 

 

 

 

 

 

 

Provision for income taxes  41,204   21,642   27,534 

 

 

35,557

 

 

 

29,904

 

 

 

24,635

 

Net income $41,305  $47,480  $43,599 

 

$

100,339

 

 

$

102,330

 

 

$

101,202

 

            

 

 

 

 

 

 

 

 

 

Net income per share:            

 

 

 

 

 

 

 

 

 

Basic $1.57  $1.79  $1.64 

 

$

1.96

 

 

$

1.98

 

 

$

1.92

 

Diluted $1.53  $1.75  $1.60 

 

$

1.94

 

 

$

1.96

 

 

$

1.90

 

Shares used in per share computations:            

 

 

 

 

 

 

 

 

 

Basic  26,362   26,488   26,606 

 

 

51,152

 

 

 

51,727

 

 

 

52,610

 

Diluted  26,986   27,166   27,298 

 

 

51,635

 

 

 

52,280

 

 

 

53,331

 

            

 

 

 

 

 

 

 

 

 

Cash dividends declared per common share $0.84  $0.72  $0.60 

 

$

1.04

 

 

$

0.96

 

 

$

0.80

 

See accompanying notes to the Consolidated Financial Statements.

36

41


Exponent, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

       
Net income $41,305  $47,480  $43,599 

 

$

100,339

 

 

$

102,330

 

 

$

101,202

 

            
Other comprehensive income (loss), net of tax:            
Foreign currency translation adjustments, net of tax of $0, $0, and $(38), respectively  1,187   (1,240)  (822)
Unrealized loss arising during the period on investments, net of tax of $60, $53, and $53, respectively  (90)  (81)  (79)

Other comprehensive (loss) income, net of tax:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments, net of tax of $0, $0,
and $
0, respectively

 

 

610

 

 

 

(1,604

)

 

 

14

 

Unrealized loss arising during the period on
investments, net of tax benefit of $
0, $0 and $2, respectively

 

 

 

 

 

 

 

 

(65

)

Comprehensive income $42,402  $46,159  $42,698 

 

$

100,949

 

 

$

100,726

 

 

$

101,151

 

See accompanying notes to the Consolidated Financial Statements.

37

42


Exponent, Inc. and Subsidiaries

Consolidated Balance Sheets

(In thousands, except par value) December 29,
2017
 December 30,
2016
 

 

December 29,
2023

 

 

December 30,
2022

 

     
Assets        

 

 

 

 

 

 

        
Current assets:        

 

 

 

 

 

 

Cash and cash equivalents $124,794  $114,967 

 

$

187,150

 

 

$

161,458

 

Short-term investments  71,604   58,755 
Accounts receivable, net of allowance for contract losses and doubtful accounts of $3,526 and $3,417, respectively  110,100   87,409 
Prepaid expenses and other assets  9,011   12,913 

Accounts receivable, net of allowance for contract losses and doubtful
accounts of $
5,281 and $6,193, respectively

 

 

167,360

 

 

 

170,114

 

Prepaid expenses and other current assets

 

 

25,022

 

 

 

17,585

 

Total current assets  315,509   274,044 

 

 

379,532

 

 

 

349,157

 

        

 

 

 

 

 

 

Property, equipment and leasehold improvements, net  35,014   36,710 

 

 

75,318

 

 

 

65,539

 

Operating lease right-of-use assets

 

 

24,600

 

 

 

18,007

 

Goodwill  8,607   8,607 

 

 

8,607

 

 

 

8,607

 

Deferred income taxes  30,437   42,166 

 

 

53,824

 

 

 

53,909

 

Deferred compensation plan assets  48,676   41,153 

 

 

101,169

 

 

 

89,437

 

Other assets  1,346   1,064 

 

 

3,727

 

 

 

2,006

 

 $439,589  $403,744 

Total assets

 

$

646,777

 

 

$

586,662

 

        

 

 

 

 

 

 

Liabilities and Stockholders’ Equity        

 

 

 

 

 

 

        
Current liabilities:        

 

 

 

 

 

 

Accounts payable and accrued liabilities $14,741  $10,073 

 

$

22,125

 

 

$

29,115

 

Accrued payroll and employee benefits  70,064   62,539 

 

 

111,773

 

 

 

105,822

 

Deferred revenues  8,302   7,624 

 

 

21,709

 

 

 

18,834

 

Operating lease liabilities

 

 

6,302

 

 

 

5,258

 

Total current liabilities  93,107   80,236 

 

 

161,909

 

 

 

159,029

 

        

 

 

 

 

 

 

Other liabilities  3,326   2,005 

 

 

3,426

 

 

 

2,355

 

Deferred compensation  52,776   46,503 
Deferred rent  1,292   1,654 

Deferred compensation plan liabilities

 

 

103,398

 

 

 

91,183

 

Operating lease liabilities

 

 

21,959

 

 

 

13,343

 

Total liabilities  150,501   130,398 

 

$

290,692

 

 

$

265,910

 

        

 

 

 

 

 

 

Commitments and contingencies (Note 11)        

Commitments and contingencies (Note 13)

 

 

 

 

 

 

        

 

 

 

 

 

 

Stockholders’ equity:        

 

 

 

 

 

 

Preferred stock, $.001 par value; 2,000 shares authorized; no shares outstanding  -   - 
Common stock, $.001 par value; 80,000 shares authorized; 32,853 shares issued  33   33 

Preferred stock, $0.001 par value; 2,000 shares authorized; no shares
outstanding

 

 

 

 

 

 

Common stock, $0.001 par value; 120,000 shares authorized; 65,707
shares issued

 

 

66

 

 

 

66

 

Additional paid-in capital  210,263   194,632 

 

 

321,448

 

 

 

301,002

 

Accumulated other comprehensive income (loss)        
Investment securities, available for sale  (236)  (146)

Accumulated other comprehensive income/(loss)

 

 

 

 

 

 

Foreign currency translation adjustments  (1,793)  (2,980)

 

 

(2,977

)

 

 

(3,587

)

  (2,029)  (3,126)
Retained earnings  303,990   291,243 

 

 

574,082

 

 

 

528,810

 

Treasury stock, at cost: 7,084 and 7,256 shares held, respectively  (223,169)  (209,436)

Treasury stock, at cost: 15,134 and 15,064 shares held, respectively

 

 

(536,534

)

 

 

(505,539

)

Total stockholders’ equity  289,088   273,346 

 

 

356,085

 

 

 

320,752

 

 $439,589  $403,744 

Total liabilities and stockholders’ equity

 

$

646,777

 

 

$

586,662

 

See accompanying notes to the Consolidated Financial Statements.

38

43


Exponent, Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

       Accumulated       

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

     Additional other       

 

 

 

 

 

Additional

 

other com-

 

 

 

 

 

 

 

 

 

 

 Common Stock paid-in comprehensive Retained Treasury Stock   

 

Common Stock

 

 

paid-in

 

prehensive

 

 

Retained

 

Treasury Stock

 

 

 

 

(In thousands) Shares Amount capital income (loss) earnings Shares Amount Total 

 

Shares

 

 

Amount

 

 

capital

 

 

income(loss)

 

 

earnings

 

 

Shares

 

 

Amount

 

 

Total

 

                 
Balance at January 2, 2015  32,853  $33  $160,208  $(904) $246,961   7,111  $(162,010) $244,288 
                                

Balance at January 1, 2021

 

 

65,707

 

 

$

66

 

 

$

265,328

 

 

$

(1,932

)

 

$

421,809

 

 

 

13,903

 

 

$

(323,773

)

 

$

361,498

 

Employee stock purchase plan  -   -   836   -   -   (27)  350   1,186 

 

 

 

 

 

 

 

 

1,777

 

 

 

 

 

 

 

 

 

(20

)

 

 

200

 

 

 

1,977

 

Exercise of stock options, net of swaps  -   -   (94)  -   -   (150)  1,922   1,828 
Excess tax benefit for equity incentive plans  -   -   6,396   -   -   -   -   6,396 

Exercise of stock options

 

 

 

 

 

 

 

 

657

 

 

 

 

 

 

 

 

 

(48

)

 

 

477

 

 

 

1,134

 

Amortization of unrecognized stock-based compensation  -   -   6,618   -   -   -   -   6,618 

 

 

 

 

 

 

 

 

9,296

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,296

 

Purchase of treasury shares  -   -   -   -       530   (23,314)  (23,314)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

78

 

 

 

(7,000

)

 

 

(7,000

)

Foreign currency translation adjustments  -   -   -   (822)  -   -   -   (822)

 

 

 

 

 

 

 

 

 

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

14

 

Grant of restricted stock units to settle accrued bonus  -   -   6,169   -   -   -   -   6,169 

 

 

 

 

 

 

 

 

7,637

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,637

 

Settlement of restricted stock units  -   -   (975)  -   (4,943)  (331)  (1,447)  (7,365)

 

 

 

 

 

 

 

 

(3,276

)

 

 

 

 

 

(1,679

)

 

 

(322

)

 

 

(10,711

)

 

 

(15,666

)

Unrealized loss on investments  -   -   -   (79)  -   -   -   (79)

 

 

 

 

 

 

 

 

 

 

 

(65

)

 

 

59

 

 

 

 

 

 

 

 

 

(6

)

Dividends and dividend equivalent rights  -   -   658   -   (16,358)  -   -   (15,700)

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

(43,021

)

 

 

 

 

 

 

 

 

(43,021

)

Net income  -   -   -   -   43,599   -   -   43,599 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101,202

 

 

 

 

 

 

 

 

 

101,202

 

Balance at January 1, 2016  32,853  $33  $179,816  $(1,805) $269,259   7,133  $(184,499) $262,804 
                                

Balance at December 31, 2021

 

 

65,707

 

 

$

66

 

 

$

281,419

 

 

$

(1,983

)

 

$

478,370

 

 

 

13,591

 

 

$

(340,807

)

 

$

417,065

 

Employee stock purchase plan  -   -   883   -   -   (23)  307   1,190 

 

 

 

 

 

 

 

 

1,805

 

 

 

 

 

 

 

 

 

(22

)

 

 

215

 

 

 

2,020

 

Exercise of stock options, net of swaps  -   -   161   -   -   (30)  405   566 
Amortization of unrecognized stock-based compensation  -   -   7,152   -   -   -   -   7,152 

 

 

 

 

 

 

 

 

9,999

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,999

 

Purchase of treasury shares  -   -   -   -       491   (24,456)  (24,456)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,756

 

 

 

(155,856

)

 

 

(155,856

)

Foreign currency translation adjustments  -   -   -   (1,240)  -   -   -   (1,240)

 

 

 

 

 

 

 

 

 

 

 

(1,604

)

 

 

 

 

 

 

 

 

 

 

 

(1,604

)

Grant of restricted stock units to settle accrued bonus  -   -   6,334   -   -   -   -   6,334 

 

 

 

 

 

 

 

 

10,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,200

 

Settlement of restricted stock units  -   -   (701)  -   (5,791)  (315)  (1,193)  (7,685)

 

 

 

 

 

 

 

 

(2,421

)

 

 

 

 

 

(1,392

)

 

 

(261

)

 

 

(9,091

)

 

 

(12,904

)

Unrealized loss on investments  -   -   -   (81)  -   -   -   (81)
Dividends and dividend equivalent rights  -   -   854   -   (19,627)  -   -   (18,773)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(50,498

)

 

 

 

 

 

 

 

 

(50,498

)

Other  -   -   133   -   (78)  -   -   55 
Net income  -   -   -   -   47,480   -   -   47,480 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

102,330

 

 

 

 

 

 

 

 

 

102,330

 

Balance at December 30, 2016  32,853  $33  $194,632  $(3,126) $291,243   7,256  $(209,436) $273,346 

Balance at December 30, 2022

 

 

65,707

 

 

$

66

 

 

$

301,002

 

 

$

(3,587

)

 

$

528,810

 

 

 

15,064

 

 

$

(505,539

)

 

$

320,752

 

Employee stock purchase plan

 

 

 

 

 

 

 

 

1,840

 

 

 

 

 

 

 

 

 

(24

)

 

 

244

 

 

 

2,084

 

Exercise of stock options

 

 

 

 

 

 

 

 

22

 

 

 

 

 

 

 

 

 

(8

)

 

 

78

 

 

 

100

 

Amortization of unrecognized stock-based compensation

 

 

 

 

 

 

 

 

9,912

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,912

 

Purchase of treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

288

 

 

 

(24,208

)

 

 

(24,208

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

610

 

 

 

 

 

 

 

 

 

 

 

 

610

 

Grant of restricted stock units to settle accrued bonus

 

 

 

 

 

 

 

 

10,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,496

 

Settlement of restricted stock units

 

 

 

 

 

 

 

 

(1,824

)

 

 

 

 

 

(1,009

)

 

 

(186

)

 

 

(7,109

)

 

 

(9,942

)

Dividends and dividend equivalent rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(54,058

)

 

 

 

 

 

 

 

 

(54,058

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100,339

 

 

 

 

 

 

 

 

 

100,339

 

Balance at December 29, 2023

 

 

65,707

 

 

$

66

 

 

$

321,448

 

 

$

(2,977

)

 

$

574,082

 

 

 

15,134

 

 

$

(536,534

)

 

$

356,085

 

See accompanying notes to the Consolidated Financial Statements.

39

44


Exponent, Inc. and Subsidiaries

           Accumulated             
        Additional  other             
  Common Stock  paid-in  comprehensive  Retained  Treasury Stock    
(In thousands) Shares  Amount  capital  income (loss)  earnings  Shares  Amount  Total 
                         
Balance at December 30, 2016  32,853  $33  $194,632  $(3,126) $291,243   7,256  $(209,436) $273,346 
                                 
Employee stock purchase plan  -   -   847   -   -   (20)  360   1,207 
Exercise of stock options, net of swaps  -   -   144   -   -   (35)  674   818 
Amortization of unrecognized stock-based compensation  -   -   7,824   -   -   -   -   7,824 
Purchase of treasury shares  -   -   -   -       186   (11,931)  (11,931)
Foreign currency translation adjustments  -   -   -   1,187   -   -   -   1,187 
Grant of restricted stock units to settle accrued bonus  -   -   6,918   -   -   -   -   6,918 
Settlement of restricted stock units  -   -   (1,017)  -   (5,667)  (303)  (2,836)  (9,520)
Unrealized loss on investments  -   -   -   (90)  -   -   -   (90)
Dividends and dividend equivalent rights  -   -   915   -   (22,891)  -   -   (21,976)
Net income  -   -   -   -   41,305   -   -   41,305 
Balance at December 27, 2017  32,853  $33  $210,263  $(2,029) $303,990   7,084  $(223,169) $289,088 

Consolidated Statements of Cash Flows

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income

 

$

100,339

 

 

$

102,330

 

 

$

101,202

 

Adjustments to reconcile net income to net cash provided by
   operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization of property, equipment and
   leasehold improvements

 

 

8,916

 

 

 

7,079

 

 

 

6,487

 

Amortization of premiums and accretion of discounts on
   short-term investments

 

 

 

 

 

 

 

 

(11

)

Provision for contract losses and doubtful accounts

 

 

3,225

 

 

 

3,081

 

 

 

1,958

 

Stock-based compensation

 

 

20,357

 

 

 

20,364

 

 

 

19,263

 

Deferred income tax provision

 

 

85

 

 

 

(7,363

)

 

 

(6,005

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(471

)

 

 

(33,334

)

 

 

(30,254

)

Prepaid expenses and other current assets

 

 

(6,669

)

 

 

(6,124

)

 

 

(4,407

)

Change in operating leases

 

 

(152

)

 

 

(7

)

 

 

(406

)

Accounts payable and accrued liabilities

 

 

(5,055

)

 

 

2,215

 

 

 

8,443

 

Accrued payroll and employee benefits

 

 

3,902

 

 

 

6,494

 

 

 

20,336

 

Deferred revenues

 

 

2,875

 

 

 

(928

)

 

 

7,962

 

Net cash provided by operating activities

 

 

127,352

 

 

 

93,807

 

 

 

124,568

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(16,356

)

 

 

(12,043

)

 

 

(6,826

)

Purchase of short-term investments

 

 

 

 

 

 

 

 

(34,994

)

Maturity of short-term investments

 

 

 

 

 

 

 

 

79,998

 

Net cash (used in) / provided by investing activities

 

 

(16,356

)

 

 

(12,043

)

 

 

38,178

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Payroll taxes for restricted stock units

 

 

(9,942

)

 

 

(12,904

)

 

 

(15,666

)

Repurchase of common stock

 

 

(24,208

)

 

 

(155,856

)

 

 

(7,000

)

Exercise of stock-based payment awards

 

 

2,184

 

 

 

2,020

 

 

 

3,111

 

Dividends and dividend equivalent rights

 

 

(54,043

)

 

 

(49,237

)

 

 

(43,198

)

Net cash used in financing activities

 

 

(86,009

)

 

 

(215,977

)

 

 

(62,753

)

 

 

 

 

 

 

 

 

 

Effect of foreign currency exchange rates on cash and cash
   equivalents

 

 

705

 

 

 

(2,016

)

 

 

169

 

Net increase in cash and cash equivalents

 

 

25,692

 

 

 

(136,229

)

 

 

100,162

 

Cash and cash equivalents at beginning of year

 

 

161,458

 

 

 

297,687

 

 

 

197,525

 

Cash and cash equivalents at end of year

 

$

187,150

 

 

$

161,458

 

 

$

297,687

 

See accompanying notes to the Consolidated Financial Statements.

40

45


Exponent, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Cash flows from operating activities:            
Net income $41,305  $47,480  $43,599 
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization of property, equipment and leasehold improvements  6,285   6,131   5,479 
Amortization of premiums and accretion of discounts on short-term investments  -   2   595 
Deferred rent expense  (362)  (340)  (65)
Provision for contract losses and doubtful accounts  2,506   2,452   929 
Stock-based compensation  16,155   13,333   12,959 
Deferred income tax provision  11,786   (2,602)  (3,827)
Excess tax benefit for equity incentive plans  -   -   (6,396)
Changes in operating assets and liabilities:            
Accounts receivable  (25,197)  (1,284)  (3,138)
Prepaid expenses and other assets  2,867   (598)  421 
Accounts payable and accrued liabilities  5,984   (370)  7,718 
Accrued payroll and employee benefits  5,831   2,920   2,639 
Deferred revenues  678   (178)  (424)
Net cash provided by operating activities  67,838   66,946   60,489 
             
Cash flows from investing activities:            
Capital expenditures  (4,725)  (14,393)  (5,379)
Purchase of short-term investments  (28,997)  (51,000)  (43,946)
Maturity of short-term investments  16,000   37,950   22,290 
Net cash used in investing activities  (17,722)  (27,443)  (27,035)
             
Cash flows from financing activities:            
Excess tax benefit for equity incentive plans  -   -   6,396 
Payroll taxes for restricted stock units  (9,520)  (7,685)  (7,365)
Repurchase of common stock  (11,931)  (24,456)  (23,314)
Exercise of share-based payment awards  2,025   1,756   3,014 
Dividends and dividend equivalent rights  (21,835)  (18,781)  (15,647)
Net cash used in financing activities  (41,261)  (49,166)  (36,916)
             
Effect of foreign currency exchange rates on cashand cash equivalents  972   (1,121)  (277)
             
Net increase (decrease) in cash and cash equivalents  9,827   (10,784)  (3,739)
Cash and cash equivalents at beginning of year  114,967   125,751   129,490 
Cash and cash equivalents at end of year $124,794  $114,967  $125,751 

See accompanying notes to the Consolidated Financial Statements.

41

Exponent, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

Note 1: Summary of Significant Accounting Policies

Basis of Presentation

Exponent, Inc. together with its subsidiaries (collectively referred to as the “Company”) is a science and engineering consulting firm that provides solutions to complex problems. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

The Company operates on a 52-53 week fiscal year with each year ending on the Friday closest to December 31st. Fiscal periods 2017, 2016 and 2015period 2023 included 52 weeks of activity and ended on December 29, 2017,2023. Fiscal period 2022 included 52 weeks of activity and ended on December 30, 2016 and January 1, 2016, respectively.2022. Fiscal period 20182021 included 52 weeks of activity and ended on December 31, 2021. Fiscal period 2024 is 53 weeks and will end on December 28, 2018.January 3, 2025.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Estimates are used for, but not limited to, revenue recognition, allowance for contract losses and doubtful accounts, stock-based compensation, income taxes, goodwill, the useful life of property, equipment and investments.leasehold improvements, and operating lease liabilities. Actual results could differ from those estimates.

Revenue Recognition

The Company derives its revenues primarily from professional fees earned on consulting engagements, fees earned for the use of its equipment and facilities, and reimbursements for outside direct expenses associated with the services that are billed to its clients. Any taxes assessed on revenues relating to services provided to its clients are recorded on a net basis.

The Company reports service revenues net of subcontractor fees. The Company has determined that it is not the primary obligor with respect to these subcontractors because:

·its clients are directly involved in the subcontractor selection process;
·the subcontractor is responsible for fulfilling the scope of work; and
·the Company passes through the costs of subcontractor agreements with only a minimal fixed percentage mark-up to compensate it for processing the transactions.

Reimbursements, including those related to travel and other out-of-pocket expenses, and other similar third party costs such as the cost of materials, are included in revenues, and an equivalent amount of reimbursable expenses are included in operating expenses. Any mark-up on reimbursable expenses is included in revenues.

Substantially all of the Company’s engagements are performed under time and material or fixed-price billing arrangements. On time and material and fixed-price projects, revenue is generally recognized as the services are performed. For substantially all of the Company’s fixed-price engagements, it recognizes revenue based on the relationship of incurred labor hours at standard rates to its estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed-price contracts given the nature of the consulting services the Company provides and the following additional considerations:

·the Company considers labor hours at standard rates and expenses to be incurred when pricing its contracts;
·the Company generally does not incur set up costs on its contracts;

42

·the Company does not believe that there are reliable milestones to measure progress toward completion;
·if the contract is terminated early, the customer is required to pay the Company for time at standard rates plus materials incurred to date;
·the Company does not recognize revenue for award fees or bonuses until specific contractual criteria are met;
·the Company does not include revenue for unpriced change orders until the customer agrees with the changes;
·historically the Company has not had significant accounts receivable write-offs or cost overruns; and
·its contracts are typically progress billed on a monthly basis.

Gross revenues and reimbursements for fiscal years 2017, 2016 and 2015, respectively, were:

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Gross revenues $373,840  $322,293  $320,404 
Less: Subcontractor fees  26,041   7,217   7,572 
Revenues  347,799   315,076   312,832 
             
Reimbursements:            
Out-of-pocket reimbursements  7,693   5,474   5,967 
Other outside direct expenses  10,442   10,405   11,160 
   18,135   15,879   17,127 
Revenues before reimbursements $329,664  $299,197  $295,705 

Management judgments and estimates must be made in connection with the revenues recognized in any accounting period. These judgments and estimates include an estimate as to the total effort required to complete fixed-price projects. If the Company made different judgments or utilized different estimates, the amount and timing of its revenue for any period could be materially different.

All consulting contracts are subject to review by management, which requires a positive assessment of the collectability of contract amounts. If, during the course of the contract, the Company determines that collection of revenue is not reasonably assured, it does not recognize the revenue until its collection becomes reasonably assured, which in those situations would generally be upon receipt of cash. The Company assesses collectability based on a number of factors, including past transaction history with the client, as well as the credit-worthiness of the client. Losses on fixed-price contracts are recognized during the period in which the loss first becomes evident. Contract losses are determined to be the amount by which the estimated total costs of the contract exceeds the total fixed price of the contract.

Foreign Currency Translation

The Company translates the assets and liabilities of foreign subsidiaries, whose functional currency is the local currency, at exchange rates in effect at the balance sheet date. Revenues and expenses are translated at the average rates of exchange prevailing during the year. The adjustment resulting from translating the financial statements of such foreign subsidiaries is included in accumulated other comprehensive income,income/(loss), which is reflected as a separate component of stockholders’ equity.

Cash Equivalents

Cash equivalents consist of highly liquid investments such as money market mutual funds, commercial paper and debt securities with original remaining maturities of three months or less from the date of purchase.

Short-term Investments

Short-term investments consist of debt securities classified as available-for-sale and are carried at their fair value as of the balance sheet date. Short-term investments generally mature between three months and three years from the purchase date. Investments with maturities beyond one year are classified as short-term based on their highly liquid nature and because such marketable securities represent investments readily available for current operations.

The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in interest income. Realized gains or losses are determined on the specific identification method and are reflected in other income. Net unrealized gains and losses are recorded directly in accumulated other comprehensive income except for unrealized losses that are deemed to be other-than-temporary, which are reflected in net income.

43

Investments are reviewed on a regular basis to evaluate whether or not any security has experienced an other-than temporary decline in fair value. When assessing investments for other-than-temporary declines in fair value, the Company considers the significance of the decline in value as a percentage of the original cost, how long the market value of the investment has been less than its original cost, any news that has been released specific to the investee, and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis.

Allowances for Contract Losses and Doubtful Accounts

The Company maintains allowances for estimated losses resulting from the inability of customers to meet their financial obligations or for disputes that affect the Company’s ability to fully collect amounts due. In circumstances where the Company is aware of a specific customer’s inability to meet its financial obligations or is aware of a dispute with a specific customer, a specific allowance is recorded to reduce the net recognized receivable to the amount the Company reasonably believes will be collected. For all other customers the Company recognizes allowances for doubtful accounts based upon historical write-offs, customer concentration, customer credit-worthiness,creditworthiness, current and forecasts of future economic conditions, aging of amounts due and changes in customer payment terms.

Property, Equipment and Leasehold Improvements

Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are recognized using the straight-line method. Buildings are depreciated over their estimated useful lives ranging from thirty 30 to forty40 years. Equipment is depreciated over its estimated useful life, which generally ranges from two three to seven years.years. Leasehold improvements are amortized over the shorter of their estimated useful lives, generally seven years, or the term of the related lease.

46


Impairment of Long-Lived Assets

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted cash flows to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. The Company has not recognized impairment losses on any long-lived assets in fiscal years 2017, 20162023, 2022 or 2015.2021.

Goodwill

Goodwill

The Company assesses the impairment of goodwill annually and whenever events or changes in circumstances indicate that the carrying amount may be impaired. The Company’s annual goodwill impairment review is completed during the fourth quarter of each year. The Company evaluates goodwill for each reporting unit for impairment by assessing qualitative factors to determine whether it is necessary to perform the two-stepa quantitative goodwill impairment test. The Company considers events and circumstances, including but not limited to, macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, changes in management or key personnel, changes in strategy, changes in customers, a change in the composition or carrying amount of a reporting unit’s net assets and changes in the price of its common stock. If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, then the two-stepquantitative goodwill impairment test is not performed.

If the two-step goodwill test is performed, the Company determines the existence of impairment by assessing the fair value of the applicable reporting unit, including goodwill, using expected future cash flows to be generated by the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of the goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation. The residual fair value after this allocation is the implied value of the reporting unit goodwill.

The Company completed its annual assessment for all reporting units with goodwill for fiscal 20172023 and determined, after assessing the totality of the qualitative factors, that it is more likely than not that the fair value of each reporting unit is greater than its respective carrying amount. Accordingly, there was no indication of impairment of goodwill for any of the Company’s reporting units and the two-stepquantitative goodwill impairment test was not performed. The Company did not recognize any goodwill impairment losses in fiscal years 2017, 20162023, 2022 or 2015.2021.

44

Deferred Revenues

Deferred revenues represent amounts billed to clients in advance of services provided.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax basis and the financial reporting basis of assets and liabilities. Deferred tax assets and liabilities are measured using the enacted tax rates and laws in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities from changes in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. An uncertain tax position is recognized if it is determined that it is more likely than not to be sustained upon examination. The tax position is measured as the largest amount of benefit that is greater than fifty percent50% likely of being realized upon ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as income tax expense. Accrued interest and penalties are insignificant at December 29, 20172023 and December 30, 2016.2022.

Fair Value of Financial Instruments

Financial instruments consist of cash and cash equivalents, short-term investments, accounts receivable, other assets and accounts payable. Cash, cash equivalents and short-term investments are recorded at fair value. The carrying amount of the Company’s accounts receivable, other assets and accounts payable approximates their fair values due to their short maturities.

Stock-Based Compensation

Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense on a straight-line basis over the requisite service period of the entire award. The Company accounts for forfeitures of share-basedstock-based awards when they occur.

47


Net Income Per Share

Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. DilutiveDiluted per share amounts are computed using the weighted-average number of common shares outstanding and potentially dilutive securities, using the treasury stock method if their effect would be dilutive.

The following schedule reconciles the denominators of the Company’s calculation for basic and diluted net income per share:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Shares used in basic per share computation

 

 

51,152

 

 

 

51,727

 

 

 

52,610

 

Effect of dilutive common stock options outstanding

 

 

188

 

 

 

204

 

 

 

241

 

Effect of unvested restricted stock units outstanding

 

 

295

 

 

 

349

 

 

 

480

 

Shares used in diluted per share computation

 

 

51,635

 

 

 

52,280

 

 

 

53,331

 

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Shares used in basic per share computation  26,362   26,488   26,606 
             
Effect of dilutive common stock options outstanding  145   124   135 
             
Effect of unvested restricted stock units outstanding  479   554   557 
             
Shares used in diluted per share computation  26,986   27,166   27,298 

Common stock options to purchase 59,459 shares were excluded from the diluted per share calculation for 2023 due to their anti-dilutive effect. There were no equity awards excluded from the diluted per share calculation for fiscal years 2017, 20162022 and 2015.2021.

RecentRecently Accounting Pronouncements Not Yet Effective. On May 28, 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2014-09,Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. generally accepted

There are no new accounting principles (“GAAP”) when it becomes effective. The new standard is effective for the Company on the first day of fiscal 2018 (December 30, 2017). The two permitted transition methods under the new standardpronouncements that are the full retrospective method, in which case the standard would be applied to each prior reporting period presented, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application.

The impact of adopting the new standard is not expected to be material because the analysis ofmaterially impact the Company’s contracts under the new revenue recognition standard supports the recognition of revenue over time, which is consistent with the Company’s current revenue recognition model.consolidated financial statements.

45

Note 2: Revenue Recognition

Substantially all of the Company’s engagements are performed under time and materialmaterials or fixed-price arrangements. For time and materials contracts, the Company anticipates utilizingutilizes the practical expedient under the ASUAccounting Standards Codification 606 – Revenue from Contracts with Customers, which states, if an entity has a right to consideration from a customer in an amount that corresponds directly with the value of the entity’s performance completed to date (for example, a service contract in which an entity bills a fixed amount for each hour orof service provided), the entity may recognize revenue in the amount to which the entity has a right to invoice. Application

The following table discloses the percent of the practical expedient toCompany’s revenue generated from time and material contracts is consistent with the Company’s current revenue recognition policy.materials contracts:

 

 

Fiscal Years

 

 

2023

 

2022

 

2021

Engineering & Other Scientific

 

63%

 

63%

 

61%

Environmental and Health

 

15%

 

16%

 

17%

Total time and materials revenues

 

78%

 

79%

 

78%

For fixed pricefixed-price contracts the Company will recognizerecognizes revenue over time under the ASU because of the continuous transfer of control to the customer. The customer typically controls the work in process as evidenced either by contractual termination clauses or by the Company’s rights to payment for work performed to date to deliver services that do not have an alternative use to the Company. Input methods are an acceptable method of measuring progress towards completing under the ASU. ThisRevenue for fixed-price contracts is consistent with the Company’s current policy of measuring progress towards completionrecognized based on the relationship of incurred labor hours at standard rates to itsthe Company’s estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed-price contracts given the nature of the consulting services the Company provides.

The following table discloses the percent of the Company’s revenue generated from fixed price contracts.contracts:

48


 

 

Fiscal Years

 

 

2023

 

2022

 

2021

Engineering & Other Scientific

 

20%

 

20%

 

21%

Environmental and Health

 

2%

 

1%

 

1%

Total fixed price revenues

 

22%

 

21%

 

22%

Deferred revenues represent amounts billed to clients in advance of services provided. During 2023, $14,463,000 of revenues were recognized that were included in the deferred revenue balance at December 30, 2022. During 2022, $15,384,000 of revenues were recognized that were included in the deferred revenue balance at December 31, 2021. During 2021, $8,387,000 of revenues were recognized that were included in the deferred revenue balance at January 1, 2021.

Reimbursements, including those related to travel and other out-of-pocket expenses, and other similar third-party costs such as the cost of materials and certain subcontracts, are included in revenues, and an equivalent amount of reimbursable expenses are included in operating expenses. Any service fee associated with reimbursable expenses is included in revenues before reimbursements. The Company anticipates adopting the standard using the modified retrospective method. The Company is currently evaluating the required disclosures under the new standard.

On February 25, 2016, the FASB issued ASU No. 2016-02,Leases, which requires lessees to recognize most leases on their balance sheet.  The new standard will be effectivereports revenues net of subcontractor fees for certain subcontracts where the Company onhas determined that it is acting as an agent because its performance obligation is to arrange for and not control the first dayprovision of fiscal 2019 (December 29, 2018).  Early adoption is permitted.goods or services by another party. The standard requires usetotal amount of the modified retrospective transition method, with elective relief, which requires application of the guidance for all periods presented.  The Company is evaluating the effect that ASU No. 2016-02 will have on its consolidated financial statements and related disclosures.  The Company hassubcontractor fees not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting. The standard will requireincluded in revenues because the Company to record a right of use assetwas acting as an agent were $12,268,000, $28,754,000 and a lease liability that will materially gross up its balance sheet. $15,357,000 during 2023, 2022 and 2021, respectively.

46

Note 2:3: Cash and cash equivalents

Cash and short-term investments

Cash, cash equivalents and short-term investments consisted of the following as of December 29, 2017:2023:

 Amortized Unrealized Unrealized Estimated 

 

 

 

 

 

 

 

 

 

 

Estimated

 

(In thousands) Cost Gains Losses Fair Value 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

         
Classified as current assets:                

 

 

 

 

 

 

 

 

 

 

 

 

Cash $115,052  $-  $-  $115,052 

 

$

132,464

 

 

$

 

 

$

 

 

$

132,464

 

                

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:                

 

 

 

 

 

 

 

 

 

 

 

Money market securities  9,742   -   -   9,742 

 

 

54,686

 

 

 

 

 

 

 

 

 

54,686

 

Total cash equivalents  9,742   -   -   9,742 

 

 

54,686

 

 

 

 

 

 

 

 

 

54,686

 

Total cash and cash equivalents  124,794   -   -   124,794 

 

 

187,150

 

 

 

 

 

 

 

 

 

187,150

 

                
Short-term investments:                
U.S. Agency securities  71,997   -   (393)  71,604 
Total short-term investments  71,997   -   (393)  71,604 
                
Total cash, cash equivalents and short-term investments $196,791  $-  $(393) $196,398 

Cash and cash equivalents and short-term investments consisted of the following as of December 30, 2016:2022:

 Amortized Unrealized Unrealized Estimated 

 

 

 

 

 

 

 

 

 

 

Estimated

 

(In thousands) Cost Gains Losses Fair Value 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

         
Classified as current assets:                

 

 

 

 

 

 

 

 

 

 

 

 

Cash $93,049  $-  $-  $93,049 

 

$

109,299

 

 

$

 

 

$

 

 

$

109,299

 

                

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:                

 

 

 

 

 

 

 

 

 

 

 

Money market securities  21,918   -   -   21,918 

 

 

52,159

 

 

 

 

 

 

 

 

 

52,159

 

Total cash equivalents  21,918   -   -   21,918 

 

 

52,159

 

 

 

 

 

 

 

 

 

52,159

 

Total cash and cash equivalents  114,967   -   -   114,967 

 

 

161,458

 

 

 

 

 

 

 

 

 

161,458

 

                
Short-term investments:                
U.S. Agency securities  59,000   -   (245)  58,755 
Total short-term investments  59,000   -   (245)  58,755 
                
Total cash, cash equivalents and short-term investments $173,967  $-  $(245) $173,722 

47

49


Note 3:4: Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There have been no transfers between fair value measurement levels during fiscal years 2017, 20162023, 2022 and 2015.2021. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. The fair value of these certain financial assets and liabilities was determined using the following inputs at December 29, 20172023 (in thousands):

  Fair Value Measurements at Reporting Date Using 
  Total  Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
  Significant Other
Observable Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
 
Assets                
Money market  securities(1) $9,742  $9,742  $-  $- 
                 
Fixed income available  for sale securities(2)  71,604   -   71,604   - 
                 
Fixed income trading securities held in deferred compensation plan(3)  13,686   13,686   -   - 
                 
Equity trading securities held in deferred compensation plan(3)  39,664   39,664   -   - 
                 
Total $134,696  $63,092  $71,604  $- 
                 
Liabilities                
Deferred compensation plan(4)  59,050   59,050   -   - 
                 
Total $59,050  $59,050  $-  $- 

(1)Included in cash and cash equivalents on the Company’s consolidated balance sheet.
(2)Included in short-term investments on the Company’s consolidated balance sheet.
(3)Included in other current assets and deferred compensation plan assets on the Company’s consolidated balance sheet.
(4)Included in accrued liabilities and deferred compensation on the Company’s consolidated balance sheet.

48

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

54,686

 

 

$

54,686

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income trading securities held in
   deferred compensation plan
(2)

 

 

36,788

 

 

 

36,788

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity trading securities held in deferred
   compensation plan
(2)

 

 

78,399

 

 

 

78,399

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

169,873

 

 

$

169,873

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (3)

 

 

116,564

 

 

 

116,564

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

116,564

 

 

$

116,564

 

 

$

 

 

$

 

(1)
Included in cash and cash equivalents on the Company’s consolidated balance sheet.
(2)
Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s consolidated balance sheet.
(3)
Included in accounts payable and accrued liabilities and deferred compensation plan liabilities on the Company’s consolidated balance sheet.

50


The fair value of these certain financial assets and liabilities was determined using the following inputs at December 30, 20162022 (in thousands):

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted
Prices in
Active Markets
for Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

52,159

 

 

$

52,159

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income trading securities held in
   deferred compensation plan
(2)

 

 

32,851

 

 

 

32,851

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity trading securities held in deferred
   compensation plan
(2)

 

 

67,880

 

 

 

67,880

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

152,890

 

 

$

152,890

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (3)

 

 

101,354

 

 

 

101,354

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

101,354

 

 

$

101,354

 

 

$

 

 

$

 

  Fair Value Measurements at Reporting Date Using 
  Total  Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
  Significant Other
Observable Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
 
Assets                
Money market securities(1) $21,918  $21,918  $-  $- 
                 
Fixed income available for sale securities(2)  58,755   -   58,755   - 
                 
Fixed income trading securities held in deferred compensation plan(3)  11,872   11,872   -   - 
                 
Equity trading securities held in deferred compensation plan(3)  36,395   36,395   -   - 
                 
Total $128,940  $70,185  $58,755  $- 
                 
Liabilities                
Deferred compensation plan(4)  53,617   53,617   -   - 
                 
Total $53,617  $53,617  $-  $- 
(1)
Included in cash and cash equivalents on the Company’s consolidated balance sheet.
(2)
Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s consolidated balance sheet.
(3)
Included in accounts payable and accrued liabilities and deferred compensation plan liabilities on the Company’s consolidated balance sheet.

(1)Included in cash and cash equivalents on the Company’s consolidated balance sheet.
(2)Included in short-term investments on the Company’s consolidated balance sheet.
(3)Included in other current assets and deferred compensation plan assets on the Company’s consolidated balance sheet.
(4)Included in accrued liabilities and deferred compensation on the Company’s consolidated balance sheet.

Fixed income available-for-saleand equity trading securities as of December 29, 20172023 and December 30, 2016 represent primarily obligations of United States agencies. Fixed income and equity trading securities2022 represent mutual funds held in the Company’s deferred compensation plan. See Note 1011 for additional information about the Company’s deferred compensation plan.

The following table summarizes the cost and estimated fair value of short-term fixed income securities classified as short-term investments based on remaining effective maturities as of December 29, 2017:

  Amortized  Estimated 
(In thousands) Cost  Fair Value 
       
Due within one year $43,000  $42,816 
Due between one and two years  28,997   28,788 
Total $71,997  $71,604 

49

At December 29, 2017 and December 30, 2016, the Company did not have any assets or liabilities valued using significant unobservable inputs.

The following financial instruments are not measured at fair value on the Company's consolidated balance sheet at December 29, 2017,2023, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at December 29, 20172023 approximates their carrying value as reported on the consolidated balance sheet.

There were no other-than-temporary impairments or credit losses related to available-for-sale securities during fiscal years 2017, 20162023, 2022 and 2015.2021.

51


Note 4:5: Property, Equipment and Leasehold Improvements

 

 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017 2016 

 

2023

 

 

2022

 

     
Property:        

 

 

 

 

 

 

Land $11,888  $11,888 

 

$

18,339

 

$

18,339

 

Buildings  38,112   37,883 

 

69,698

 

69,600

 

Construction in progress  632   67 

 

1,114

 

1,381

 

Equipment:        

 

 

 

 

 

Machinery and equipment  42,803   40,440 

 

54,008

 

54,476

 

Office furniture and equipment  9,911   9,669 

 

12,411

 

10,632

 

Leasehold improvements  15,178   14,464 

 

 

23,759

 

 

 

14,145

 

  118,524   114,411 

 

179,329

 

168,573

 

        
Less accumulated depreciation and amortization  83,510   77,701 

 

 

104,011

 

 

 

103,034

 

        
Property, equipment and leasehold improvements, net $35,014  $36,710 

 

$

75,318

 

 

$

65,539

 

Depreciation and amortization for fiscal years 2017, 20162023, 2022 and 20152021 was $6,285,000, $6,131,000$8,916,000, $7,079,000 and $5,479,000,$6,487,000, respectively.

50

Note 5:6: Other Significant Balance Sheet Components

Account receivable, net

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

Billed accounts receivable

 

$

128,052

 

 

$

120,212

 

Unbilled accounts receivable

 

 

44,589

 

 

 

56,095

 

Allowance for contract losses and doubtful accounts

 

 

(5,281

)

 

 

(6,193

)

Total accounts receivable, net

 

$

167,360

 

 

$

170,114

 

  Fiscal Years 
(In thousands) 2017  2016 
       
Billed accounts receivable $78,139  $60,510 
Unbilled accounts receivable  35,487   30,316 
Allowance for contract losses and doubtful accounts  (3,526)  (3,417)
Total accounts receivable, net $110,100  $87,409 

Accounts payable and accrued liabilities

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

Accounts payable

 

$

4,489

 

 

$

8,642

 

Accrued liabilities

 

 

17,636

 

 

 

20,473

 

Total accounts payable and other accrued liabilities

 

$

22,125

 

 

$

29,115

 

  Fiscal Years 
(In thousands) 2017  2016 
       
Accounts payable $2,784  $3,193 
Accrued liabilities  11,957   6,880 
Total accounts payable and other accrued liabilities $14,741  $10,073 

Accrued payroll and employee benefits

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

Accrued bonuses payable

 

$

68,415

 

 

$

67,805

 

Accrued 401(k) contributions

 

 

11,138

 

 

 

9,812

 

Accrued vacation

 

 

13,492

 

 

 

13,106

 

Deferred compensation plan

 

 

13,166

 

 

 

10,171

 

Other accrued payroll and employee benefits

 

 

5,562

 

 

 

4,928

 

Total accrued payroll and employee benefits

 

$

111,773

 

 

$

105,822

 

  Fiscal Years 
(In thousands) 2017  2016 
       
Accrued bonuses payable $44,752  $37,120 
Accrued 401(k) contributions  7,691   7,440 
Accrued vacation  9,707   9,177 
Deferred compensation  6,274   7,114 
Other accrued payroll and employee benefits  1,640   1,688 
Total accrued payroll and employee benefits $70,064  $62,539 

Other accrued payroll and employee benefits consist primarily of accrued wages, payroll taxes and disability insurance programs. A portion of accrued bonuses payable will be settled by issuing fully vested restricted stock units. See Note 89 and Note 1416 for additional information.

52


Note 6:7: Income Taxes

Income before income taxes includes income from foreign operations of $7,707,000, $5,616,000$10,353,000, $10,646,000 and $6,656,000$12,326,000 for fiscal years 2017, 20162023, 2022 and 2015,2021, respectively.

Total income tax expense for fiscal years 2017, 20162023, 2022 and 20152021 consisted of the following:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Current

 

 

 

 

 

 

 

 

 

Federal

 

$

23,193

 

 

$

24,411

 

 

$

19,800

 

Foreign

 

 

2,254

 

 

 

1,973

 

 

 

2,252

 

State

 

 

10,025

 

 

 

10,883

 

 

 

8,588

 

 

 

35,472

 

 

 

37,267

 

 

 

30,640

 

Deferred

 

 

 

 

 

 

 

 

 

Federal

 

 

(775

)

 

 

(4,910

)

 

 

(3,930

)

State

 

 

860

 

 

 

(2,453

)

 

 

(2,075

)

 

 

85

 

 

 

(7,363

)

 

 

(6,005

)

Total

 

$

35,557

 

 

$

29,904

 

 

$

24,635

 

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Current            
Federal $22,821  $18,877  $25,081 
Foreign  1,514   1,085   1,385 
State  5,083   4,282   4,895 
   29,418   24,244   31,361 
Deferred            
Federal  12,570   (2,047  (3,411)
State  (784)  (555)  (416)
   11,786   (2,602)  (3,827)
Total $41,204  $21,642  $27,534 

The Company’s effective tax rate differs from the statutory federal tax rate of 35%21% as shown in the following schedule:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Tax at federal statutory rate

 

$

28,538

 

 

$

27,769

 

 

$

26,426

 

State taxes, net of federal benefit

 

 

8,587

 

 

 

6,726

 

 

 

5,174

 

Non-deductible officer compensation

 

 

870

 

 

 

1,160

 

 

 

997

 

Non-deductible expenses

 

 

456

 

 

 

52

 

 

 

19

 

Non-deductible stock-based compensation

 

 

12

 

 

 

12

 

 

 

13

 

Excess tax benefit from equity incentive plans

 

 

(2,844

)

 

 

(4,533

)

 

 

(7,850

)

Difference between statutory rate and foreign effective tax rate

 

 

(264

)

 

 

(693

)

 

 

(622

)

Other

 

 

202

 

 

 

(589

)

 

 

478

 

Tax expense

 

$

35,557

 

 

$

29,904

 

 

$

24,635

 

 

 

 

 

 

 

 

 

 

Effective tax rate

 

 

26.2

%

 

 

22.6

%

 

 

19.6

%

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Tax at federal statutory rate $28,878  $24,193  $24,897 
Re-measurement of deferred tax assets to lower enacted domestic tax rate  15,137   -   - 
Mandatory repatriation of foreign earnings  1,370   -   - 
State taxes, net of federal benefit  2,806   2,423   2,910 
Tax exempt interest income  -   (7)  (23)
Non-deductible expenses  417   274   261 
Non-deductible stock-based compensation  18   11   (42)
Excess tax benefit from equity incentive plans  (5,831)  (4,321)  - 
Difference between statutory rate and foreign effective tax rate  (1,339)  (889)  (897)
Other  (252)  (42)  428 
Tax expense $41,204  $21,642  $27,534 
             
Effective tax rate  49.9%  31.3%  38.7%

51

53


The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 29, 20172023 and December 30, 20162022 are presented in the following schedule:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

Deferred tax assets:

 

 

 

 

 

 

Accrued liabilities and allowances

 

$

21,235

 

 

$

20,740

 

Deferred compensation plan

 

 

40,280

 

 

 

36,819

 

Operating leases

 

 

7,853

 

 

 

5,386

 

Unrealized loss on trading securities

 

 

 

 

 

453

 

Property, equipment and leasehold improvements

 

 

 

 

 

212

 

Other

 

 

 

 

 

88

 

Total deferred tax assets

 

$

69,368

 

 

$

63,698

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

State taxes

 

$

(2,255

)

 

$

(2,265

)

Deductible goodwill

 

 

(2,071

)

 

 

(2,138

)

Operating leases

 

 

(7,853

)

 

 

(5,386

)

Unrealized gain of deferred compensation plan assets

 

 

(1,652

)

 

 

 

Property, equipment and leasehold improvements

 

 

(1,695

)

 

 

 

Other

 

 

(18

)

 

 

 

Total deferred tax liabilities

 

 

(15,544

)

 

 

(9,789

)

Net deferred tax assets

 

$

53,824

 

 

$

53,909

 

  Fiscal Years 
(In thousands) 2017  2016 
       
Deferred tax assets:        
Accrued liabilities and allowances $13,265  $18,335 
Deferred compensation  22,297   30,603 
Property, equipment and leasehold improvements  288   - 
Other  98   97 
Total deferred tax assets  35,948   49,035 
         
Deferred tax liabilities:        
State taxes  (1,232)  (1,958)
Deductible goodwill  (2,078)  (3,075)
Property, equipment and leasehold improvements  -   (195)
Unrealized gain of deferred compensation plan assets  (2,119)  (1,641)
Other  (82)  - 
Total deferred tax liabilities  (5,511)  (6,869)
Net deferred tax assets $30,437  $42,166 

Management believes it is more likely than not that the results of future operations will generate sufficient taxable income to realize the net deferred tax assets.

The Tax Cuts and Jobs Act (Tax Legislation) was enacted on December 22, 2017 and lowers U.S. corporate income tax rates as of January 1, 2018, implements a territorial tax system and imposes a repatriation tax on deemed repatriated earnings of foreign subsidiaries. The estimated impact of the Tax Legislation to the Company was an increase in income tax expense of $16,507,000 during 2017. The Company’s deferred tax assets were re-measured at the lower enacted corporate tax rate of 21% which contributed $15,137,000 to the estimated increase in income tax expense associated with the Tax Legislation. The Company also has foreign earnings that were subject to the mandatory repatriation tax. The total mandatory repatriation tax, net of the benefit of the Company’s foreign tax credits, contributed $1,370,000 to the estimated increase in income tax expense associated with the Tax Legislation. The mandatory repatriation tax may be elected to be paid over a period of eight years. The Company intends to make this election.

The Tax Legislation also includes a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries. The company will be subject to the GILTI provisions effective December 30, 2017 and is in the process of analyzing the effects, including how to account for the GILTI provision from an accounting policy standpoint.

Due to the change in U.S. federal tax law, the Company has decided not to indefinitely reinvest any of its unremitted foreign earnings as of December 29, 2017. Deferred U.S. state and foreign withholding taxes related to these undistributed foreign earnings are not expected to be material but are subject to further legislative action from the states regarding conformity with the Tax Legislation.

The Company is entitled to a deduction for federal and state tax purposes with respect to employees’ stock award activity. The net deduction in taxes otherwise payable arising from that deduction has been recorded as an income tax benefit for fiscal year 2017benefit. For 2023, 2022 and 2016. The net deduction in taxes otherwise payable arising from that deduction was credited to additional paid-in capital for fiscal year 2015. For fiscal years 2017, 2016 and 2015,2021, the net deduction in tax payable arising from employees’ stock award activity was $6,528,000, $4,827,000$3,620,000, $5,829,000 and $6,396,000,$10,009,000, respectively.

The Company and its subsidiaries file income tax returns in the United States federal jurisdiction, California and various other state and foreign jurisdictions. The Company is no longer subject to United States federal income tax examination for years prior to 2014.2020. The Company is no longer subject to California franchise tax examinations for years prior to 2013.2019. With few exceptions, the Company is no longer subject to state and local or non-United States income tax examination by tax authorities for years prior to 2013.2019.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:follows (in thousands):

Balance at December 31, 2021

 

$

1,949

 

  Additions based on tax positions related to the current year

 

 

630

 

  Reductions due to lapse of statute of limitations

 

 

(532

)

Balance at December 30, 2022

 

$

2,047

 

  Additions based on tax positions related to the current year

 

 

571

 

  Reductions due to lapse of statute of limitations

 

 

(473

)

Balance at December 29, 2023

 

$

2,145

 

Balance at January 1, 2016 $1,878,000 
Additions based on tax positions related to the current year  502,000 
Additions for tax positions of prior years  6,000 
Reductions due to lapse of statute of limitations  (430,000)
Settlements  - 
Balance at December 30, 2016 $1,956,000 
Additions based on tax positions related to the current year  597,000 
Additions for tax positions of prior years  11,000 
Reductions due to lapse of statute of limitations  (338,000)
Reductions for tax positions of prior years  (437,000
Settlements  - 
Balance at December 29, 2017 $1,789,000 

Unrecognized tax benefits are included in other liabilities in the accompanying consolidated balance sheet.sheets. To the extent these unrecognized tax benefits are ultimately recognized, they will impact the effective tax rate by $1,459,000$1,695,000 in a future period. There are no uncertain tax positions whose resolution in the next 12 months is expected to materially affect operating results.

52

54


Note 7:8: Stockholders’ Equity

Preferred Stock

The Company has authorized 2,000,000 shares of undesignated preferred stock with a par value of $0.001$0.001 per share. None of the preferred shares were issued and outstanding at December 29, 20172023 and December 30, 2016.2022.

Dividends

Dividends

The Company declared and paid cash dividends per share of common sharestock during the periods presented as follows:

 

 

Fiscal Years

 

 

 

2023

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.260

 

 

$

13,169

 

Second Quarter

 

$

0.260

 

 

 

13,217

 

Third Quarter

 

$

0.260

 

 

 

13,177

 

Fourth Quarter

 

$

0.260

 

 

 

13,148

 

 

 

 

 

$

52,711

 

 

 

 

 

 

 

 

 

 

Fiscal Years

 

 

 

2022

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.240

 

 

$

12,383

 

Second Quarter

 

$

0.240

 

 

 

12,345

 

Third Quarter

 

$

0.240

 

 

 

12,225

 

Fourth Quarter

 

$

0.240

 

 

 

12,153

 

 

 

 

 

$

49,106

 

  Fiscal Year 2017 
  Dividends  Amount 
  Per Share  (in thousands) 
First Quarter $0.21  $5,374 
Second Quarter $0.21   5,424 
Third Quarter $0.21   5,424 
Fourth Quarter $0.21   5,416 
      $21,638 

  Fiscal Year 2016 
  Dividends  Amount 
  Per Share  (in thousands) 
First Quarter $0.18  $4,628 
Second Quarter $0.18   4,675 
Third Quarter $0.18   4,659 
Fourth Quarter $0.18   4,607 
      $18,569 

On February 1, 2018 the Company’s Board of Directors announced a cash dividend of $0.26 per share of the Company’s common stock, payable March 23, 2018, to stockholders of record as of March 2, 2018. The Company expects to continue paying quarterly dividends in the future, subject to declaration by the Company’s Board of Directors.

Treasury Stock

Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $5,667,000, $5,791,000$1,009,000, $1,392,000 and $4,943,000$1,679,000 were recorded as a reduction to retained earnings during fiscal 2017, 20162023, 2022 and 2015,2021, respectively.

Repurchase of Common Stock

The Company repurchased 186,000288,000 shares of its common stock for $11,931,000$24,208,000 during fiscal year 2017.2023. The Company repurchased 491,0001,756,000 shares of its common stock for $24,456,000$155,856,000 during fiscal year 2016.2022. The Company repurchased 530,00078,000 shares of its common stock for $23,314,000$7,000,000 during fiscal year 2015.2021. On October 18, 2016February 22, 2022, the Board of Directors authorized $35,000,000$150,000,000 for the repurchase of Exponent’sthe Company’s common stock.On October 20, 2015May 29, 2020, the Board of Directors authorized $35,000,000$45,000,000 for the repurchase of Exponent’s common stock. On May 29, 2014 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’sCompany’s common stock. These repurchase programs have no expiration dates. As of December 29, 2017,2023, the Company had remaining authorization under its stock repurchase plan of $45,376,000$38,390,000 to repurchase shares of common stock.

Note 8:9: Stock-Based Compensation

On May 29, 2008, the Company’s stockholders approved the 2008 Equity Incentive Plan and the 2008 Employee Stock Purchase Plan (“ESPP”). The 2008 Equity Incentive Plan and ESPP were previously adopted by the Company’s Board of Directors on April 8, 2008, subject to stockholder approval.

55


The 2008 Equity Incentive Plan allows for the award of stock options, stock awards (including stock units, stock grants and stock appreciation rights or other similar equity awards) and cash awards to officers, employees, consultants and non-employee members of the Board of Directors. The total number of shares reserved for issuance under the 2008 Equity Incentive Plan was 5,928,15011,856,300 shares of common stock, subject to adjustment resulting from a stock split or the payment of a stock dividend or any other increase or decrease in the number of issued shares of the Company’s stock effected without receipt of consideration by the Company. As of December 29, 2017, 1,495,4372023, 1,126,909 shares were available for grant under the 2008 Equity Incentive Plan.

The ESPP allows for officers and employees to purchase common stock through payroll deductions of up to 15%15% of a participant’s eligible compensation. Shares of common stock are purchased under the ESPP at 95%95% of the fair market value of the Company’s common stock on each purchase date. Subject to adjustment resulting from a stock split or the payment of a stock dividend or any other increase or decrease in the number of issued shares of the Company’s stock effected without receipt of consideration by the Company, the total number of shares reserved for issuance under the ESPP was 600,0001,200,000 shares of common stock. As of December 29, 2017, 223,4292023, 296,047 shares were available for grant. Weighted average purchase prices for shares sold under the ESPP plan in fiscal 2017, 20162023, 2022 and 20152021 were $61.33, $51.97$87.12, $91.17 and $43.88,$98.64, respectively.

53

Restricted Stock Units

The Company grants restricted stock units to employees and outside directors. These restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40%40% of their annual bonus is settled with fully vested restricted stock unit awards. Under these fully vested restricted stock unit awards, the holder of each award has the right to receive one share of the Company’s common stock for each fully vested restricted stock unit four years from the date of grant. Each individual who received a fully vested restricted stock unit award is granted a matching number of unvested restricted stock unit awards. These unvested restricted stock unit awards cliff vest four years from the date of grant, at which time the holder of each award will have the right to receive one share of the Company’s common stock for each restricted stock unit award, provided the holder of each award has met certain employment conditions. In the case of retirement at 59 ½ years or older, all unvested restricted stock unit awards will continue to vest provided the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company.

All restricted stock units granted have dividend equivalent rights (“DER”), which entitle holders of restricted stock units to the same dividend value per share as holders of common stock. DER are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs.restricted stock units. DER are accumulated and paid when the underlying shares vest and are forfeited if the underlying shares are forfeited.

The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. For fiscal years 2017, 20162023, 2022 and 2015,2021, the Company recorded stock-based compensation expense associated with accrued bonus awards of $8,331,000, $6,181,000$10,445,000, $10,365,000 and $6,341,000,$9,967,000, respectively.

The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $7,075,000, $6,583,000$8,831,000, $9,164,000 and $6,066,000$8,560,000 during fiscal years 2017, 20162023, 2022 and 2015,2021, respectively.The total fair value of restricted stock unit awards vested during fiscal years 2017, 20162023, 2022 and 20152021 was $21.3 million, $18.5 million$25,277,000, $29,875,000 and $18.6 million,$31,984,000, respectively. The weighted-average grant date fair values of restricted stock unit awards granted during fiscal years 2017, 20162023, 2022 and 20152021 were $59.00, $48.29$99.47, $94.24 and $43.76,$97.80, respectively.

56


The number of unvested restricted stock unit awards outstanding as of December 29, 20172023 is as follows(1):

 

 

Number
of awards
outstanding

 

 

Weighted-
average
grant date
fair value

 

 

Weighted-
average
remaining
contractual
term (years)

 

 

Aggregate
intrinsic value
(in thousands)
(2)

 

Balance at December 30, 2022

 

 

467,199

 

 

$

76.89

 

 

 

 

 

 

 

Awards granted

 

 

229,779

 

 

 

99.47

 

 

 

 

 

 

 

Awards vested

 

 

(248,513

)

 

 

76.21

 

 

 

 

 

 

 

Awards forfeited

 

 

(29,757

)

 

 

89.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 29, 2023

 

 

418,708

 

 

$

88.78

 

 

 

1.7

 

 

$

36,863

 

        Weighted-average    
  Number  Weighted-average  remaining  Aggregate 
  of awards  grant date  contractual  intrinsic value 
  outstanding  fair value  term (years)   (in thousands)(2) 
             
Balance as of December 30, 2016  695,314  $37.82         
Awards granted  262,212   59.00         
Awards vested  (359,174)  39.77         
Awards forfeited  (5,760)  46.97         
Balance as of December 29, 2017  592,592  $45.91   1.6  $42,133 

(1)Does not include employee stock purchase plans or stock option plans.
(2)The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market value as of December 29, 2017 was $71.10.

54
(1)
Does not include employee stock purchase plans or stock option plans.

(2)
The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market value as of December 29, 2023 was $88.04.

Stock Options

The Company currently grants stock options under the 2008 Equity Incentive Plan. Options are granted for terms of ten10 years and generally vest ratably over a four-year period from the grant date. The Company grants options at exercise prices equal to the fair value of the Company’s common stock on the date of grant. All stock options have dividend equivalent rights (“DER”),DER, which entitle holders of stock options to the same dividend value per share as holders of common stock. DER are subject to the same vesting terms as the corresponding stock options. DER are accumulated and paid in cash when the underlying stock options vest and are forfeited if the underlying stock options do not vest. During fiscal years 2017, 20162023, 2022 and 2015,2021, the Company recorded stock-based compensation expense of $749,000, $569,000$1,081,000, $835,000 and $552,000,$736,000, respectively, associated with stock options.

Option activity is as follows(1):

 

 

Number
of shares
outstanding

 

 

Weighted-
average
exercise
price

 

 

Weighted-
average
remaining
contractual
term (years)

 

 

Aggregate
intrinsic value
(in thousands)

 

Exercisable at December 30, 2022

 

 

441,227

 

 

$

47.38

 

 

 

 

 

 

 

Options granted

 

 

30,000

 

 

 

107.31

 

 

 

 

 

 

 

Options forfeited and expired

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(7,992

)

 

 

12.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 29, 2023

 

 

463,235

 

 

$

51.86

 

 

 

4.78

 

 

$

17,543

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 29, 2023

 

 

378,444

 

 

$

42.19

 

 

 

4.04

 

 

$

17,453

 

        Weighted-average    
  Number  Weighted-average  remaining  Aggregate 
  of shares  exercise  contractual  intrinsic value 
  outstanding  price  term (years)  (in thousands) 
             
Balance as of December 30, 2016  319,000  $31.58         
Options granted  56,000   58.10         
Options forfeited and expired  -   -         
Options exercised  (35,000)  23.38         
                 
Balance as of December 29, 2017  340,000  $36.79   6.23  $11,665 
                 
Exercisable at December 29, 2017  204,750  $27.55   4.88  $8,917 

(1)
Does not include restricted stock or employee stock purchase plans.

The total intrinsic value of options exercised during fiscal years 2017, 20162023, 2022 and 20152021 was $1,461,000, $999,000$742,000, $0 and $5,524,000,$4,335,000, respectively. The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the fiscal year ended December 29, 2017,2023, and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 29, 2017.2023. This amount changes based on the fair-value of the Company’s stock.

57


The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends.

The Company used historical exercise and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero coupon issues with remaining terms similar to the expected term on the options. The dividend yield assumption considers the expectation of continued declaration of dividends, offset by option holders’ dividend equivalent rights.DER. All share-basedstock-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards.

55

The assumptions used to value option grants for fiscal years 2017, 20162023, 2022 and 20152021 are as follows:

 

 

Stock Option Plan

 

 

 

Fiscal Years

 

 

 

2023

 

 

2022

 

 

2021

 

Expected term (in years)

 

 

5.8

 

 

 

5.6

 

 

 

5.7

 

Risk-free interest rate

 

 

3.99

%

 

 

1.90

%

 

 

0.64

%

Volatility

 

 

29

%

 

 

28

%

 

 

28

%

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

  Stock Option Plan 
  2017  2016  2015 
          
Expected term (in years)  5.9   6.0   6.1 
Risk-free interest rate  2.11%  1.28%  1.69%
Volatility  24%  25%  27%
Dividend yield  0%  0%  0%

The weighted-average grant date fair value of options granted during fiscal years 2017, 20162023, 2022 and 20152021 were $16.18, $13.08$38.29, $26.64 and $13.30,$25.32, respectively.

The amount of stock-based compensation expense and the related income tax benefit recognized in the Company’s consolidated statements of income for fiscal years 2017, 20162023, 2022 and 20152021 is as follows:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Compensation and related expenses:

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

18,542

 

 

$

18,810

 

 

$

17,755

 

Stock option grants

 

 

1,081

 

 

 

835

 

 

 

736

 

Sub-total

 

 

19,623

 

 

 

19,645

 

 

 

18,491

 

 

 

 

 

 

 

 

 

 

General and administrative expenses:

 

 

 

 

 

 

 

 

 

Restricted stock units

 

 

734

 

 

 

719

 

 

 

772

 

Sub-total

 

 

734

 

 

 

719

 

 

 

772

 

Total stock-based compensation expense

 

$

20,357

 

 

$

20,364

 

 

$

19,263

 

 

 

 

 

 

 

 

 

 

Income tax benefit

 

$

3,620

 

 

$

5,829

 

 

$

10,009

 

  2017  2016  2015 
(In thousands)            
Compensation and related expenses:            
Restricted stock units $14,809  $12,225  $11,907 
Stock option grants  749   569   552 
Sub-total  15,558   12,794   12,459 
             
General and administrative expenses:            
Restricted stock units  597   539   500 
Sub-total  597   539   500 
Total stock-based compensation expense $16,155  $13,333  $12,959 
             
Income tax benefit $6,331  $5,214  $5,068 

As of December 29, 2017,2023, there was $7,570,000$12,842,000 of unrecognized compensation cost, expected to be recognized over a weighted average period of 2.4 2.6 years, related to unvested restricted stock unit awards and $790,000$1,542,000 of unrecognized compensation cost, expected to be recognized over a weighted average period of 2.72.1 years, related to unvested stock options.

58


Note 9:10: Retirement Plans

The Company provides a defined contribution retirement plan for its employees whereby the Company contributes to each eligible employee’s account 7%7% of the employee’s eligible base salary plus overtime.salary. The employee does not need to make a contribution to the plan to be eligible for the Company’s 7%7% contribution. To be eligible under the plan, an employee must be at least 21 years of age and be either a full-time or part-time salaried employee. The 7%7% Company contribution will vest 20%20% per year for the first 5five years of employment and then immediately thereafter. These contributions are made to the 401(k) plan up to the statutory maximum. Any portion of the 7% contribution in excess of the statutory maximum is made to the Company’s nonqualified deferred compensation plan. The Company’s expenses related to this plan were $7,914,000, $7,761,000,$11,867,000, $10,166,000 and $7,317,000$9,923,000 in fiscal years 2017, 2016,2023, 2022 and 2015,2021, respectively.

Note 10:11: Deferred Compensation Plans

The Company maintains nonqualified deferred compensation plans for the benefit of a select group of highly compensated employees. Under these plans, participants may elect to defer up to 100%100% of their compensation. Company assets that are earmarked to pay benefits under the plans are held in a rabbi trust and are subject to the claims of the Company’s creditors. As of December 29, 20172023 and December 30, 2016 the2022, invested amounts under the plans totaled $53,350,000$115,187,000 and $48,267,000,$100,731,000, respectively. These assets are classified as trading securities and are recorded at fair market value with changes recorded as adjustments to other income.miscellaneous income, net.

As of December 29, 20172023 and December 30, 2016,2022, vested amounts due under the plans totaled $59,050,000$116,564,000 and $53,617,000,$101,354,000, respectively. Changes in the liability are recorded as adjustments to compensation and related expense. During fiscal years 2017, 20162023, 2022 and 2015,2021, the Company recognized compensation expense of $6,547,000, $3,861,000,$14,315,000, ($14,187,000) and $(325,000)$14,730,000, respectively, as a result of changes in the market value of the trust assets with the same amount being recorded as other income.income, net.

56

Note 12: Leases

The Company determines if an arrangement is a lease at the inception of the arrangement. Operating leases are included in operating lease right-of-use (“ROU”) assets, current operating lease liabilities, and long-term operating lease liabilities in the Company’s consolidated balance sheet. The Company does not have any finance leases as of December 29, 2023.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate, based on the information available at commencement date, in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The amortization of operating lease ROU assets and the change in operating lease liabilities is disclosed as a single line item in the consolidated statements of cash flows.

The Company leases office, laboratory, and storage space in 13 states and the District of Columbia, as well as in China, Germany, Hong Kong, Ireland, Singapore, Switzerland and the United Kingdom. Leases for these office, laboratory, and storage facilities have terms generally ranging between one and 10 years. Some of these leases include options to extend or terminate the lease, none of which are currently included in the lease term as the Company has determined that exercise of these options is not reasonably certain.

The Company has a Test and Engineering Center on 147 acres of land in Phoenix, Arizona. The Company leases this land from the state of Arizona under a 30-year lease agreement that expires in January of 2028 and has options to renew for two15-year periods. As of December 29, 2023, the Company has determined that exercise of the renewal options is not reasonably certain and thus the extension is not included in the lease term.

The Company’s equipment leases are included in the ROU asset and liability balances but are not material.

59


The components of lease expense included in other operating expenses on the consolidated statements of income were as follows:

 

 

Fiscal Year

 

 

Fiscal Year

 

 

Fiscal Year

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Operating lease cost

 

$

7,732

 

 

$

7,050

 

 

$

6,930

 

Variable lease cost

 

 

1,635

 

 

 

1,263

 

 

 

1,065

 

Short-term lease cost

 

 

1,174

 

 

 

651

 

 

 

619

 

Supplemental cash flow information related to operating leases was as follows:

 

 

Fiscal Year

 

 

Fiscal Year

 

 

Fiscal Year

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Cash paid for amounts included in the measurement of operating lease liabilities

 

$

7,249

 

 

$

6,564

 

 

$

6,962

 

Supplemental balance sheet information related to operating leases was as follows:

 

 

Fiscal Year

 

Fiscal Year

 

Fiscal Year

 

 

2023

 

2022

 

2021

Weighted Average Remaining Lease Term

 

6.1 years

 

4.1 years

 

4.1 years

Weighted Average Discount Rate

 

5.1%

 

4.3%

 

4.2%

Maturities of operating lease liabilities as of December 29, 2023:

 

 

Operating

 

(In thousands)

 

Leases

 

2024

 

 

7,260

 

2025

 

 

6,380

 

2026

 

 

5,734

 

2027

 

 

4,446

 

2028

 

 

1,868

 

Thereafter

 

 

8,247

 

Total lease payments

 

$

33,935

 

Less imputed interest

 

 

(5,674

)

Total lease liability

 

$

28,261

 

Note 11:13: Commitments and Contingencies

The following is a summary of the future minimum payments, required under non-cancelable operating leases, with terms in excess of one year, as of December 29, 2017:

(In thousands)   
  Lease 
Fiscal year commitments 
2018 $8,442 
2019  7,115 
2020  4,513 
2021  3,477 
2022  2,399 
Thereafter  4,005 
  $29,951 

Total rent expense from property leases in fiscal 2017, 2016, and 2015 was $6,712,000, $6,478,000 and $6,202,000, respectively. Total expense from other operating leases in fiscal 2017, 2016, and 2015 was $1,710,000, $1,749,000 and $1,794,000, respectively. The Company had $1,696,000 in outstanding purchase commitments as of December 29, 2017. These commitments are expected to be fulfilled by the end of fiscal 2018.

The Company is a party to various legal actions from time to time and may be contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition, results of operations or liquidity. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results. All legal costs associated with litigation are expensed as incurred.

60


Note 12:14: Miscellaneous Income, Net

Miscellaneous income, net, consisted of the following:

 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

       
Rental income  2,655   2,435   2,015 

 

$

3,371

 

$

2,938

 

$

2,658

 

Gain (loss) on deferred compensation investments  6,547   3,861   (325)

 

14,315

 

(14,187

)

 

14,730

 

Gain (loss) on foreign exchange  (19)  224   255 

 

(259

)

 

522

 

(517

)

Other  (19)  8   48 

 

 

(3

)

 

 

23

 

 

 

(27

)

Total $9,164  $6,528  $1,993 

 

$

17,424

 

 

$

(10,704

)

 

$

16,844

 

Note 13:15: Industry and Client Credit Risk

The Company serves clients in various segments of the economy. During fiscal 20172023, the Company provided services representing approximately 27%22%, 18%, 17% and 11% of revenues to clients in the consumer products industry. During fiscal 2017 the Company provided services representing approximately 15% of revenues to clients in theindustry, energy and utilities industries. During fiscal 2017 the Company provided services representing approximately 15% of revenues to clients inindustries, the transportation industry.industry and the chemical industry, respectively.

OneNo single client comprised 14%more than 10% of the Company’s revenues during fiscal year 2017. No other single2023. One client comprised more than 10%15% of the Company’s revenues during fiscal year 2017. No single2022. One client comprised more than 10%13% of the Company’s revenues during fiscal years 2016 and 2015. The same client comprised 24% of the Company’s accounts receivable at December 29, 2017. No other single client comprised more than 10% of the Company’s accounts receivable at December 29, 2017. No single client comprised more than 10% of the Company’s accounts receivable at December 30, 2016.2021.

57

Note 14:16: Supplemental Cash Flow Information

The following is supplemental disclosure of cash flow information:

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Cash paid during the year:

 

 

 

 

 

 

 

 

 

Income taxes

 

$

38,944

 

 

$

40,121

 

 

$

27,912

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

 

Unrealized loss on investments

 

 

-

 

 

 

-

 

 

 

(65

)

Vested stock unit awards granted to settle accrued bonus

 

 

10,496

 

 

 

10,200

 

 

 

7,637

 

Right-of-use asset obtained in exchange for operating
   lease obligation

 

 

15,749

 

 

 

9,476

 

 

 

792

 

Leasehold improvements obtained in exchange for right-of-use asset

 

 

3,219

 

 

 

-

 

 

 

-

 

Accrual for capital expenditures

 

 

137

 

 

 

1,017

 

 

 

413

 

  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Cash paid during the year:            
Income taxes $25,849  $22,280  $24,651 
             
Non-cash investing and financing activities:            
Unrealized loss on investments $(90) $(81) $(79)
Vested stock unit awards granted to settle accrued bonus $6,910  $6,334  $6,169 
Accrual for capital expenditures $148  $284  $321 

Note 15:17: Segment Reporting

The Company has two reportable operating segments based on two primary areas of service. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

Segment information is presented for selected data from the statements of income and statements of cash flows for fiscal years 2017, 20162023, 2022 and 2015.2021. Segment information for selected data from the balance sheets is presented for the fiscal years ended December 29, 20172023 and December 30, 2016. Our2022. The Company’s CEO, the chief operating decision maker, does not review total assets in hisher evaluation of segment performance and capital allocation.

Revenues

Revenues
 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017 2016 2015 

 

2023

 

 

2022

 

 

2021

 

       
Engineering and Other Scientific $277,603  $248,297  $237,959 

 

$

446,888

 

$

427,796

 

$

380,909

 

Environmental and Health  70,196   66,779   74,873 

 

 

89,878

 

 

 

85,497

 

 

 

85,360

 

            
Total revenues $347,799  $315,076  $312,832 

 

$

536,766

 

 

$

513,293

 

 

$

466,269

 

61


Operating Income

 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017  2016  2015 

 

2023

 

 

2022

 

 

2021

 

       
Engineering and Other Scientific $93,451  $80,494  $76,817 

 

$

153,918

 

$

152,679

 

$

140,400

 

Environmental and Health  22,340   18,650   21,810 

 

 

28,432

 

 

 

27,340

 

 

 

27,952

 

            

 

 

 

 

 

 

 

 

 

Total segment operating income  115,791   99,144   98,627 

 

182,350

 

180,019

 

168,352

 

            

 

 

 

 

 

 

 

 

 

Corporate operating expense  (43,740)  (37,233)  (29,694)

 

 

(71,028

)

 

 

(39,177

)

 

 

(59,425

)

            
Total operating income $72,051  $61,911  $68,933 

 

$

111,322

 

 

$

140,842

 

 

$

108,927

 

Capital Expenditures
  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Engineering and Other Scientific $3,648  $4,309  $3,197 
Environmental and Health  218   124   164 
             
Total segment capital expenditures  3,866   4,433   3,361 
             
Corporate capital expenditures  859   9,960   2,018 
             
Total capital expenditures $4,725  $14,393  $5,379 

Certain operating expenses are excluded from the Company's measure of segment operating income. These expenses include the costs associated with the Company’s human resources, finance, information technology, and business development groups; the deferred compensation expense/benefit due to the change in value of assets associated with the Company’s deferred compensation plan; stock-based compensation associated with restricted stock unit and stock option awards; and the change in the Company’s allowance for contract losses and doubtful accounts.

Depreciation and Amortization
  Fiscal Years 
(In thousands) 2017  2016  2015 
          
Engineering and Other Scientific $4,449  $4,429  $3,919 
Environmental and Health  179   181   182 
             
Total segment depreciation and amortization  4,628   4,610   4,101 
             
Corporate depreciation and amortization  1,657   1,521   1,378 
             
Total depreciation and amortization $6,285  $6,131  $5,479 

58

Capital Expenditures

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Engineering and Other Scientific

 

$

3,895

 

 

$

4,661

 

 

$

2,792

 

Environmental and Health

 

 

170

 

 

 

174

 

 

 

160

 

 

 

 

 

 

 

 

 

 

Total segment capital expenditures

 

 

4,065

 

 

 

4,835

 

 

 

2,952

 

 

 

 

 

 

 

 

 

 

Corporate capital expenditures

 

 

14,630

 

 

 

7,812

 

 

 

3,685

 

Total capital expenditures

 

$

18,695

 

 

$

12,647

 

 

$

6,637

 

Certain capital expenditures associated with the Company's corporate cost centers and the related depreciation are excluded from the Company's segment information.

Depreciation and Amortization

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Engineering and Other Scientific

 

$

6,087

 

 

$

4,489

 

 

$

4,031

 

Environmental and Health

 

 

213

 

 

 

171

 

 

 

193

 

 

 

 

 

 

 

 

 

 

Total segment depreciation and amortization

 

 

6,300

 

 

 

4,660

 

 

 

4,224

 

 

 

 

 

 

 

 

 

 

Corporate depreciation and amortization

 

 

2,616

 

 

 

2,419

 

 

 

2,263

 

Total depreciation and amortization

 

$

8,916

 

 

$

7,079

 

 

$

6,487

 

Information regarding the Company’s operations in different geographical areas:

Property, Equipment and Leasehold Improvements, net

Property, Equipment and Leasehold Improvements, net
 Fiscal Years 

 

Fiscal Years

 

(In thousands) 2017  2016 

 

2023

 

 

2022

 

     
United States $33,771  $35,746 

 

$

74,668

 

$

64,742

 

Foreign Countries  1,243   964 

 

 

650

 

 

 

797

 

        
Total $35,014  $36,710 

 

$

75,318

 

 

$

65,539

 

Revenues(1)   
  Fiscal Years 
(In thousands) 2017  2016  2015 
          
United States $308,406  $281,223  $281,618 
Foreign Countries  39,393   33,853   31,214 
             
Total $347,799  $315,076  $312,832 

62


Revenues (1)

 

 

Fiscal Years

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

United States

 

$

470,078

 

 

$

450,445

 

 

$

397,001

 

Foreign Countries

 

 

66,688

 

 

 

62,848

 

 

 

69,268

 

 

 

 

 

 

 

 

 

 

Total

 

$

536,766

 

 

$

513,293

 

 

$

466,269

 

(1)
Geographic revenues are allocated based on the location of the client.

Below is a breakdown of goodwill, reported by segment as of December 29, 20172023 and December 30, 2016:2022:

(In thousands)

 

Environmental
and Health

 

 

Engineering
and Other
Scientific

 

 

Total

 

Goodwill

 

$

8,099

 

 

$

508

 

 

$

8,607

 

  Environmental  Engineering and    
(In thousands) and Health  Other Scientific  Total 
             
Goodwill $8,099  $508  $8,607 

There were no changes in the carrying amount of goodwill for fiscal years 2017, 20162023, 2022 and 2015.2021. There were no goodwill impairments or gains or losses on disposals for any portion of the Company’s reporting units during fiscal years 2017, 20162023, 2022, and 2015.

59

2021.

Note 18: Subsequent Events

Comparative Quarterly Financial Data (unaudited)

SummarizedOn February 1, 2024, the Company announced that its Board of Directors had declared a quarterly financial data is as follows:

Fiscal 2017 March 31,  June 30,  September 29,  December 29, 
(In thousands, except per share data) 2017  2017  2017  2017 
             
Revenues before reimbursements $80,467  $84,120  $82,359  $82,718 
Revenues  84,122   87,840   87,555   88,282 
Operating income  14,634   20,317   19,305   17,795 
Income before income taxes  17,410   22,348   22,030   20,721 
                 
Net income (loss) $16,576  $13,791  $14,643  $(3,705)(1)
                 
Net income per share                
Basic $0.63  $0.52  $0.56  $(0.14)
Diluted $0.61  $0.51  $0.54  $(0.14)
Shares used in per share computations                
Basic  26,302   26,415   26,370   26,363 
Diluted  26,981   26,968   26,963   26,363 

Fiscal 2016 April 1,  July 1,  September 30,  December 30, 
(In thousands, except per share data) 2016  2016  2016  2016 
             
Revenues before reimbursements $78,950  $73,334  $74,160  $72,753 
Revenues  83,156   77,295   77,612   77,013 
Operating income  16,436   14,931   15,595   14,949 
Income before income taxes  17,734   16,677   17,920   16,791 
                 
Net income $15,350  $10,453  $11,289  $10,388 
                 
Net income per share                
Basic $0.58  $0.39  $0.43  $0.40 
Diluted $0.56  $0.38  $0.42  $0.39 
Shares used in per share computations                
Basic  26,513   26,631   26,545   26,262 
Diluted  27,239   27,264   27,185   26,955 

(1)     The decrease in net income and diluted earningscash dividend of $0.28 per share duringto be paid on March 22, 2024 to all common stockholders of record as of March 8, 2024. The Company's Board of Directors also authorized an additional $61,600,000 for the fourth quarter of 2017 was due to the impactrepurchase of the new tax legislation. During the fourth quarter of 2017, the Company recorded a tax expense of $16,507,000 related to the new tax legislation signed into law during the fourth quarter of 2017. The Company has domestic deferred tax assets primarily associated with its deferred compensation plan and stock-based compensation program, which were previously valued at the federal corporate income tax rate of 35%. The Company’s deferred tax assets were re-measured at the lower enacted corporate tax rate of 21% which contributed $15,137,000 to the increase in income tax associated with the new tax legislation. The Company also has foreign earnings that were subject to the mandatory repatriation tax. The total mandatory repatriation tax, net of the benefit of its foreign tax credits, contributed $1,370,000 to the increase in income tax expense associated with the tax legislation.Company's common stock.

60

63


Schedule II

Valuation and Qualifying Accounts

 

 

 

 

 

Additions

 

 

Deletions (1)

 

 

 

 

(In thousands)

 

Balance at
Beginning
of Year

 

 

Provision
Charged to
Expense

 

 

Provision
Charged to
Revenues

 

 

Accounts
Written-
off Net of
Recoveries

 

 

Balance
at End
of Year

 

Year Ended December 29, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for bad debt

 

$

1,239

 

 

$

856

 

 

$

 

 

$

(933

)

 

$

1,162

 

Allowance for contract losses

 

$

4,954

 

 

$

 

 

$

2,368

 

 

$

(3,203

)

 

$

4,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for bad debt

 

$

973

 

 

$

455

 

 

$

 

 

$

(189

)

 

$

1,239

 

Allowance for contract losses

 

$

3,450

 

 

$

 

 

$

2,626

 

 

$

(1,122

)

 

$

4,954

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for bad debt

 

$

879

 

 

$

454

 

 

$

 

 

$

(360

)

 

$

973

 

Allowance for contract losses

 

$

3,116

 

 

$

 

 

$

1,505

 

 

$

(1,171

)

 

$

3,450

 

     Additions  

Deletions(1)

    
           Accounts    
  Balance at  Provision  Provision  Written-off  Balance 
  Beginning of  Charged to  Charged to  Net of  at End of 
(In thousands) Year  Expense  Revenues  Recoveries  Year 
Year Ended December 29, 2017                    
Allowance for bad debt $923  $473  $-  $(479) $917 
Allowance for contract losses $2,494  $-  $2,033  $(1,918) $2,609 
                     
Year Ended December 30, 2016                    
Allowance for bad debt $838  $443  $-  $(358) $923 
Allowance for contract losses $1,954  $-  $2,009  $(1,469) $2,494 
                     
Year Ended January 1, 2016                    
Allowance for bad debt $1,016  $284  $-  $(462) $838 
Allowance for contract losses $2,370  $-  $645  $(1,061) $1,954 

(1)
Balance includes currency translation adjustments.

Recoveries of accounts receivable previously written off were $84,000, $114,000$181,000, $11,000 and $7,000$23,000 for fiscal years 2017, 20162023, 2022 and 2015,2021, respectively.

Schedules other than above have been omitted since they are either not required, not applicable, or the information is otherwise included in the Report.Annual Report on Form 10-K.

61

64


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

EXPONENT, INC.
(Registrant)
Date: February 23, 2018/s/ Richard L. Schlenker, Jr.

Richard L. Schlenker, Jr., Executive Vice President,

Chief Financial Officer and Corporate Secretary

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

SignatureTitleDate
/s/ Paul R. JohnstonChief Executive Officer and DirectorFebruary 23, 2018
Paul R. Johnston, Ph.D. (Principal Executive Officer)
/s/ Richard L. Schlenker, Jr.Executive Vice President, Chief Financial Officer andFebruary 23, 2018
Richard L. Schlenker, Jr.Corporate Secretary (Principal Financial and Accounting Officer)
/s/ Michael R. GaulkeChairman of the Board of DirectorsFebruary 23, 2018
Michael R. Gaulke
/s/ Carol LindstromDirectorFebruary 23, 2018
Carol Lindstrom
/s/ Karen A. RichardsonDirectorFebruary 23, 2018
Karen A. Richardson
/s/ John B. ShovenDirectorFebruary 23, 2018
John B. Shoven, Ph.D.
/s/ Debra L. ZumwaltDirectorFebruary 23, 2018
Debra L. Zumwalt

62

EXHIBIT INDEX

The following exhibits are filed as part of, or incorporated by reference into (as indicated parenthetically), the Annual Report on Form 10-K. Unless otherwise indicated all filings are under SEC File Number 000-18655:

3.1(i)

Restated Certificate of Incorporation of the Company (incorporated by reference from the Company’s Registration Statement on Form S-1 as filed on June 25, 1990, registration number 33-35562). (P)

3.1(ii)

Certificate of Amendment of Restated Certificate of Incorporation dated January 30, 1998.

    3.1(iii)

Certificate of Amendment of Restated Certificate of Incorporation of the Company (incorporated by reference from the Company’s Current Report on Form 8-K filed on May 24, 2006).

3.1(iii)

    3.1(iv)

Certificate of Amendment of Restated Certificate of Incorporation of the Company (incorporated by reference from the Company’s Current Report on Form 8-K filed on May 28, 2015).

3.2(i)

    3.1(v)

Certificate of Amendment of Restated Certificate of Incorporation of the Company (incorporated by reference from the Company’s Current Report on Form 8-K filed on May 31, 2018).

    3.2(i)

Amended and Restated Bylaws of the Company, as amended and restated May 29, 2014December 15, 2022 (incorporated by reference from the Company’s Current Report on Form 8-K as filed on May 30, 2014)December 19, 2022).

4.1

Specimen copy of Common Stock Certificate of the Company (incorporated by reference from the Company’s Registration Statement on Forms S-1 as filed on June 25, 1990, registration number 33-35562). (P)

*10.6

  *4.2

Exponent, Inc. 1998 Non Statutory Stock Option Plan dated October 24, 1998Description of the Registrant’s Securities (incorporated by reference from the Company’s Annual Report on FormFrom 10-K for the fiscal year ended January 1, 1999)2021).

*10.10

  10.15

Exponent, Inc. 1999 Stock Option Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999).

*10.11Exponent, Inc. 1999 Restricted Stock Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999).
10.15Commercial Lease No. 03-53542 between the Company and the Arizona State Land Department, effective January 17, 1998 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 3, 2003).

*10.17

Exponent Nonqualified Deferred Compensation Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).

*10.18

Amended and Restated Nonqualified Deferred Compensation Plan dated January 1, 2022 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021)

*10.19

Form of Indemnification Agreement entered into or proposed to be entered into between the Company and its officers and directors (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2006).

10.20

Services Agreement between the Company and Exponent Engineering P.C. (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the fiscal period ended March 31, 2006).

*10.2410.28

Amendment No. 1 to Exponent, Inc. 1998 Nonstatutory Stock Option Plan dated January 29, 2007 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2006).

*10.25Amendment No. 1 to Exponent, Inc. 1999 Stock Option Plan dated January 29, 2007 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2006).
*10.26Amendment No. 1 to Exponent, Inc. 1999 Restricted Stock Plan dated January 29, 2007 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2006).
*10.282008 Employee Stock Purchase Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).

63

*10.31

Form of Restricted Stock Unit Employee Bonus Grant Agreement under the 2008 Equity Incentive Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).

*10.32

Form of Restricted Stock Unit Employee Matching Grant Agreement under the 2008 Equity Incentive Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).

*10.33

Form of Restricted Stock Unit Director Grant Agreement under the 2008 Equity Incentive Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).

65


*10.3410.37

Amended and Restated Restricted Stock Unit Bonus Grant Agreement under the 1999 Restricted Stock Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).

*10.35Amended and Restated Restricted Stock Unit Matching Grant Agreement under the 1999 Restricted Stock Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).
*10.36Amended and Restated Restricted Stock Unit Director Grant Agreement under the 1999 Restricted Stock Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2009).
*10.37Exponent, Inc. Amended and Restated 2008 Equity Incentive Plan (filed as Appendix A to the Company’s Schedule 14A filed on April 19, 2012).

*10.38

Exponent, Inc. 401(k) Savings Plan, as amended and restated effective January 1, 20102014 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010)January 1, 2021).

*10.39

First Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2010) (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the fiscal period ended July 1, 2011).

*10.40Second Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2010)2014) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2011)January 1, 2021).

*10.40

Second Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2021).

*10.41

Form of Stock Option Agreement under the 2008 Equity Incentive Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2011).

*10.4210.43

Third Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2010) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2012).

*10.43Amendment to Form of Stock Option Agreement under the 2008 Equity Incentive Plan (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2012).

*10.4410.45

Fourth Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2010) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 3, 2014).

*10.45Form of Indemnification Agreement entered into or proposed to be entered into between the Company and its officers and directors (incorporated by reference from the Company’s Current Report on Form 8-K as filed on May 30, 2014).

64

*10.46

Executive Compensation Clawback Policy (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the fiscal period ended September 30, 2016).

*10.47

Exponent, Inc. Amended and Restated 2008 Equity Incentive Plan (filed as Appendix A to the Company’s Schedule 14A on April 18, 2017).

*10.48

Exponent, Inc. Amended and Restated 2008 Employee Stock Purchase Plan (filed as Appendix B to the Company’s Schedule 14A on April 18, 2017).

21.1

List of subsidiaries.

23.1

Consent of Independent Registered Public Accounting Firm.

31.1

Certification of Chief Executive Officer pursuant to Rule 13a – 14(a) of the Securities Exchange Act of 1934.

31.2

Certification of Chief Financial Officer pursuant to Rule 13a – 14(a) of the Securities Exchange Act of 1934.

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

101.INS

  97.01

Exponent, Inc. Incentive Compensation Recovery Policy

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Schema DocumentDocument.

101.CAL

Inline XBRL Taxonomy Calculation Linkbase DocumentDocument.

101.LAB

Inline XBRL Taxonomy Label Linkbase DocumentDocument.

101.PRE

Inline XBRL Taxonomy Presentation Linkbase DocumentDocument.

101.DEF

Inline XBRL Taxonomy Definition Linkbase DocumentDocument.

Exhibit 104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

* Indicates management compensatory plan, contract or arrangement

66


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

65

EXPONENT, INC.

(Registrant)

Date: February 23, 2024

By:

/s/ Richard L. Schlenker, Jr.

Richard L. Schlenker, Jr., Executive Vice President,

Chief Financial Officer and Corporate Secretary

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

Signature

Title

Date

/s/ Catherine Ford Corrigan

Chief Executive Officer and Director

February 23, 2024

Catherine Ford Corrigan, Ph.D.

(Principal Executive Officer)

/s/ Richard L. Schlenker, Jr.

Executive Vice President, Chief Financial Officer and Corporate Secretary (Principal Financial and Accounting Officer)

February 23, 2024

Richard L. Schlenker, Jr.

/s/ Paul R. Johnston

Chairman of the Board of Directors

February 23, 2024

Paul R. Johnston, Ph.D.

/s/ George Brown

Director

February 23, 2024

George Brown

/s/ Carol Lindstrom

Director

February 23, 2024

Carol Lindstrom

/s/ Karen Richardson

Director

February 23, 2024

Karen Richardson

/s/ Debra L. Zumwalt

Director

February 23, 2024

Debra L. Zumwalt

67